GO,Function,Proteins,Gene Name,Ontology group,Count of protein,Number of proteins detected within the genome,GO frequency within the dataset (%),GO frequency within the genome (%),P-Value,P-Values_BH
GO:0005576,extracellular region,E1BPW0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P00741(Evidence code:IEA/Database source:InterPro:IPR000294|I)Q29RU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P56652(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P13384(Evidence code:IEA/Database source:InterPro:IPR000867|I)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P60986(Evidence code:IEA/Database source:InterPro:IPR007990)P35445(Evidence code:IEA/Database source:InterPro:IPR008859)P49259(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P18915(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A5D7S8(Evidence code:IEA/Database source:InterPro:IPR000020)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)O18739(Evidence code:IEA/Database source:InterPro:IPR000867)Q8MJ24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P55906(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P19159(Evidence code:IEA/Database source:InterPro:IPR001400|I)Q8SPF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P50291(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P00743(Evidence code:IEA/Database source:InterPro:IPR000294|I)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P39873(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BG25(Evidence code:IEA/Database source:InterPro:IPR018195)A5D7V3(Evidence code:IEA/Database source:InterPro:IPR000867)Q3T004(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q28019(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)O02659(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A6QQ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A5D7R1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q32L50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A6QQ95(Evidence code:IEA/Database source:UniProtKB:Q92876|ens)P00978(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q05443(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q3SYW2(Evidence code:IEA/Database source:InterPro:IPR011360)Q2KJ63(Evidence code:IEA/Database source:InterPro:IPR000177)F1MW38(Evidence code:IEA/Database source:InterPro:IPR000867)Q3Y5Z3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A2VE29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P21793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P98140(Evidence code:IEA/Database source:InterPro:IPR000083)Q58D84(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BI98(Evidence code:IEA/Database source:UniProtKB:P12109|ens)P58073(Evidence code:IEA/Database source:InterPro:IPR001415|I)P80109(Evidence code:IEA/Database source:InterPro:IPR001028)E1BFD0(Evidence code:IBA/Database source:PANTHER:PTN000126434)A7YWG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A6QR11(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1B805(Evidence code:IEA/Database source:InterPro:IPR000020|I)A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P35541(Evidence code:IEA/Database source:InterPro:IPR000096)A1A4K5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q58D62(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q05718(Evidence code:IEA/Database source:InterPro:IPR000867|I)F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens)G3MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P52176(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q3SWW8(Evidence code:IEA/Database source:InterPro:IPR008859)Q3T0Z0(Evidence code:IEA/Database source:InterPro:IPR008197)Q95M17(Evidence code:IEA/Database source:InterPro:IPR002557)Q05717(Evidence code:IEA/Database source:InterPro:IPR000867|I)E1BF81(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q5GN72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P16368(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q0VCG9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A4FUZ9(Evidence code:IEA/Database source:InterPro:IPR000074)P19879(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P17453(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A5PKI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P49907(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)O19116(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A7MB70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q3T0A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q2KIV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A6QLI0(Evidence code:IEA/Database source:InterPro:IPR001299)A5PJT7(Evidence code:IEA/Database source:InterPro:IPR008605)Q9TT36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q3T0K1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)O77482(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964), ENTPD5 F9 C6 ITIH3 IGFBP2 GALNT1 PIP COMP PLA2R1 CA6 FBLN1 ANG2 CTGF LOXL4 BMP3 TGFBI CSH2 BPIFB1 FST F10 MMP2 BRN MELTF ESM1 APCS LTBP2 PPT1 MBL BTD TNFRSF11B SBSPON KLK6 AMBP LUM HPSE C2 KLKB1 CRIM1 ADIPOQ CPQ ITIH5 DCN F12 FSTL1 COL6A1 PTHLH GPLD1 CHI3L2 GGH NELL2 LOC528040 IL34 SAA1 ENPP2 FETUB IGFBP6 CLSTN1 AFM FURIN MMP9 THBS4 WFDC2 CHIA IGFBP5 SERPINA6 agp TIMP2 PTX3 APOA5 OGN BPI FAM3C SELENOP SFRP1 SEMA3C CFD C1QB EPDR1 ECM1 SERPINA7 CALU IL1RN,CC,82,82 of 300,22.16,27.33,1.971E-73,3.28E-70
GO:0005615,extracellular space,Q9TT36(Evidence code:IEA/Database source:InterPro:IPR000215)Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens)Q58D62(Evidence code:IEA/Database source:InterPro:IPR001363)Q95M17(Evidence code:ISS/Database source:UniProtKB:Q9BZP6)O19116(Evidence code:IDA/Database source:)Q8SPF8(Evidence code:IEA/Database source:InterPro:IPR021193)P58073(Evidence code:IBA/Database source:PANTHER:PTN000425409)E1BIR5(Evidence code:IEA/Database source:UniProtKB:O75339|ens)A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens)A7YWG4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q58DL9(Evidence code:IEA/Database source:InterPro:IPR030675)P13384(Evidence code:ISS/Database source:UniProtKB:P18065)A5PJ69(Evidence code:IEA/Database source:InterPro:IPR000215)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens)P98140(Evidence code:IEA/Database source:InterPro:IPR014394)P52176(Evidence code:ISS/Database source:UniProtKB:P14780)P00741(Evidence code:ISS/Database source:UniProtKB:P00740)A1A4K5(Evidence code:ISS/Database source:UniProtKB:Q13822)Q5GN72(Evidence code:IEA/Database source:InterPro:IPR001500)E1B805(Evidence code:IEA/Database source:InterPro:IPR011626)P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens)G3MYZ3(Evidence code:IEA/Database source:InterPro:IPR000264|I)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646)Q5EA85(Evidence code:IBA/Database source:PANTHER:PTN000744245)A6QQ07(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BF81(Evidence code:IEA/Database source:InterPro:IPR000215)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848)Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2)Q2KJ63(Evidence code:IEA/Database source:UniProtKB:P03952|ens)P62326(Evidence code:IDA/Database source:)G3X6G7(Evidence code:IEA/Database source:UniProtKB:Q8VE43|ens)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens)Q05718(Evidence code:IBA/Database source:PANTHER:PTN000167605)Q0VCU3(Evidence code:IBA/Database source:PANTHER:PTN000274640)F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens)F1MG91(Evidence code:IEA/Database source:InterPro:IPR000215)A3KLR9(Evidence code:IEA/Database source:UniProtKB:O09164|ens)P35541(Evidence code:IBA/Database source:PANTHER:PTN001159395)A5PJT7(Evidence code:IEA/Database source:InterPro:IPR020858)A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens)P80109(Evidence code:IDA/Database source:)E1BCA5(Evidence code:IEA/Database source:InterPro:IPR000215)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens)Q5BIR5(Evidence code:IEA/Database source:InterPro:IPR000215)P16368(Evidence code:IBA/Database source:PANTHER:PTN000931945)P17453(Evidence code:IEA/Database source:InterPro:IPR030675)Q9XSC6(Evidence code:ISS/Database source:UniProtKB:P00565)Q17QB3(Evidence code:IEA/Database source:UniProtKB:Q13510|ens)P19879(Evidence code:IBA/Database source:PANTHER:PTN001224703)G8JKW7(Evidence code:IEA/Database source:InterPro:IPR000215)E1BFD0(Evidence code:IEA/Database source:InterPro:IPR028541)A5D7R1(Evidence code:IEA/Database source:UniProtKB:O00300|ens)O02659(Evidence code:IEA/Database source:UniProtKB:P11226|ens)E1BG25(Evidence code:IEA/Database source:InterPro:IPR016357)Q2KJ64(Evidence code:IEA/Database source:UniProtKB:P05089|ens)Q05717(Evidence code:IBA/Database source:PANTHER:PTN000167605)F1MEW1(Evidence code:IBA/Database source:PANTHER:PTN000744245)Q8MJ24(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q05443(Evidence code:IBA/Database source:PANTHER:PTN001224703)A6QL48(Evidence code:IEA/Database source:InterPro:IPR020415)O77482(Evidence code:IEA/Database source:InterPro:IPR000975|I)Q3SYW7(Evidence code:IEA/Database source:InterPro:IPR001999)A5PK77(Evidence code:IEA/Database source:InterPro:IPR000215), SERPINA7 APCS FETUB CHIA SFRP1 BPIFB1 PTHLH CILP APOA5 GGH PLTP IGFBP2 SERPINA10 BMP3 LMAN2 F12 MMP9 F9 ENPP2 agp LOC528040 CTSL AFM CPQ SEMA4A BTD SERPINA6 ADIPOQ THBS4 KLKB1 TMSB4 METRNL LCAT IGFBP6 CTSF ENPP1 SERPINB2 ECSOD SAA1 ECM1 CTSL1 GPLD1 SERPINI1 SEMA4D SEMA3C SERPINB8 TIMP2 BPI CKM ASAH1 OGN SERPINA3 CHI3L2 TNFRSF11B MBL MELTF ARG1 IGFBP5 SEMA3A LOXL4 LUM IL34 IL1RN SPARCL1 SERPINA11,CC,65,65 of 426,17.57,15.26,3.239E-45,2.695E-42
GO:0016020,membrane,Q2TBL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2TBU3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MME1(Evidence code:IEA/Database source:InterPro:IPR000998)F1MS00(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1MIP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7Z080(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5PJN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MMI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MWN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QLR1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MY87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QLT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VCH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G5E5W4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJD1(Evidence code:IEA/Database source:InterPro:IPR005052)E1BJP8(Evidence code:IEA/Database source:InterPro:IPR002126|I)O62830(Evidence code:ISS/Database source:UniProtKB:P36993)F1ML75(Evidence code:IEA/Database source:UniProtKB:P14778|ens)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1ML49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N780(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9GKR2(Evidence code:IEA/Database source:InterPro:IPR003987|I)A5D7C8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9TTK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N2J8(Evidence code:IEA/Database source:UniProtKB:Q6UX73|ens)E1B8L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9X0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MNL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MUU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P40682(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BMC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5EA03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q1ZYR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7MB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QP36(Evidence code:IEA/Database source:InterPro:IPR005052)P49259(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BKZ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MS76(Evidence code:IEA/Database source:UniProtKB:Q8C341|ens)A7Z047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B969(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1MW38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BEC6(Evidence code:IEA/Database source:InterPro:IPR008078)F1ME33(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1ME65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MUI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7E335(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1B7L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DN1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)P17453(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3MHK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MNS5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MYL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0K1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BEL6(Evidence code:IEA/Database source:InterPro:IPR000998)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G5E626(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P29473(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5EA01(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BD40(Evidence code:IEA/Database source:InterPro:IPR002126|I)A7MAZ2(Evidence code:IEA/Database source:InterPro:IPR006011|I)F1MD95(Evidence code:IEA/Database source:InterPro:IPR002126|I)A5PKH0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8MJ24(Evidence code:IEA/Database source:InterPro:IPR001190|I)Q0VC12(Evidence code:IEA/Database source:InterPro:IPR006977)Q9MYY0(Evidence code:IEA/Database source:InterPro:IPR005199)F1N283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2TBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDS6(Evidence code:IEA/Database source:InterPro:IPR001571|I)P00514(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MJV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MCA2(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1MFJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BKS1(Evidence code:IEA/Database source:InterPro:IPR001050)O02675(Evidence code:ISS/Database source:UniProtKB:Q16555)A8E4Q7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N084(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2TBM9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VC16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q58DR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KIW4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q769I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O62829(Evidence code:ISS/Database source:UniProtKB:P49443)Q3T083(Evidence code:IEA/Database source:InterPro:IPR016093|I), CADM1 GOSR1 PTPRK RET ABCC2 SLC38A10 ERO1A  LRRC15 IL10RB GOLIM4 PVRL4 MGAM FOLH1 GAL3ST3 CNTNAP4 LMAN2L PCDHGA7 PPM1B IL1R1 GPC3 ERAP2 KIAA0319L EPHA7 VCAM1 SEMA4D AOC3 C16orf89 FCAMR GFRA2 NEO1 OR8D4 ATP6AP1 SLMAP TMEM186 GALNT5 GAA CLN5 KTN1 LMAN2 PLA2R1 ST8SIA1 SORT1 SUCO TMEM132A DCHS1 CRIM1 ADGRF1 LOC788438 CKAP4 TDRKH COLEC12 CDH16 OR6C75 TNFRSF21 ERO1B BPI METTL7A ENPP1 CNTNAP5 CALU GALNT1 FURIN NRP2 FKBP1B MMP2 ABCC6 NOS3 B4GAT1  PCDHGB2 STX12 CLSTN1 TOR1AIP2 LOXL4 YIPF3 HPSE XXYLT1 MGC133692 VIPR1 PRKAR1A ADGRG6 PCDHGB1 PTPRG SDC4 DPYSL2 CLEC12A LOC530348 SERAC1 MIA3 SEMA4A DNAJB12 LCAT MET GALNT3 LDLR PPM1A SDF2L1,CC,96,96 of 1837,25.95,5.23,3.896E-29,2.161E-26
GO:0016021,integral component of membrane,F1ME65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2TBU3(Evidence code:IEA/Database source:InterPro:IPR023601)Q5EA03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2TBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394)Q2TBM9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MFJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QLT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VCH4(Evidence code:IEA/Database source:InterPro:IPR009729)G3MWN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5PKH0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BKZ9(Evidence code:IEA/Database source:InterPro:IPR006581)E1B8L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7MAZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MNS5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KIW4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)A2VDS6(Evidence code:IEA/Database source:InterPro:IPR000832|I)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7E335(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7Z047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9TTK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MME1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G5E626(Evidence code:IEA/Database source:InterPro:IPR005292|I)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G5E5W4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2TBL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08DU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N780(Evidence code:IEA/Database source:InterPro:IPR001426)F1MYL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MJV6(Evidence code:IEA/Database source:InterPro:IPR000832|I)F1ME33(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MD95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9GKR2(Evidence code:IEA/Database source:InterPro:IPR008424)Q3MHK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MUI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BEL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BEC6(Evidence code:IEA/Database source:InterPro:IPR000832|I)E1B7L5(Evidence code:IEA/Database source:InterPro:IPR000276|I)A7MB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MMI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q58DR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q17QV5(Evidence code:IEA/Database source:InterPro:IPR029588)F1MIP7(Evidence code:IEA/Database source:InterPro:IPR005292|I)E1BKS1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MNL4(Evidence code:IEA/Database source:InterPro:IPR010560)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BD40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MCA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MY87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N084(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BMC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B969(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MW38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A8E4Q7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P49259(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5EA01(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P40682(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QLR1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VC12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q769I5(Evidence code:IEA/Database source:InterPro:IPR016244)F1ML49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BJP8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08DN1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MUU8(Evidence code:IEA/Database source:InterPro:IPR000276|I)A7Z080(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812), CKAP4 GOSR1 TMEM186 MGC133692 SFRP1 SERAC1 PTPRG FOLH1 GAL3ST3 GOLIM4 TOR1AIP2 SORT1 FCAMR STX12 ENPP1 LCAT MIA3 CLN5 VIPR1 LMAN2L CDH16 TMEM132A AOC3 PTPRK ABCC6 GALNT5 CNTNAP4 CADM1 GALNT1 IL10RB EPHA7 CNTNAP5 ADGRG6 LOC788438 CLSTN1 VCAM1 METTL7A TDRKH NRP2 ADGRF1 OR6C75 KTN1 LRRC15 DNAJB12 TRPM3 ABCC2 SDC4 NEO1 ST8SIA1 PCDHGB2 FURIN LMAN2 LDLR PCDHGB1 MGAM GALNT3 LOC530348 SEMA4A SLMAP DCHS1 COLEC12 CRIM1 CLEC12A PLA2R1 B4GAT1  XXYLT1 ATP6AP1 PVRL4 YIPF3 MET KIAA0319L ERAP2 PCDHGA7 TNFRSF21 OR8D4 SLC38A10,CC,76,76 of 1299,20.54,5.85,1.277E-26,5.314E-24
GO:0005737,cytoplasm,Q0P5H6(Evidence code:IBA/Database source:PANTHER:PTN001871492)A4IF78(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2KJ64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0VD27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P63048(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P58073(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9TS87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4IFD0(Evidence code:IEA/Database source:InterPro:IPR006267)F1MS60(Evidence code:IEA/Database source:UniProtKB:Q80YF9|ens)Q08DY1(Evidence code:IEA/Database source:InterPro:IPR004148)E1BCN3(Evidence code:IEA/Database source:InterPro:IPR013530|I)P51122(Evidence code:ISS/Database source:UniProtKB:P39687)Q5E9A1(Evidence code:ISS/Database source:UniProtKB:Q60817)O62830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZC66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4FUG5(Evidence code:IEA/Database source:InterPro:IPR004148)P00570(Evidence code:IEA/Database source:InterPro:IPR006267)G3X823(Evidence code:IEA/Database source:UniProtKB:Q99PN3|ens)E1BE60(Evidence code:IEA/Database source:InterPro:IPR008025|I)Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens)Q0VD31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0VC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BGS4(Evidence code:IEA/Database source:UniProtKB:P40222|ens)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646)P46446(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694)F1MXK2(Evidence code:IEA/Database source:UniProtKB:Q7Z417|ens)E1BD35(Evidence code:IBA/Database source:PANTHER:PTN000965417)A4Z945(Evidence code:IBA/Database source:PANTHER:PTN000192346)A3KLR9(Evidence code:IBA/Database source:PANTHER:PTN000000113)Q29RY4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MMI6(Evidence code:IBA/Database source:PANTHER:PTN000043893)Q1RMH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q27965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P68138(Evidence code:ISS/Database source:UniProtKB:P08023)P62958(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)O62829(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens)Q95M17(Evidence code:ISS/Database source:UniProtKB:Q91XA9)Q9XSC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5PJH9(Evidence code:IEA/Database source:InterPro:IPR010059)E1B902(Evidence code:IBA/Database source:PANTHER:PTN000684825)P80109(Evidence code:ISS/Database source:UniProtKB:O70362)P68107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164249)A0JN97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)G3N0A1(Evidence code:IEA/Database source:UniProtKB:Q96D09|ens)F1MUI1(Evidence code:IEA/Database source:UniProtKB:Q80VL1|ens)A6QQ95(Evidence code:IEA/Database source:UniProtKB:Q92876|ens)Q2T9V8(Evidence code:IEA/Database source:InterPro:IPR003732)E1BJZ0(Evidence code:IEA/Database source:GO:0039530)P21752(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P21793(Evidence code:IBA/Database source:PANTHER:PTN000043893)E1BFD0(Evidence code:IBA/Database source:PANTHER:PTN001341036)P62964(Evidence code:IEA/Database source:InterPro:IPR031279)P02639(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BMK9(Evidence code:IEA/Database source:UniProtKB:Q9NXG0|ens)Q9XSK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5BIR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P12036|ens)O02675(Evidence code:IEA/Database source:InterPro:IPR011778)Q5PXY7(Evidence code:IEA/Database source:InterPro:IPR031281)P29473(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens)A6QQV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4IFN7(Evidence code:IBA/Database source:PANTHER:PTN000134256)P62326(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963), TBL2 TNFAIP8 ARG1 ENOPH1 UBA52 PTHLH TAGLN Ak5 ARHGAP33 BIN3 PADI4 ANP32A NACA PPM1B AIMP2 ALYREF CRIPT BIN2 AK1 TRIM26 PPP1R14A CARKL FBXL4 SEPT5 TXLNA CPQ ASPA USP10 NUFIP2 RIC8B ZBED8 ECSOD ELAC1 LRRC15 DNAJC2 HSPA1B ACTA1 HINT1 SSB PPM1A PLEK CHIA CKM UPP1 MAP4K2 GPLD1 FKBP1B ERAP2 PRKCD GPRASP2 TDRKH KLK6 DTD1 IFIH1 TMSB10 DCN CHI3L2 CRABP1 S100A1 CNTLN HDGF SERPINB8 NEFH DPYSL2 CRABP2 NOS3 PRKAR1A AFAP1L1 UBE3A TMSB4,CC,70,70 of 1304,18.92,5.37,7.664E-23,2.551E-20
GO:0010951,negative regulation of endopeptidase activity,Q5DPW9(Evidence code:IEA/Database source:GO:0004869)P16368(Evidence code:IEA/Database source:InterPro:IPR015613)Q5BIR5(Evidence code:IEA/Database source:UniProtKB:P50452|ens)E1BCA5(Evidence code:IEA/Database source:GO:0004867)Q58D62(Evidence code:ISS/Database source:UniProtKB:Q9QXC1)E1B805(Evidence code:IEA/Database source:GO:0004866)A6QPK7(Evidence code:IEA/Database source:GO:0004867)F1MW38(Evidence code:IEA/Database source:GO:0004867)A5PJ69(Evidence code:IEA/Database source:GO:0004867)G8JKW7(Evidence code:IEA/Database source:GO:0004867)Q9TT36(Evidence code:IEA/Database source:GO:0004867)A2VE29(Evidence code:IEA/Database source:GO:0004867)I6MS71(Evidence code:IEA/Database source:GO:0004867)P56652(Evidence code:IEA/Database source:GO:0004867)A5PK77(Evidence code:IEA/Database source:GO:0004867)P00978(Evidence code:IEA/Database source:GO:0004867)F1MG91(Evidence code:IEA/Database source:GO:0004867)E1BF81(Evidence code:IEA/Database source:GO:0004867), CST6 TIMP2 SERPINB8 SERPINI1 FETUB LOC528040 PTI CRIM1 SERPINA10 SERPINA3 SERPINA7 ITIH5 ELP ITIH3 SERPINA11 AMBP SERPINB2 SERPINA6,BP,18,18 of 31,4.86,58.06,1.191E-22,3.304E-20
GO:0005509,calcium ion binding,E1BA44(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q3MHJ4(Evidence code:IEA/Database source:InterPro:IPR002048)F1MCA2(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BD40(Evidence code:IEA/Database source:InterPro:IPR002126|I)P00741(Evidence code:IEA/Database source:InterPro:IPR000294|I)A1A4K5(Evidence code:ISS/Database source:UniProtKB:Q13822)A6QR11(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens)Q58D84(Evidence code:IEA/Database source:InterPro:IPR002048)Q28019(Evidence code:IEA/Database source:InterPro:IPR001881|I)P01131(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q3T0K1(Evidence code:IEA/Database source:InterPro:IPR002048|I)A7E335(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q3SYW7(Evidence code:IEA/Database source:InterPro:IPR002048|I)A6QLI0(Evidence code:IEA/Database source:InterPro:IPR001299)F1MD95(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q3SWW8(Evidence code:IEA/Database source:InterPro:IPR001881|I)E1B969(Evidence code:IEA/Database source:InterPro:IPR002126|I)P00743(Evidence code:IEA/Database source:InterPro:IPR000294|I)E1BJP8(Evidence code:IEA/Database source:InterPro:IPR002126|I)A5D7S8(Evidence code:IEA/Database source:InterPro:IPR001881|I)P98140(Evidence code:IEA/Database source:InterPro:IPR001881)Q05JF3(Evidence code:IEA/Database source:InterPro:IPR001393|I)P02639(Evidence code:IEA/Database source:InterPro:IPR001751|I)F1MS00(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens)P35445(Evidence code:IEA/Database source:InterPro:IPR001881|I)O02659(Evidence code:IBA/Database source:PANTHER:PTN001522730)E1BCN3(Evidence code:IEA/Database source:InterPro:IPR013530|I)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR014615), LTBP4 MCFD2 PCDHGB1 PCDHGB2 F9 ENPP2 NELL2 APCS FSTL1 LTBP2 LDLR CALU CDH16 SPARCL1 EPDR1 CLSTN1 THBS4 DCHS1 F10 PCDHGA7 FBLN1 F12 casq1 S100A1 RET GALNT3 COMP MBL PADI4 SULF2,MF,30,30 of 203,8.11,14.78,6.996E-22,1.663E-19
GO:0016787,hydrolase activity,P25975(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q29444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)M5FI38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7YWG4(Evidence code:IEA/Database source:InterPro:IPR011697)Q3T0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7MBI8(Evidence code:IEA/Database source:InterPro:IPR000086|I)P45478(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q17QB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)O02675(Evidence code:IEA/Database source:InterPro:IPR006680)O62829(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6H713(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QNQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5PJS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P00743(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P00741(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0V8B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A4IFS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2T9V8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q17QX0(Evidence code:IEA/Database source:InterPro:IPR000086|I)P80109(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QQ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q95M12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q29RY4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2T9S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P39873(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BJZ0(Evidence code:IEA/Database source:InterPro:IPR006935)Q0VD27(Evidence code:IEA/Database source:InterPro:IPR006439)F1MME1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MNS5(Evidence code:IEA/Database source:InterPro:IPR001604|I)P46446(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KJ64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3SYW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MFJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7MBC0(Evidence code:IEA/Database source:InterPro:IPR006680)O62830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F2X047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T0A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QQ95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P56965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BAU6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001604|I)E1BPW0(Evidence code:IEA/Database source:InterPro:IPR000407)P52176(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P62958(Evidence code:ISS/Database source:UniProtKB:P49773), CTSL MANBA PRSS22 GGH CES2 MMP2 NUDT9 PPT1 ASAH1 DPYSL2 PPM1A LIPA RBBP8 USP10 F10 F9 TPP1 CTSL1 DTD1 GAA F12 NUDT5 GPLD1 BTD LGMN FURIN ELAC1 PGP BRN CPQ IFIH1 ENOPH1 PTPRK KLKB1 ANG2 ENPP1 ASPA HPSE CHIA ARG1 C2 PTPRG AMDHD2 PPM1B LYZ CFD ERAP2 KLK6 DDAH1 INPP5E ENPP2 ENTPD5 MMP9 HINT1,MF,54,54 of 836,14.59,6.46,1.43E-21,2.974E-19
GO:0005886,plasma membrane,G3MXM5(Evidence code:IEA/Database source:UniProtKB:P54826|ens)O02675(Evidence code:IEA/Database source:UniProtKB:A0A1C7CYX9)F1MS60(Evidence code:IEA/Database source:UniProtKB:Q80YF9|ens)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BJP8(Evidence code:IEA/Database source:InterPro:IPR020894)Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens)P00570(Evidence code:IEA/Database source:UniProtKB:Q9R0Y5|ens)P63048(Evidence code:IEA/Database source:UniProtKB:P62987|ens)E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q08DU4(Evidence code:IBA/Database source:PANTHER:PTN000466212)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens)E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)E1BKG4(Evidence code:IEA/Database source:UniProtKB:G1UI16|ens)P00978(Evidence code:ISS/Database source:UniProtKB:P02760)Q5E9X0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)O19116(Evidence code:IDA/Database source:)F1MYJ3(Evidence code:IEA/Database source:UniProtKB:Q9Z2A9|ens)G5E626(Evidence code:IBA/Database source:PANTHER:PTN002384279)P00514(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A6QLR1(Evidence code:IEA/Database source:UniProtKB:K4PZ75|ens)F1MCG9(Evidence code:IEA/Database source:UniProtKB:Q5KSL6|ens)A7E335(Evidence code:IEA/Database source:InterPro:IPR020894|I)P49259(Evidence code:ISS/Database source:UniProtKB:Q13018)E1BD35(Evidence code:IBA/Database source:PANTHER:PTN000276703)E1B7L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q9TTK6(Evidence code:ISS/Database source:UniProtKB:Q16853)F1MNT5(Evidence code:IBA/Database source:PANTHER:PTN002204522)F1ME33(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MUU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BD40(Evidence code:IEA/Database source:InterPro:IPR020894)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens)F1MCA2(Evidence code:IEA/Database source:InterPro:IPR020894)F1MX00(Evidence code:IEA/Database source:UniProtKB:Q5JU67|ens)F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q86SQ4|ens)A5D7C8(Evidence code:IBA/Database source:PANTHER:PTN000112375)F1MNL4(Evidence code:IEA/Database source:UniProtKB:Q92859|ens)A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164501)P29473(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P62958(Evidence code:IEA/Database source:UniProtKB:P49773|ens)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1B969(Evidence code:IEA/Database source:InterPro:IPR020894), GAS1 DPYSL2 ARHGAP33 SEMA4A FURIN PCDHGA7 CADM1 AK1 UBA52 ADGRF1 RET IL10RB SORT1 SULF2 PTPRK PDS5A AMBP GFRA2 SFRP1 GGT5 ABCC6 PRKAR1A PVRL4 DGKK CDH16 PLA2R1 RIC8B OR6C75 AOC3 MUC20 LOC788438 OR8D4 PCDHGB2 GPC3 ENPP1 PCDHGB1 CFAP157 ADGRG6 SEMA4D NEO1 ERAP2 NOS3 HINT1 LDLR DCHS1,CC,45,45 of 630,12.16,7.14,6.098E-20,1.128E-17
GO:0005794,Golgi apparatus,E1BIY5(Evidence code:IEA/Database source:InterPro:IPR014615)P01131(Evidence code:ISS/Database source:UniProtKB:P01130)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q6IRK9)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)Q3T0K1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q3T086(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q0VCH4(Evidence code:IEA/Database source:InterPro:IPR009729)E1BLA8(Evidence code:IEA/Database source:UniProtKB:B3KNK9|ens)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)P29473(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BKK9(Evidence code:IEA/Database source:UniProtKB:Q8VHC3|ens)A5PKI3(Evidence code:IEA/Database source:UniProtKB:Q92520|ens)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q5EA01(Evidence code:ISS/Database source:UniProtKB:O43505)P58073(Evidence code:IEA/Database source:UniProtKB:A0A024RB29)Q0VC12(Evidence code:IEA/Database source:UniProtKB:Q9GZM5|ens)E1BKZ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)F1MNL4(Evidence code:IEA/Database source:UniProtKB:Q92859|ens)Q2TBU3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333), SULF2 LDLR GALNT5 GALNT3 AKAP9 ST8SIA1 CPQ PPT1 CALU TRAPPC6A GAL3ST3 GOLM1 GALNT1 FURIN NOS3 SELENOM FAM3C LMAN2L B4GAT1  PTHLH YIPF3 SORT1 LMAN2 CLN5 NEO1 GOSR1,CC,26,26 of 202,7.03,12.87,6.765E-18,1.126E-15
GO:0005783,endoplasmic reticulum,Q5PXY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)F1ME65(Evidence code:IEA/Database source:UniProtKB:Q07065|ens)Q2TBM9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q6IRK9)F1MW08(Evidence code:IEA/Database source:InterPro:IPR007266|I)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994)Q0P5H6(Evidence code:IEA/Database source:UniProtKB:Q9Y4P3|ens)Q3T0K1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)P63048(Evidence code:IEA/Database source:UniProtKB:P62987|ens)Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2)E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9)A5PJN2(Evidence code:IEA/Database source:InterPro:IPR007266|I)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q3T086(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q58DR2(Evidence code:ISS/Database source:UniProtKB:Q9NXW2)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR014615)A5PKH0(Evidence code:IEA/Database source:UniProtKB:A0A024R957)Q05JF3(Evidence code:IEA/Database source:UniProtKB:P31415|ens)Q0VC16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)P40682(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q3T083(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A6QPT7(Evidence code:IEA/Database source:InterPro:IPR033528)P51122(Evidence code:ISS/Database source:UniProtKB:P39687)E1BKK9(Evidence code:IEA/Database source:UniProtKB:Q8VHC3|ens), CRABP2 CLN5 CKAP4 SERAC1 CPQ ERO1B ADIPOQ TBL2 CALU UBA52 THBS4 ENTPD5 ERO1A  LMAN2L TRAPPC6A DNAJB12 SULF2 TOR1AIP2 casq1 MIA3 ATP6AP1 SDF2L1 ERAP2 ANP32A SELENOM,CC,25,25 of 220,6.76,11.36,3.906E-16,5.908E-14
GO:0004867,serine-type endopeptidase inhibitor activity,I6MS71(Evidence code:IEA/Database source:InterPro:IPR002223|I)E1BF81(Evidence code:IBA/Database source:PANTHER:PTN000156122)A5PK77(Evidence code:IBA/Database source:PANTHER:PTN000156122)F1MG91(Evidence code:IEA/Database source:InterPro:IPR015556)A6QPK7(Evidence code:IEA/Database source:InterPro:IPR002223|I)Q5BIR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0722)P00978(Evidence code:IEA/Database source:InterPro:IPR002223|I)P56652(Evidence code:IEA/Database source:InterPro:IPR010600)A5PJ69(Evidence code:IBA/Database source:PANTHER:PTN000156122)G8JKW7(Evidence code:IBA/Database source:PANTHER:PTN000156122)A2VE29(Evidence code:IEA/Database source:InterPro:IPR010600)E1BCA5(Evidence code:IEA/Database source:UniProtKB:Q99574|ens)Q9TT36(Evidence code:IBA/Database source:PANTHER:PTN000156122)F1MW38(Evidence code:IEA/Database source:InterPro:IPR004094), ELP SERPINA6 SERPINA11 SERPINB2 PTI SERPINB8 AMBP ITIH3 SERPINA10 SERPINA3 ITIH5 SERPINI1 SERPINA7 CRIM1,MF,14,14 of 43,3.78,32.56,3.592E-15,4.98E-13
GO:0006508,proteolysis,Q0V8B6(Evidence code:IEA/Database source:InterPro:IPR030400|I)A4IFS7(Evidence code:IEA/Database source:InterPro:IPR000668)Q3SYW2(Evidence code:IEA/Database source:InterPro:IPR001254|I)I2E4T6(Evidence code:IEA/Database source:GO:0004252)A8E4N2(Evidence code:IEA/Database source:InterPro:IPR001254)M5FI38(Evidence code:IEA/Database source:InterPro:IPR001254|I)P98140(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q28193(Evidence code:IEA/Database source:InterPro:IPR000209|I)Q95M12(Evidence code:IEA/Database source:InterPro:IPR001096)A6QQ95(Evidence code:IEA/Database source:InterPro:IPR001254|I)P00743(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q9GLE5(Evidence code:IEA/Database source:InterPro:IPR001818|I)A5PJS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646)A7YWG4(Evidence code:IEA/Database source:GO:0034722)F1MYJ3(Evidence code:IEA/Database source:UniProtKB:P36269|ens)F1N1S6(Evidence code:IEA/Database source:InterPro:IPR001254|I)P52176(Evidence code:IEA/Database source:InterPro:IPR001818|I)A6QPT7(Evidence code:IEA/Database source:InterPro:IPR001930)Q2KJ63(Evidence code:IEA/Database source:InterPro:IPR000177|I)Q3T0A3(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q0VCU3(Evidence code:IEA/Database source:InterPro:IPR000668)P00741(Evidence code:IEA/Database source:InterPro:IPR001254|I)P25975(Evidence code:IEA/Database source:InterPro:IPR000668), TPP1 CTSL1 C2 MASP2 MASP1 PRSS22 F12 FURIN LGMN KLK6 F10 MMP2 USP10 CPQ GGH GGT5 C1RL MMP9 ERAP2 KLKB1 CFD CTSF F9 CTSL,BP,24,24 of 230,6.49,10.43,8.175E-15,1.046E-12
GO:0005634,nucleus,Q9XSK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q8SQ24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N685(Evidence code:IBA/Database source:PANTHER:PTN000284569)Q1RMH9(Evidence code:ISS/Database source:UniProtKB:Q99543)Q2T9V8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SZL4(Evidence code:IEA/Database source:InterPro:IPR016592)E1BIL7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0VD27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P02316(Evidence code:IEA/Database source:InterPro:IPR000079)Q3T0I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694)E1BKG4(Evidence code:IBA/Database source:PANTHER:PTN000292173)Q58DC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BMT1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A6QNQ6(Evidence code:IEA/Database source:InterPro:IPR033594)O62829(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BCN3(Evidence code:IEA/Database source:UniProtKB:Q9UM07|ens)Q0VD31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P62958(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P10881(Evidence code:IEA/Database source:InterPro:IPR002344)P63048(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7E3B5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7MBC0(Evidence code:IBA/Database source:PANTHER:PTN000874110)Q58DR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2M2T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A4IFN7(Evidence code:IEA/Database source:UniProtKB:O08759|ens)G3N0U2(Evidence code:IEA/Database source:InterPro:IPR004367)P46446(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q29RY4(Evidence code:ISS/Database source:UniProtKB:Q9H777)A0JN97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)P58073(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P51122(Evidence code:ISS/Database source:UniProtKB:P39687)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2TBR3(Evidence code:IEA/Database source:InterPro:IPR002164)Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801)F1MXK2(Evidence code:IEA/Database source:UniProtKB:Q7Z417|ens)Q5PXY7(Evidence code:IEA/Database source:InterPro:IPR031281)A2VE56(Evidence code:IEA/Database source:InterPro:IPR004092)F1MIX6(Evidence code:IEA/Database source:UniProtKB:A0A096LNH6)Q3ZC66(Evidence code:IEA/Database source:UniProtKB:Q9P021|ens)E1BNP7(Evidence code:IEA/Database source:InterPro:IPR004979)E1BDZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q5E9A1(Evidence code:ISS/Database source:UniProtKB:Q60817)F1N1D2(Evidence code:IEA/Database source:InterPro:IPR011940)F1N7Q0(Evidence code:IEA/Database source:InterPro:IPR018574)Q28161(Evidence code:IEA/Database source:InterPro:IPR028432), HDGF MYOZ1 JMJD1C DNAJC2 DTD1 NBN ZKSCAN1 ENOPH1 HMGN1 ALYREF ANG2 USP10 PDS5A ORC1 SIX3 RBBP8 PPM1A ZKSCAN2 PADI4 FBXL4 HINT1 SSB UBA52 HPSE ARID4B CTSL MMP2 AMDHD2 DNAJB12 HIST1H2BK UBE3A CCNB3 ASPA ELAC1 PRKCD PPT1 PTHLH ANP32A AIMP2 SET ATF6 NUFIP2 CRABP2 PHF20L1 DOCK1 CRIPT TFAP2D EPC2 NACA DMC1 SLX4 PKP1,CC,52,52 of 1172,14.05,4.44,1.411E-14,1.677E-12
GO:0046872,metal ion binding,Q3T004(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q9TTK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P56965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A0JN97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P52176(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BIL7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BEL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MNS5(Evidence code:IEA/Database source:InterPro:IPR001604|I)G3X823(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P18915(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q08DD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2KJ64(Evidence code:IEA/Database source:InterPro:IPR006035|I)O62830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P16368(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q8MJ24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P02192(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q58DK5(Evidence code:IEA/Database source:InterPro:IPR001731)Q2T9S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P02639(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2T9V8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001604|I)E1BN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P29473(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7MBC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3MHX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0VD27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P00741(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SZT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P46446(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BJZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3T0K1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)O62829(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P19159(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A3KLR9(Evidence code:IEA/Database source:InterPro:IPR001424|I)Q3SYW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q5EA01(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BIY5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q05JF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BBX5(Evidence code:IEA/Database source:InterPro:IPR002888|I)Q0V8B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q29RY4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479), APCS AOC3 DDAH1 PRKCD MMP9 ZKSCAN1 NRP2 ENPP1 TRIM26 CA6 CYP46A1 ARG1 PPM1B TIMP2 ANG2 LOXL4 MB ALAD PGP FURIN S100A1 DTD1 ENPP2 ZKSCAN2 NOS3 AMDHD2 SUOX ERAP2 CAT ENOPH1 F9 CYCT ASPA MMP2 IFIH1 CALU GALNT1 PPM1A CSH2 COLEC12 ECSOD C2 B4GAT1  SULF2 LMAN2L CPQ casq1 AOX2 TPP1 ELAC1,MF,50,50 of 1125,13.51,4.44,3.92E-14,4.349E-12
GO:0030246,carbohydrate binding,Q2HJD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)Q9MYM4(Evidence code:IEA/Database source:InterPro:IPR011013)O02659(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)I2E4T6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)A6QP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)G3MY87(Evidence code:IEA/Database source:InterPro:IPR011013)P49259(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)Q3T004(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)A8E4Q7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)P23805(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430), LMAN2L GAA MBL MASP2 GALNT1 COLEC12 MGAM PLA2R1 GALNT5 APCS CLEC12A CGN1 LMAN2 CNTN2 GALNT3,MF,15,15 of 73,4.05,20.55,1.247E-13,1.22E-11
GO:0005882,intermediate filament,A7YWM2(Evidence code:IEA/Database source:InterPro:IPR001664)Q2KI75(Evidence code:IEA/Database source:InterPro:IPR001664)A6QQQ9(Evidence code:IEA/Database source:InterPro:IPR001664)A4FUZ0(Evidence code:IEA/Database source:InterPro:IPR001664)A5PJJ1(Evidence code:IEA/Database source:InterPro:IPR001664)Q148H8(Evidence code:IEA/Database source:InterPro:IPR001664)A6QP32(Evidence code:IEA/Database source:InterPro:IPR001664)Q148J0(Evidence code:IEA/Database source:InterPro:IPR001664)A1A4M3(Evidence code:IEA/Database source:InterPro:IPR001664)F1MXG6(Evidence code:IEA/Database source:InterPro:IPR001664)G3X7V4(Evidence code:IEA/Database source:InterPro:IPR001664)F1MSQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0403)A3KMY1(Evidence code:IEA/Database source:InterPro:IPR001664), KRT40 KRT222 KRT20 KRT83 KRT33A KRT72 KRT85 KRT34 KRT86 LOC618455 LOC787600 NEFH KRT82,CC,13,13 of 45,3.51,28.89,1.232E-13,1.22E-11
GO:0005764,lysosome,P45478(Evidence code:ISS/Database source:UniProtKB:P50897)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)P01131(Evidence code:ISS/Database source:UniProtKB:P01130)Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773)A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens)P25975(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q1ZYR0(Evidence code:IEA/Database source:InterPro:IPR026138)Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017)A7YWG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)A6QLI0(Evidence code:IEA/Database source:UniProtKB:Q99M71|ens)Q29444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q17QB3(Evidence code:IEA/Database source:InterPro:IPR016699)Q0VCU3(Evidence code:IBA/Database source:PANTHER:PTN000274640)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q6IRK9)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458), PPT1 GAA LDLR TPP1 CTSL1 CTSL CLN5 LGMN GGH EPDR1 MANBA ASAH1 CTSF GPC3 CPQ HPSE,CC,16,16 of 93,4.32,17.2,2.202E-13,2.036E-11
GO:0004252,serine-type endopeptidase activity,I2E4T6(Evidence code:IEA/Database source:InterPro:IPR037571)Q2KJ63(Evidence code:IEA/Database source:InterPro:IPR001254|I)M5FI38(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q0V8B6(Evidence code:IEA/Database source:InterPro:IPR036852)A6QQ95(Evidence code:IEA/Database source:InterPro:IPR001254|I)A8E4N2(Evidence code:IEA/Database source:InterPro:IPR001254)Q3SYW2(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q28193(Evidence code:IEA/Database source:InterPro:IPR000209|I)F1N1S6(Evidence code:IEA/Database source:InterPro:IPR001254|I)P00743(Evidence code:IEA/Database source:InterPro:IPR001254|I)P98140(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q3T0A3(Evidence code:IEA/Database source:InterPro:IPR001254|I)P00741(Evidence code:IEA/Database source:InterPro:IPR001254|I), MASP2 KLKB1 PRSS22 TPP1 KLK6 MASP1 C2 FURIN C1RL F10 F12 CFD F9,MF,13,13 of 57,3.51,22.81,1.625E-12,1.423E-10
GO:0010469,regulation of signaling receptor activity,P58073(Evidence code:IEA/Database source:GO:0005179)P19159(Evidence code:IEA/Database source:GO:0005179)A6QL48(Evidence code:IEA/Database source:GO:0005125)P22444(Evidence code:IEA/Database source:GO:0005125)P19879(Evidence code:IEA/Database source:GO:0008083)G3X6G7(Evidence code:IEA/Database source:GO:0005179)Q3Y5Z3(Evidence code:IEA/Database source:GO:0005179)Q9XSK7(Evidence code:IEA/Database source:GO:0008083)O77482(Evidence code:IEA/Database source:GO:0005125)Q3SWW8(Evidence code:IEA/Database source:GO:0008083), PTHLH CSH2 IL34 BMP3 OGN METRNL ADIPOQ HDGF IL1RN THBS4,BP,10,10 of 22,2.7,45.45,2.044E-12,1.7E-10
GO:0007399,nervous system development,Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)A7MB70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens)E1BJP8(Evidence code:IBA/Database source:PANTHER:PTN001932250)E1BD40(Evidence code:IBA/Database source:PANTHER:PTN001932250)E1BEL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)O02675(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024)E1BPC9(Evidence code:IEA/Database source:InterPro:IPR032991)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524), TPP1 PPT1 SEMA3C RET PCDHGA7 PCDHGB2 NRP2 DPYSL2 NEO1 CNTN2 SEMA4A,BP,11,11 of 36,2.97,30.56,5.519E-12,4.373E-10
GO:0009986,cell surface,P49259(Evidence code:IEA/Database source:UniProtKB:Q13018|ens)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens)Q9TTK6(Evidence code:ISS/Database source:UniProtKB:Q16853)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)F1MIP7(Evidence code:IEA/Database source:UniProtKB:Q92887|ens)P01131(Evidence code:ISS/Database source:UniProtKB:P01130)E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR014615)F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens)F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens), PLA2R1 CNTN2 IL1R1 AOC3 ADIPOQ PTPRK ABCC2 LDLR MELTF SORT1 SULF2 CLSTN1 ENPP1 LMAN2,CC,14,14 of 94,3.78,14.89,3.724E-11,2.817E-09
GO:0010466,negative regulation of peptidase activity,P16368(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)P56652(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)Q5DPW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)Q3ZBZ6(Evidence code:IEA/Database source:GO:0060422)Q58D62(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)Q5BIR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)Q3T0Z0(Evidence code:IEA/Database source:GO:0030414)A2VE29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)P00978(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q16610|ens), TIMP2 ITIH3 CST6 GPC3 FETUB SERPINB8 WFDC2 ITIH5 AMBP ECM1,BP,10,10 of 32,2.7,31.25,4.192E-11,3.033E-09
GO:0007155,cell adhesion,A6QLR1(Evidence code:IEA/Database source:InterPro:IPR033320)O18739(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)Q3SWW8(Evidence code:IEA/Database source:InterPro:IPR003367|I)A0A0M3T9B6(Evidence code:IEA/Database source:InterPro:IPR002038|I)P35445(Evidence code:IEA/Database source:InterPro:IPR003367|I)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)E1BD40(Evidence code:IEA/Database source:InterPro:IPR020894)P55906(Evidence code:IEA/Database source:InterPro:IPR032954)E1B969(Evidence code:IEA/Database source:InterPro:IPR020894)E1BJP8(Evidence code:IEA/Database source:InterPro:IPR020894)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)Q28161(Evidence code:IEA/Database source:InterPro:IPR028432)F1MCA2(Evidence code:IEA/Database source:InterPro:IPR020894)A7E335(Evidence code:IEA/Database source:InterPro:IPR020894)Q9GKR2(Evidence code:IEA/Database source:InterPro:IPR008424)Q9TTK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130), PVRL4 CTGF THBS4 OPN COMP PTPRK PCDHGB2 TGFBI DCHS1 PCDHGA7 RET PKP1 PCDHGB1 CDH16 VCAM1 AOC3 HPSE,BP,17,17 of 171,4.59,9.94,1.109E-10,7.69E-09
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024)A7E335(Evidence code:IEA/Database source:InterPro:IPR002126)E1BJP8(Evidence code:IEA/Database source:InterPro:IPR002126)F1MD95(Evidence code:IEA/Database source:InterPro:IPR002126)E1BD40(Evidence code:IEA/Database source:InterPro:IPR002126)E1B969(Evidence code:IEA/Database source:InterPro:IPR002126)F1MS00(Evidence code:IEA/Database source:InterPro:IPR002126)F1MCA2(Evidence code:IEA/Database source:InterPro:IPR002126), CADM1 CDH16 PCDHGA7 CLSTN1 PCDHGB2 DCHS1 RET PCDHGB1,BP,8,8 of 16,2.16,50,1.851E-10,1.232E-08
GO:0008233,peptidase activity,Q0V8B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q95M12(Evidence code:IEA/Database source:InterPro:IPR001096)A5PJS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P52176(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A6QQ95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T0A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P25975(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3SYW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P00741(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P00743(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A4IFS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)M5FI38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645), TPP1 LGMN USP10 MMP9 MMP2 KLKB1 FURIN ERAP2 CPQ KLK6 CFD CTSL C2 F12 F9 F10 CTSL1 PRSS22,MF,18,18 of 205,4.86,8.78,2.09E-10,1.338E-08
GO:0005829,cytosol,F1MX00(Evidence code:IEA/Database source:UniProtKB:Q5JU67|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:A0A024R7T2)P45478(Evidence code:IDA/Database source:)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens)Q5BIR5(Evidence code:IEA/Database source:UniProtKB:P50452|ens)Q29RY4(Evidence code:ISS/Database source:UniProtKB:Q9H777)E1BD35(Evidence code:IEA/Database source:UniProtKB:B7WPL0|ens)E1BIJ5(Evidence code:IEA/Database source:UniProtKB:F8VQG7|ens)F1MIX6(Evidence code:IEA/Database source:UniProtKB:A0A096LNH6)P63048(Evidence code:IEA/Database source:UniProtKB:P62987|ens)A4IFN7(Evidence code:IEA/Database source:UniProtKB:O08759|ens)A5PJS6(Evidence code:IEA/Database source:UniProtKB:Q14694|ens)F1MXK2(Evidence code:IEA/Database source:UniProtKB:Q7Z417|ens)A4IFD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6K8|ens)P58073(Evidence code:IEA/Database source:UniProtKB:A0A024RB29)P62958(Evidence code:IEA/Database source:UniProtKB:P49773|ens)O02675(Evidence code:ISS/Database source:UniProtKB:Q16555)O62830(Evidence code:ISS/Database source:UniProtKB:P36993)Q1ZYR0(Evidence code:IEA/Database source:GO:0042147)P62326(Evidence code:ISS/Database source:UniProtKB:P62328)Q0II26(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)O62829(Evidence code:ISS/Database source:UniProtKB:P49443)E1BF59(Evidence code:IEA/Database source:UniProtKB:Q15149|ens)Q58DK5(Evidence code:IBA/Database source:PANTHER:PTN000156046)Q56JY8(Evidence code:IEA/Database source:UniProtKB:P20290|ens)Q1RMH9(Evidence code:ISS/Database source:UniProtKB:Q99543)E1BMK9(Evidence code:IEA/Database source:UniProtKB:Q9NXG0|ens)E1BBX5(Evidence code:IBA/Database source:PANTHER:PTN000225632)P00570(Evidence code:IEA/Database source:UniProtKB:Q5T9B7|ens)Q2T9S4(Evidence code:IBA/Database source:PANTHER:PTN000445812)Q3T186(Evidence code:IBA/Database source:PANTHER:PTN000232509)F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens)F1ME65(Evidence code:IEA/Database source:UniProtKB:A0A024RBH2)F1N2J8(Evidence code:IEA/Database source:UniProtKB:Q6UX73|ens), CFAP157 RET PPT1 SORT1 SERPINB8 ELAC1 RIC8B N4BP2 DOCK1 UBA52 UBE3A USP10 NUFIP2 Ak5 PTHLH HINT1 DPYSL2 PPM1B CLN5 TMSB4 AIMP2 PPM1A PLEC ALAD BTF3 DNAJC2 CNTLN AOX2 AK1 PGP RPIA SLX4 CKAP4 C16orf89,CC,34,34 of 769,9.19,4.42,3.222E-10,1.986E-08
GO:0050919,negative chemotaxis,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens)A7MB70(Evidence code:IBA/Database source:PANTHER:PTN000744245)E1BEL6(Evidence code:ISS/Database source:UniProtKB:O35375)Q5EA85(Evidence code:IBA/Database source:PANTHER:PTN000744245)A5D7C8(Evidence code:IBA/Database source:PANTHER:PTN000744245)F1N780(Evidence code:IEA/Database source:GO:0045499), SEMA3A SEMA3C NRP2 SEMA4A SEMA4D EPHA7,BP,6,6 of 4,1.62,150,4.495E-10,2.671E-08
GO:0005622,intracellular,Q9MYY0(Evidence code:IBA/Database source:PANTHER:PTN001024080)F1MCG9(Evidence code:IEA/Database source:GO:0035556)L8B5P3(Evidence code:IEA/Database source:GO:0035556)F1MJV6(Evidence code:IEA/Database source:GO:0007189)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)Q56JZ1(Evidence code:IEA/Database source:InterPro:IPR001380|I)P63048(Evidence code:IEA/Database source:UniProtKB:P62984|ens)E1BN90(Evidence code:IEA/Database source:InterPro:IPR001909|I)E1BIL7(Evidence code:IEA/Database source:InterPro:IPR001909|I)E1B969(Evidence code:IEA/Database source:GO:0035329)E1BEC6(Evidence code:IEA/Database source:GO:0007189)G3X823(Evidence code:IEA/Database source:InterPro:IPR000315)A2VDX0(Evidence code:IEA/Database source:InterPro:IPR002108), HPSE DGKK ADCY10 ADGRG6 LDLR RPL13 UBA52 ZKSCAN2 ZKSCAN1 DCHS1 ADGRF1 TRIM26 TWF2,CC,13,13 of 95,3.51,13.68,4.66E-10,2.674E-08
GO:0006898,receptor-mediated endocytosis,Q8MJ24(Evidence code:IEA/Database source:GO:0005044)A1A4K5(Evidence code:IEA/Database source:GO:0005044)Q864Z4(Evidence code:IEA/Database source:GO:0030229)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)G3MYM8(Evidence code:IEA/Database source:GO:0005044)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)P49259(Evidence code:ISS/Database source:UniProtKB:Q13018-1)Q32L50(Evidence code:IEA/Database source:GO:0005044)F1MNS5(Evidence code:IEA/Database source:GO:0005044), LOXL4 ENPP2 vldlr LDLR PRG4 PPT1 PLA2R1 SBSPON ENPP1,BP,9,9 of 36,2.43,25,2.092E-09,0.000000116
GO:0005524,ATP binding,G5E626(Evidence code:IEA/Database source:InterPro:IPR003439|I)A5D791(Evidence code:IEA/Database source:InterPro:IPR000719)P40682(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1N1D2(Evidence code:IEA/Database source:InterPro:IPR011940|I)Q27965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1B902(Evidence code:IEA/Database source:InterPro:IPR000719|I)F6RF21(Evidence code:IEA/Database source:InterPro:IPR010935|I)F1MCG9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BIJ5(Evidence code:IEA/Database source:UniProtKB:Q86UW6|ens)F1N780(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens)F1MIP7(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1MS00(Evidence code:IEA/Database source:InterPro:IPR000719|I)P00570(Evidence code:IEA/Database source:InterPro:IPR000850|I)A4IFD0(Evidence code:IEA/Database source:InterPro:IPR000850|I)Q9XSC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BJZ0(Evidence code:IEA/Database source:InterPro:IPR006935)Q58DC8(Evidence code:IEA/Database source:InterPro:IPR003959)P68138(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q769I5(Evidence code:IEA/Database source:InterPro:IPR000719|I)A0JN97(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3MHK0(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MSA4(Evidence code:IEA/Database source:InterPro:IPR000330), ABCC6 EIF2AK3 ATP6AP1 DMC1 HSPA1B MAP4K2 SMCHD1 DGKK N4BP2 EPHA7 ENPP1 ABCC2 RET AK1 Ak5 CKM IFIH1 ORC1 ACTA1 MET PRKCD KIF3A RAD54B,MF,23,23 of 403,6.22,5.71,2.207E-09,1.185E-07
GO:0006807,nitrogen compound metabolic process,A6QQ07(Evidence code:IEA/Database source:InterPro:IPR003010),BTD,BP,1,1 of 2021,0.27,0.05,9.014E-09,4.687E-07
GO:0008236,serine-type peptidase activity,P00743(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)M5FI38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)P00741(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)Q3T0A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)Q3SYW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)A6QQ95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)Q0V8B6(Evidence code:IEA/Database source:InterPro:IPR015366)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720), F10 PRSS22 F9 F12 CFD C2 KLKB1 KLK6 TPP1 FURIN,MF,10,10 of 67,2.7,14.93,2.157E-08,0.000001088
GO:0005520,insulin-like growth factor binding,P13384(Evidence code:IEA/Database source:InterPro:IPR000867|I)Q05718(Evidence code:IEA/Database source:InterPro:IPR000867|I)F1MW38(Evidence code:IEA/Database source:InterPro:IPR000867)A5D7V3(Evidence code:IEA/Database source:InterPro:IPR000867)Q05717(Evidence code:IEA/Database source:InterPro:IPR000867|I)O18739(Evidence code:IEA/Database source:InterPro:IPR000867), IGFBP2 IGFBP6 CRIM1 ESM1 IGFBP5 CTGF,MF,6,6 of 12,1.62,50,3.67E-08,0.000001796
GO:0007411,axon guidance,A7MB70(Evidence code:ISS/Database source:UniProtKB:Q62181)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)Q5EA01(Evidence code:IEA/Database source:UniProtKB:Q8BWP8|ens)E1BEL6(Evidence code:IEA/Database source:InterPro:IPR014648|I)F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024)O02675(Evidence code:IEA/Database source:InterPro:IPR030615)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), SEMA3C CNTN2 B4GAT1  NRP2 NEO1 DPYSL2 SEMA3A,BP,7,7 of 24,1.89,29.17,5.295E-08,0.000002517
GO:0038191,neuropilin binding,A7MB70(Evidence code:IBA/Database source:PANTHER:PTN000867406)Q5EA85(Evidence code:IBA/Database source:PANTHER:PTN000709529)A5D7C8(Evidence code:IBA/Database source:PANTHER:PTN000112375)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), SEMA3C SEMA4A SEMA4D SEMA3A,MF,4,4 of 1,1.08,400,8.36E-08,0.000003864
GO:0005518,collagen binding,A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens)P55906(Evidence code:IEA/Database source:InterPro:IPR032954)F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens)P21793(Evidence code:IEA/Database source:InterPro:IPR028549)Q05443(Evidence code:IEA/Database source:UniProtKB:P51884|ens)Q3SYW7(Evidence code:IEA/Database source:InterPro:IPR037641), CTSL1 TGFBI LRRC15 DCN LUM SPARCL1,MF,6,6 of 15,1.62,40,1.041E-07,0.000004684
GO:0055114,oxidation-reduction process,E1BBX5(Evidence code:IEA/Database source:InterPro:IPR002346|I)Q08DD0(Evidence code:IEA/Database source:InterPro:IPR001128|I)E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR004099|I)F1MW08(Evidence code:IEA/Database source:InterPro:IPR007266|I)A5PJN2(Evidence code:IEA/Database source:InterPro:IPR007266|I)A3KLR9(Evidence code:IEA/Database source:InterPro:IPR018152)Q3MHX0(Evidence code:IEA/Database source:InterPro:IPR005066|I)Q8MJ24(Evidence code:IEA/Database source:InterPro:IPR001695|I)Q9TTK6(Evidence code:IEA/Database source:InterPro:IPR000269|I)P00432(Evidence code:IEA/Database source:InterPro:IPR011614|I)E1BD99(Evidence code:IEA/Database source:GO:0070579)P29473(Evidence code:IEA/Database source:InterPro:IPR001094|I)Q3SZT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249), AOX2 CYP46A1 GSR ERO1B ERO1A  ECSOD SUOX LOXL4 AOC3 CAT TET2 NOS3 CYCT,BP,13,13 of 162,3.51,8.02,1.607E-07,0.000007039
GO:0045095,keratin filament,Q148H8(Evidence code:IEA/Database source:InterPro:IPR003054)A3KMY1(Evidence code:IEA/Database source:InterPro:IPR003054)A4FUZ0(Evidence code:IEA/Database source:InterPro:IPR003054)A1A4M3(Evidence code:IEA/Database source:InterPro:IPR003054)G3X7V4(Evidence code:IEA/Database source:InterPro:IPR003054)A6QP32(Evidence code:IEA/Database source:InterPro:IPR003054), KRT72 KRT82 KRT83 KRT86 LOC787600 KRT85,CC,6,6 of 17,1.62,35.29,1.899E-07,0.000008104
GO:0031012,extracellular matrix,Q2TBM9(Evidence code:IEA/Database source:UniProtKB:Q3U213|ens)Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2)A5D7R1(Evidence code:IEA/Database source:UniProtKB:O08712|ens)P52176(Evidence code:IEA/Database source:InterPro:IPR001818|I)P21793(Evidence code:IDA/Database source:)P80109(Evidence code:ISS/Database source:UniProtKB:O70362)Q9GLE5(Evidence code:IEA/Database source:InterPro:IPR001818|I)E1BI98(Evidence code:IEA/Database source:UniProtKB:Q04857|ens)Q05443(Evidence code:ISS/Database source:UniProtKB:P51885)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens)A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q16610|ens), SERAC1 THBS4 TNFRSF11B MMP9 DCN GPLD1 MMP2 COL6A1 LUM CTGF LRRC15 ECM1,CC,12,12 of 137,3.24,8.76,1.969E-07,0.000008192
GO:0016757,"transferase activity, transferring glycosyl groups",E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q29RN2(Evidence code:IEA/Database source:InterPro:IPR002495)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q95KW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)A5PJH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)F1N283(Evidence code:IEA/Database source:InterPro:IPR002495)Q5EA01(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328), GALNT5 GYG1 GALNT1 ST8SIA1 ART3 UPP1 GALNT3 XXYLT1 B4GAT1 ,MF,9,9 of 69,2.43,13.04,0.000000305,0.00001238
GO:0042803,protein homodimerization activity,Q2KIV9(Evidence code:IEA/Database source:UniProtKB:P14106|ens)F6RF21(Evidence code:IEA/Database source:UniProtKB:Q6P5D8|ens)E1BCN3(Evidence code:IEA/Database source:UniProtKB:Q9UM07|ens)P21793(Evidence code:IDA/Database source:)P00978(Evidence code:ISS/Database source:UniProtKB:P02760)A6QQK5(Evidence code:IEA/Database source:UniProtKB:Q8IVH4|ens)Q3Y5Z3(Evidence code:IEA/Database source:UniProtKB:Q15848|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens)Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024)F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646)F1N2J8(Evidence code:IEA/Database source:UniProtKB:Q6UX73|ens)Q2KJ63(Evidence code:IDA/Database source:), C1QB SMCHD1 PADI4 DCN AMBP MMAA ADIPOQ CAT PLEK CADM1 ENPP1 CPQ C16orf89 KLKB1,MF,14,14 of 210,3.78,6.67,4.559E-07,0.00001806
GO:0006915,apoptotic process,Q5EAE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)A6QQQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q3SZT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)A0JN97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)A5D7R1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P62958(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)A4IF78(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P35445(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)A5PJN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q08DN1(Evidence code:IEA/Database source:UniProtKB:O75509|ens), DAP KRT20 CYCT PRKCD TNFRSF11B HINT1 TNFAIP8 CHIA COMP AIMP2 ERO1A  TNFRSF21,BP,12,12 of 151,3.24,7.95,5.182E-07,0.00002005
GO:0071526,semaphorin-plexin signaling pathway,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens)Q769I5(Evidence code:ISS/Database source:UniProtKB:P08581)A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens), SEMA4D SEMA3A MET SEMA3C,BP,4,4 of 3,1.08,133.33,5.745E-07,0.00002173
GO:0030424,axon,F1MEW1(Evidence code:IBA/Database source:PANTHER:PTN000112586)E1BEL6(Evidence code:IEA/Database source:UniProtKB:O35375|ens)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens)F1MME1(Evidence code:IEA/Database source:UniProtKB:P35822|ens)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens), SEMA3A NRP2 CNTN2 DPYSL2 PPT1 TNFRSF21 PTPRK NEFH,CC,8,8 of 56,2.16,14.29,7.379E-07,0.00002729
GO:0045087,innate immune response,Q2KIV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q8SPF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens)A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)G3X823(Evidence code:IEA/Database source:UniProtKB:Q12899|ens)O02659(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q3T0A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q29RU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q3SYW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)G3N342(Evidence code:IBA/Database source:PANTHER:PTN001510949)E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q8R5F7|ens), C1QB BPIFB1 APCS IL34 TRIM26 MBL CFD C6 C2 IGHE IFIH1,BP,11,11 of 131,2.97,8.4,9.164E-07,0.00003315
GO:0034364,high-density lipoprotein particle,P80109(Evidence code:IEA/Database source:UniProtKB-KW:KW-0345)A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens)P35541(Evidence code:IEA/Database source:UniProtKB-KW:KW-0345)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens)Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens), GPLD1 APOA5 SAA1 LCAT PLTP,CC,5,5 of 13,1.35,38.46,0.000001464,0.00005183
GO:0030247,polysaccharide binding,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001212|I)F1MNS5(Evidence code:IEA/Database source:InterPro:IPR001212|I)Q32L50(Evidence code:IEA/Database source:InterPro:IPR001212|I)G3MYM8(Evidence code:IEA/Database source:InterPro:IPR001212|I), ENPP2 ENPP1 SBSPON PRG4,MF,4,4 of 5,1.08,80,0.00000203,0.00007039
GO:0008270,zinc ion binding,P52176(Evidence code:IEA/Database source:InterPro:IPR001818|I)G3X823(Evidence code:IEA/Database source:InterPro:IPR000315)Q9GLE5(Evidence code:IEA/Database source:InterPro:IPR001818|I)Q1LZB8(Evidence code:IEA/Database source:InterPro:IPR006572)E1BJZ0(Evidence code:IEA/Database source:UniRule:UR000401119)F1MTJ4(Evidence code:IEA/Database source:InterPro:IPR001878|I)P18915(Evidence code:IEA/Database source:InterPro:IPR018338|I)E1BD99(Evidence code:IEA/Database source:UniProtKB:Q6N021|ens)P56965(Evidence code:IDA/Database source:)A6QPT7(Evidence code:IEA/Database source:InterPro:IPR014782)A3KLR9(Evidence code:IBA/Database source:PANTHER:PTN000000113)A1A4K5(Evidence code:ISS/Database source:UniProtKB:Q13822)Q58DK5(Evidence code:ISS/Database source:UniProtKB:P13716), MMP9 TRIM26 MMP2 DBF4 IFIH1 PEG10 CA6 TET2 DDAH1 ERAP2 ECSOD ENPP2 ALAD,MF,13,13 of 207,3.51,6.28,0.000002132,0.00007241
GO:0007275,multicellular organism development,A7MB70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A5D7R1(Evidence code:IBA/Database source:PANTHER:PTN000753849)A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)O19116(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)O02675(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BEL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A5PKI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217), SEMA3C TNFRSF11B TNFRSF6B BMP3 AIMP2 SFRP1 SEMA4A ANG2 DPYSL2 NRP2 FAM3C,BP,11,11 of 145,2.97,7.59,0.000002305,0.00007671
GO:0005887,integral component of plasma membrane,F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024)F1MIP7(Evidence code:IEA/Database source:InterPro:IPR030247)E1BD40(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens)P49259(Evidence code:IBA/Database source:PANTHER:PTN000177070)Q08DN1(Evidence code:IEA/Database source:UniProtKB:O75509|ens)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens)Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024)A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)E1BJP8(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1N780(Evidence code:IEA/Database source:InterPro:IPR016257)A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens)A5D7R1(Evidence code:IBA/Database source:PANTHER:PTN000753849), NEO1 ABCC2 PCDHGB2 RET PLA2R1 TNFRSF21 LMAN2 CADM1 TNFRSF6B PCDHGA7 EPHA7 SEMA4D TNFRSF11B,CC,13,13 of 209,3.51,6.22,0.000002355,0.00007684
GO:0030145,manganese ion binding,F1N283(Evidence code:IEA/Database source:UniProtKB:Q3U4G3|ens)O62830(Evidence code:IEA/Database source:InterPro:IPR012911|I)E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens)Q07537(Evidence code:IEA/Database source:UniProtKB:Q10472|ens)O62829(Evidence code:IEA/Database source:InterPro:IPR012911|I), XXYLT1 PPM1B GALNT3 GALNT1 PPM1A,MF,5,5 of 15,1.35,33.33,0.000002599,0.00008159
GO:0006958,"complement activation, classical pathway",G3N342(Evidence code:IBA/Database source:PANTHER:PTN001510949)O02659(Evidence code:IEA/Database source:UniProtKB-KW:KW-0180)Q2KIV9(Evidence code:IEA/Database source:InterPro:IPR037573)Q29RU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0180)Q3SYW2(Evidence code:IEA/Database source:InterPro:IPR037568), IGHE MBL C1QB C6 C2,BP,5,5 of 15,1.35,33.33,0.000002599,0.00008159
GO:0001503,ossification,A5D791(Evidence code:ISS/Database source:UniProtKB:Q9NZJ5)A0A0M3T9B6(Evidence code:IEA/Database source:InterPro:IPR002038|I)P80109(Evidence code:ISS/Database source:UniProtKB:O70362)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)P52176(Evidence code:IEA/Database source:InterPro:IPR028688)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0892), EIF2AK3 OPN GPLD1 CTGF MMP9 BMP3,BP,6,6 of 30,1.62,20,0.000003223,0.00009932
GO:0005044,scavenger receptor activity,Q8MJ24(Evidence code:IEA/Database source:InterPro:IPR001190)G3MYM8(Evidence code:IEA/Database source:InterPro:IPR001212|I)Q32L50(Evidence code:IEA/Database source:InterPro:IPR001212|I)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001212|I)F1MNS5(Evidence code:IEA/Database source:InterPro:IPR001212|I), LOXL4 PRG4 SBSPON ENPP2 ENPP1,MF,5,5 of 16,1.35,31.25,0.000003378,0.0001022
GO:0020037,heme binding,P02192(Evidence code:IEA/Database source:InterPro:IPR000971|I)P00432(Evidence code:IEA/Database source:InterPro:IPR002226|I)Q3SZT9(Evidence code:IEA/Database source:InterPro:IPR002327|I)Q3MHX0(Evidence code:IEA/Database source:InterPro:IPR018506)P29473(Evidence code:IEA/Database source:InterPro:IPR012144)P00978(Evidence code:ISS/Database source:UniProtKB:P02760)Q08DD0(Evidence code:IEA/Database source:InterPro:IPR001128|I), MB CAT CYCT SUOX NOS3 AMBP CYP46A1,MF,7,7 of 49,1.89,14.29,0.000003628,0.0001078
GO:0016740,transferase activity,Q0VCH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P00570(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q769I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2KIW4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A0JN97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5EA01(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3MHK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N780(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5E9U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BBP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MCG9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A4IFD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q9XSC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q07537(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B902(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A4IFN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PJH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q95KW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q29RN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808), GAL3ST3 AK1 MET LCAT PRKCD B4GAT1  METTL7A EPHA7 TYW3 GALNT3 DGKK Ak5 CKM ST8SIA1 GALNT5 GALNT1 XXYLT1 MAP4K2 UBE3A UPP1 ART3 RET GYG1,MF,23,23 of 633,6.22,3.63,0.000004186,0.0001222
GO:0008201,heparin binding,Q58D84(Evidence code:IEA/Database source:UniProtKB-KW:KW-0358)O18739(Evidence code:IEA/Database source:UniProtKB-KW:KW-0358)Q28019(Evidence code:IEA/Database source:UniProtKB-KW:KW-0358)Q9XSK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0358)P35445(Evidence code:IEA/Database source:UniProtKB-KW:KW-0358)A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens)Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens), FSTL1 CTGF LTBP2 HDGF COMP APOA5 THBS4,MF,7,7 of 52,1.89,13.46,0.000005178,0.0001472
GO:0016529,sarcoplasmic reticulum,P68107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703)Q3T0K1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703)Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2)Q05JF3(Evidence code:IEA/Database source:UniProtKB:O09165|ens), FKBP1B CALU THBS4 casq1,CC,4,4 of 7,1.08,57.14,0.000005221,0.0001472
GO:0030215,semaphorin receptor binding,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), SEMA4D SEMA3C SEMA3A,MF,3,3 of 1,0.81,300,0.000005848,0.0001622
GO:0016310,phosphorylation,A0JN97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BIJ5(Evidence code:IEA/Database source:GO:0046404)Q1JPE3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1B902(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q769I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q9XSC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4IFD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P00570(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MCG9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1N780(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418), PRKCD RET N4BP2 CARKL MAP4K2 MET CKM Ak5 AK1 DGKK EPHA7,BP,11,11 of 164,2.97,6.71,0.000006946,0.0001895
GO:0005856,cytoskeleton,P21752(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3SYU6(Evidence code:IEA/Database source:InterPro:IPR029974)O02675(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q27965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A6QQV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P12036|ens)P68138(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P29473(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q0VC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P62326(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BF59(Evidence code:IEA/Database source:InterPro:IPR001101|I), TMSB10 CNN2 DPYSL2 HSPA1B AFAP1L1 NEFH ACTA1 NOS3 SEPT5 TMSB4 PLEC,CC,11,11 of 165,2.97,6.67,0.000007331,0.0001968
GO:0043547,positive regulation of GTPase activity,O19116(Evidence code:IMP/Database source:)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)E1BD35(Evidence code:IEA/Database source:GO:0005096)Q5E9C0(Evidence code:IEA/Database source:UniProtKB:Q15404|ens)F1MS60(Evidence code:IEA/Database source:GO:0005096)F1MIX6(Evidence code:IEA/Database source:GO:0005096), SFRP1 SEMA4D RIC8B RSU1 ARHGAP33 DOCK1,BP,6,6 of 36,1.62,16.67,0.000008182,0.0002161
GO:0030414,peptidase inhibitor activity,Q3T0Z0(Evidence code:IEA/Database source:InterPro:IPR008197)A2VE29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)Q5DPW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)Q5BIR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)P00978(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)Q58D62(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)P16368(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)P56652(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646), WFDC2 ITIH5 CST6 SERPINB8 AMBP FETUB TIMP2 ITIH3,MF,8,8 of 80,2.16,10,0.000008381,0.0002179
GO:0005537,mannose binding,P23805(Evidence code:IEA/Database source:UniProtKB-KW:KW-0465)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)O02659(Evidence code:IEA/Database source:InterPro:IPR037570)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens), CGN1 CLN5 MBL LMAN2,MF,4,4 of 9,1.08,44.44,0.00001111,0.0002843
GO:0004653,polypeptide N-acetylgalactosaminyltransferase activity,Q07537(Evidence code:IEA/Database source:EC:2.4.1.41)E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens)E1BKQ9(Evidence code:IEA/Database source:UniProtKB:Q7Z7M9|ens), GALNT1 GALNT3 GALNT5,MF,3,3 of 2,0.81,150,0.00001449,0.0003654
GO:0006955,immune response,Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849)G3MYM8(Evidence code:IEA/Database source:InterPro:IPR001212|I)O77482(Evidence code:IEA/Database source:InterPro:IPR000975)Q29RU4(Evidence code:IEA/Database source:InterPro:IPR001862)P17453(Evidence code:IEA/Database source:InterPro:IPR030181)A6QP79(Evidence code:IEA/Database source:UniProtKB:Q8K4Q8|ens)F1MNS5(Evidence code:IEA/Database source:InterPro:IPR001212|I)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001212|I)A5D7R1(Evidence code:IBA/Database source:PANTHER:PTN000753849)A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q2KIH5(Evidence code:IEA/Database source:InterPro:IPR001862)Q32L50(Evidence code:IEA/Database source:InterPro:IPR001212|I), TNFRSF21 PRG4 IL1RN C6 BPI COLEC12 ENPP1 ENPP2 TNFRSF11B TNFRSF6B C8A SBSPON,BP,12,12 of 214,3.24,5.61,0.00001502,0.0003731
GO:0030968,endoplasmic reticulum unfolded protein response,Q0P5H6(Evidence code:IEA/Database source:UniProtKB:Q9Y4P3|ens)A5D791(Evidence code:ISS/Database source:UniProtKB:Q9NZJ5)A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens)Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801), TBL2 EIF2AK3 ERO1A  ATF6,BP,4,4 of 10,1.08,40,0.00001541,0.000377
GO:0050873,brown fat cell differentiation,P02192(Evidence code:IEA/Database source:UniProtKB:P04247|ens)G3X6G7(Evidence code:IEA/Database source:UniProtKB:Q8VE43|ens)A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994), MB METRNL ERO1A  ADIPOQ,BP,4,4 of 11,1.08,36.36,0.00002082,0.000502
GO:0006954,inflammatory response,Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849)A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)F1MYJ3(Evidence code:IEA/Database source:UniProtKB:Q9Z2A9|ens)A5D7R1(Evidence code:IBA/Database source:PANTHER:PTN000753849)A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q61508|ens)Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)O77482(Evidence code:IEA/Database source:InterPro:IPR000975), TNFRSF21 IL34 GGT5 TNFRSF11B ECM1 CHIA KLKB1 TNFRSF6B IL1RN,BP,9,9 of 121,2.43,7.44,0.00002147,0.0005104
GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848)O62829(Evidence code:ISS/Database source:UniProtKB:P35813)O62830(Evidence code:ISS/Database source:UniProtKB:O75688), USP10 ADIPOQ PPM1A PPM1B,BP,4,4 of 12,1.08,33.33,0.0000275,0.0006446
GO:0001525,angiogenesis,P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)A5D7V3(Evidence code:IEA/Database source:UniProtKB:Q9NQ30|ens)A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)E1BEL6(Evidence code:IEA/Database source:InterPro:IPR014648|I), ANG2 CTGF SEMA4A ESM1 EIF2AK3 MMP2 NRP2,BP,7,7 of 71,1.89,9.86,0.00003313,0.0007656
GO:0007420,brain development,O02675(Evidence code:IEA/Database source:InterPro:IPR030615)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)E1BMT1(Evidence code:IEA/Database source:InterPro:IPR032949)F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens)P45478(Evidence code:ISS/Database source:UniProtKB:P50897), DPYSL2 CLN5 SIX3 EPHA7 PPT1,BP,5,5 of 28,1.35,17.86,0.00003513,0.0008007
GO:0001558,regulation of cell growth,Q05718(Evidence code:IEA/Database source:InterPro:IPR000867)F1MW38(Evidence code:IEA/Database source:InterPro:IPR000867)Q05717(Evidence code:IEA/Database source:InterPro:IPR000867)F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens)P13384(Evidence code:IEA/Database source:InterPro:IPR000867)O18739(Evidence code:IEA/Database source:InterPro:IPR000867)A5D7V3(Evidence code:IEA/Database source:InterPro:IPR000867), IGFBP6 CRIM1 IGFBP5 CLSTN1 IGFBP2 CTGF ESM1,BP,7,7 of 74,1.89,9.46,0.00004231,0.0009514
GO:0090305,nucleic acid phosphodiester bond hydrolysis,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens)A6QNQ6(Evidence code:IEA/Database source:GO:0004518)P80929(Evidence code:IEA/Database source:GO:0004519)E1BIJ5(Evidence code:IEA/Database source:GO:0004519)P39873(Evidence code:IEA/Database source:GO:0004519)A1A4K5(Evidence code:IEA/Database source:GO:0004528), ENPP1 RBBP8 ANG2 N4BP2 BRN ENPP2,BP,6,6 of 51,1.62,11.76,0.00004884,0.00105
GO:0001968,fibronectin binding,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens)A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens)F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens), IGFBP5 CTSL1 LRRC15,MF,3,3 of 4,0.81,75,0.00004987,0.00105
GO:0045721,negative regulation of gluconeogenesis,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994)Q2T9S4(Evidence code:ISS/Database source:UniProtKB:A6NDG6)A5PKI3(Evidence code:IEA/Database source:InterPro:IPR039219), ADIPOQ PGP FAM3C,BP,3,3 of 4,0.81,75,0.00004987,0.00105
GO:0035335,peptidyl-tyrosine dephosphorylation,F1MFJ3(Evidence code:IEA/Database source:GO:0004725)Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8)F1MME1(Evidence code:IEA/Database source:GO:0004725), PTPRG PGP PTPRK,BP,3,3 of 4,0.81,75,0.00004987,0.00105
GO:0005031,tumor necrosis factor-activated receptor activity,A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)A5D7R1(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849), TNFRSF6B TNFRSF11B TNFRSF21,MF,3,3 of 4,0.81,75,0.00004987,0.00105
GO:0007596,blood coagulation,P00743(Evidence code:IEA/Database source:InterPro:IPR012224)P00741(Evidence code:IEA/Database source:InterPro:IPR012224|I)P29473(Evidence code:IEA/Database source:UniProtKB-KW:KW-0094)P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0094)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0094), F10 F9 NOS3 F12 KLKB1,BP,5,5 of 31,1.35,16.13,0.00005422,0.001114
GO:0004197,cysteine-type endopeptidase activity,Q0VCU3(Evidence code:IBA/Database source:PANTHER:PTN000274640)A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694)A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens)Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017)P25975(Evidence code:IBA/Database source:PANTHER:PTN000274640), CTSF USP10 CTSL1 LGMN CTSL,MF,5,5 of 31,1.35,16.13,0.00005422,0.001114
GO:0016301,kinase activity,F1MCG9(Evidence code:IEA/Database source:InterPro:IPR001206)Q769I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4IFD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1N780(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P00570(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1B902(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q9XSC6(Evidence code:IEA/Database source:InterPro:IPR022413|I)Q1JPE3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A0JN97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418), DGKK MET Ak5 RET EPHA7 AK1 MAP4K2 CKM CARKL PRKCD,MF,10,10 of 174,2.7,5.75,0.00006117,0.00123
GO:0007599,hemostasis,P00743(Evidence code:IEA/Database source:UniProtKB-KW:KW-0356)P00741(Evidence code:IEA/Database source:UniProtKB-KW:KW-0356)P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0356)P29473(Evidence code:IEA/Database source:UniProtKB-KW:KW-0356)Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0356), F10 F9 F12 NOS3 KLKB1,BP,5,5 of 32,1.35,15.62,0.0000621,0.00123
GO:0005581,collagen trimer,Q2KIV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)A6QP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)O02659(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)P23805(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q3Y5Z3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176), C1QB COLEC12 MBL CGN1 ADIPOQ,CC,5,5 of 32,1.35,15.62,0.0000621,0.00123
GO:0005198,structural molecule activity,G3X7V4(Evidence code:IEA/Database source:InterPro:IPR001664)A6QP32(Evidence code:IEA/Database source:InterPro:IPR001664)A3KMY1(Evidence code:IEA/Database source:InterPro:IPR001664)A5PJJ1(Evidence code:IEA/Database source:InterPro:IPR001664|I)A1A4M3(Evidence code:IEA/Database source:InterPro:IPR001664)A7YWM2(Evidence code:IEA/Database source:InterPro:IPR001664|I)F1MSQ6(Evidence code:IEA/Database source:UniRule:UR000645361)F1MXG6(Evidence code:IEA/Database source:InterPro:IPR001664|I)Q2KI75(Evidence code:IEA/Database source:InterPro:IPR001664|I)A6QQQ9(Evidence code:IEA/Database source:InterPro:IPR001664|I)A4FUZ0(Evidence code:IEA/Database source:InterPro:IPR001664)Q148H8(Evidence code:IEA/Database source:InterPro:IPR001664)Q148J0(Evidence code:IEA/Database source:InterPro:IPR001664|I), LOC787600 KRT85 KRT82 KRT33A KRT86 KRT40 NEFH LOC618455 KRT222 KRT20 KRT83 KRT72 KRT34,MF,13,13 of 294,3.51,4.42,0.0000709,0.001372
GO:0006334,nucleosome assembly,E1BCN3(Evidence code:IEA/Database source:UniProtKB:Q9Z183|ens)P51122(Evidence code:IBA/Database source:PANTHER:PTN000146837)Q2M2T1(Evidence code:IBA/Database source:PANTHER:PTN000603808)F1MSQ6(Evidence code:IEA/Database source:InterPro:IPR005819)Q2TBR3(Evidence code:IEA/Database source:InterPro:IPR002164), PADI4 ANP32A HIST1H2BK NEFH SET,BP,5,5 of 33,1.35,15.15,0.00007083,0.001372
GO:0005975,carbohydrate metabolic process,Q9MYM4(Evidence code:IEA/Database source:InterPro:IPR000322|I)Q2T9S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)Q95M17(Evidence code:IEA/Database source:InterPro:IPR001223|I)E1BDR2(Evidence code:IEA/Database source:InterPro:IPR000514)Q1JPE3(Evidence code:IEA/Database source:InterPro:IPR018484)Q29444(Evidence code:IEA/Database source:InterPro:IPR006103)E1BFD0(Evidence code:IEA/Database source:InterPro:IPR001223)G3MY87(Evidence code:IEA/Database source:InterPro:IPR000322|I)A7MBC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119), GAA PGP CHIA IDUA CARKL MANBA CHI3L2 MGAM AMDHD2,BP,9,9 of 144,2.43,6.25,0.00007663,0.001466
GO:0007608,sensory perception of smell,F1MUU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)F1ME33(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)E1B7L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552), OR8D4 LOC788438 OR6C75,BP,3,3 of 5,0.81,60,0.0000791,0.001479
GO:0043236,laminin binding,A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q16610|ens)F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens)F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q6F3F9|ens), ECM1 LRRC15 ADGRG6,MF,3,3 of 5,0.81,60,0.0000791,0.001479
GO:0005178,integrin binding,A5D7V3(Evidence code:IEA/Database source:UniProtKB:Q9NQ30|ens)Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens)P55906(Evidence code:IEA/Database source:InterPro:IPR032954)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens), ESM1 THBS4 TGFBI CTGF,MF,4,4 of 17,1.08,23.53,0.00008639,0.001597
GO:0000166,nucleotide binding,Q769I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P40682(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0VC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G5E626(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MCG9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P00514(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MIP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N780(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1B902(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MS00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P68138(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P62958(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A0JN97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4IFD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q9XSC6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P00570(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N1D2(Evidence code:IEA/Database source:InterPro:IPR010995)Q58DC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q9XSK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3MHK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q27965(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547), MET ATP6AP1 SEPT5 ABCC6 DGKK PRKAR1A ABCC2 EPHA7 MAP4K2 RET ACTA1 HINT1 PRKCD Ak5 CKM AK1 DMC1 ORC1 HDGF KIF3A HSPA1B,MF,21,21 of 677,5.68,3.1,0.00009096,0.001663
GO:0000287,magnesium ion binding,F1N283(Evidence code:IEA/Database source:UniProtKB:Q8NBI6|ens)O62830(Evidence code:IEA/Database source:InterPro:IPR012911|I)Q0VD27(Evidence code:IEA/Database source:InterPro:IPR023943)Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8)P00741(Evidence code:IDA/Database source:)O62829(Evidence code:IEA/Database source:InterPro:IPR012911|I), XXYLT1 PPM1B ENOPH1 PGP F9 PPM1A,MF,6,6 of 58,1.62,10.34,0.00009422,0.001704
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,A4IFN7(Evidence code:IEA/Database source:UniProtKB:O08759|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens)P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens), UBE3A CAT SEMA4D DCN,BP,4,4 of 18,1.08,22.22,0.0001046,0.001872
GO:0031995,insulin-like growth factor II binding,Q05718(Evidence code:IBA/Database source:PANTHER:PTN000167605)Q05717(Evidence code:IBA/Database source:PANTHER:PTN000167605)P13384(Evidence code:ISS/Database source:UniProtKB:P12843), IGFBP6 IGFBP5 IGFBP2,MF,3,3 of 6,0.81,50,0.0001176,0.001997
GO:0031994,insulin-like growth factor I binding,Q05718(Evidence code:IBA/Database source:PANTHER:PTN000167605)P13384(Evidence code:ISS/Database source:UniProtKB:P12843)Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens), IGFBP6 IGFBP2 IGFBP5,MF,3,3 of 6,0.81,50,0.0001176,0.001997
GO:0033209,tumor necrosis factor-mediated signaling pathway,A6QPW7(Evidence code:IEA/Database source:GO:0005031)A5D7R1(Evidence code:IEA/Database source:GO:0005031)Q08DN1(Evidence code:IEA/Database source:GO:0005031), TNFRSF6B TNFRSF11B TNFRSF21,BP,3,3 of 6,0.81,50,0.0001176,0.001997
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,P13384(Evidence code:ISS/Database source:UniProtKB:Q9PTH3)Q05717(Evidence code:IBA/Database source:PANTHER:PTN000167605)Q05718(Evidence code:IBA/Database source:PANTHER:PTN000167605), IGFBP2 IGFBP5 IGFBP6,BP,3,3 of 6,0.81,50,0.0001176,0.001997
GO:0001755,neural crest cell migration,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens)E1BEL6(Evidence code:ISS/Database source:UniProtKB:O35375)A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens), RET NRP2 SEMA3C,BP,3,3 of 6,0.81,50,0.0001176,0.001997
GO:0004553,"hydrolase activity, hydrolyzing O-glycosyl compounds",G3MY87(Evidence code:IEA/Database source:InterPro:IPR000322)Q9MYM4(Evidence code:IEA/Database source:InterPro:IPR000322)E1BDR2(Evidence code:IEA/Database source:InterPro:IPR000514)Q95M17(Evidence code:IEA/Database source:InterPro:IPR001579)Q29444(Evidence code:IEA/Database source:InterPro:IPR006103), MGAM GAA IDUA CHIA MANBA,MF,5,5 of 38,1.35,13.16,0.0001295,0.002177
GO:0005654,nucleoplasm,A4IF78(Evidence code:IEA/Database source:UniProtKB:O95379|ens)A4Z945(Evidence code:IEA/Database source:UniProtKB:Q8IZ13|ens)F1N1Q9(Evidence code:IEA/Database source:UniProtKB:A0A090N8N7)A5PJS6(Evidence code:IEA/Database source:UniProtKB:Q14694|ens)F1MXK2(Evidence code:IEA/Database source:UniProtKB:Q7Z417|ens)E1BMK9(Evidence code:IEA/Database source:UniProtKB:Q9NXG0|ens)F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001489025)F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens)E1BKG4(Evidence code:IEA/Database source:UniProtKB:G1UI16|ens)F1MNL4(Evidence code:IEA/Database source:UniProtKB:Q92859|ens)P63048(Evidence code:IEA/Database source:UniProtKB:P62987|ens)P58073(Evidence code:IEA/Database source:UniProtKB:A0A024RB29)A6QNQ6(Evidence code:IEA/Database source:UniProtKB:A0A024RC34), TNFAIP8 ZBED8 PPP1R17 USP10 NUFIP2 CNTLN DMC1 SLX4 PDS5A NEO1 UBA52 PTHLH RBBP8,CC,13,13 of 315,3.51,4.13,0.0001363,0.002268
GO:0030198,extracellular matrix organization,A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens)Q2TBM9(Evidence code:IEA/Database source:UniProtKB:Q3U213|ens)F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)A5D7R1(Evidence code:IEA/Database source:UniProtKB:O08712|ens)A5D7S8(Evidence code:IEA/Database source:InterPro:IPR017048), ERO1A  SERAC1 ERO1B TNFRSF11B FBLN1,BP,5,5 of 39,1.35,12.82,0.0001447,0.002384
GO:0004721,phosphoprotein phosphatase activity,O62830(Evidence code:IEA/Database source:InterPro:IPR012911|I)Q2T9S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)O62829(Evidence code:IEA/Database source:InterPro:IPR012911|I)F1MFJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)F1MME1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904), PPM1B PGP PPM1A PTPRG PTPRK,MF,5,5 of 41,1.35,12.2,0.0001792,0.002924
GO:0006486,protein glycosylation,Q6ZXD2(Evidence code:IEA/Database source:InterPro:IPR001675|I)E1BBP1(Evidence code:IEA/Database source:UniPathway:UPA00378)Q07537(Evidence code:IEA/Database source:UniPathway:UPA00378)Q5EA01(Evidence code:IEA/Database source:UniPathway:UPA00378)E1BKQ9(Evidence code:IEA/Database source:UniPathway:UPA00378)E1BPW0(Evidence code:IEA/Database source:UniPathway:UPA00378), ST8SIA1 GALNT3 GALNT1 B4GAT1  GALNT5 ENTPD5,BP,6,6 of 66,1.62,9.09,0.0001816,0.002933
GO:0030574,collagen catabolic process,P52176(Evidence code:IEA/Database source:InterPro:IPR028688)Q9GLE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0177)A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens), MMP9 MMP2 CTSL1,BP,3,3 of 8,0.81,37.5,0.0002271,0.003566
GO:0046470,phosphatidylcholine metabolic process,P80109(Evidence code:IDA/Database source:)A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439034)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens), GPLD1 APOA5 LCAT,BP,3,3 of 8,0.81,37.5,0.0002271,0.003566
GO:0030073,insulin secretion,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)O77482(Evidence code:IEA/Database source:UniProtKB:P25085|ens)E1BQ21(Evidence code:IEA/Database source:InterPro:IPR039214), FKBP1B IL1RN FAM3B,BP,3,3 of 8,0.81,37.5,0.0002271,0.003566
GO:0007186,G-protein coupled receptor signaling pathway,F1MJV6(Evidence code:IEA/Database source:InterPro:IPR000832|I)A2VDS6(Evidence code:IEA/Database source:InterPro:IPR000832|I)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens)E1B7L5(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1BEC6(Evidence code:IEA/Database source:InterPro:IPR000832|I)E1BD35(Evidence code:IBA/Database source:PANTHER:PTN000965417)F1ME33(Evidence code:IEA/Database source:InterPro:IPR000276|I)O19116(Evidence code:IEA/Database source:GO:0004930)F1MUU8(Evidence code:IEA/Database source:InterPro:IPR000276|I), ADGRG6 VIPR1 SORT1 OR6C75 ADGRF1 RIC8B LOC788438 SFRP1 OR8D4,BP,9,9 of 168,2.43,5.36,0.0002297,0.003572
GO:0003677,DNA binding,A6QNQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q2M2T1(Evidence code:IEA/Database source:InterPro:IPR000558|I)A7E3B5(Evidence code:IEA/Database source:InterPro:IPR001606|I)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A4Z945(Evidence code:IBA/Database source:PANTHER:PTN000192346)F1MSQ6(Evidence code:IEA/Database source:InterPro:IPR005819)F1MXF5(Evidence code:IEA/Database source:InterPro:IPR005539)Q58DC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q9XSK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1N1D2(Evidence code:IEA/Database source:InterPro:IPR011940|I)Q2T9V8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)P02316(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q5E9A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BJZ0(Evidence code:IEA/Database source:InterPro:IPR006935)E1BMT1(Evidence code:IEA/Database source:InterPro:IPR001356|I)Q1RMH9(Evidence code:IEA/Database source:InterPro:IPR009057), RBBP8 HIST1H2BK ARID4B ANG2 ZBED8 NEFH AKAP9 ORC1 HDGF DMC1 DTD1 HMGN1 NACA IFIH1 SIX3 DNAJC2,MF,16,16 of 481,4.32,3.33,0.0002726,0.004199
GO:0006470,protein dephosphorylation,F1MFJ3(Evidence code:IEA/Database source:InterPro:IPR000242)F1MME1(Evidence code:IEA/Database source:InterPro:IPR000242)O62830(Evidence code:IEA/Database source:InterPro:IPR015655)O62829(Evidence code:IEA/Database source:InterPro:IPR015655), PTPRG PTPRK PPM1B PPM1A,BP,4,4 of 24,1.08,16.67,0.0002772,0.004232
GO:0005694,chromosome,E1BLN1(Evidence code:IEA/Database source:UniProtKB:Q62209|ens)F1N1D2(Evidence code:IEA/Database source:UniProtKB:Q61880|ens)Q2M2T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F6RF21(Evidence code:IEA/Database source:InterPro:IPR010935|I)A6QNQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158), SYCP1 DMC1 HIST1H2BK SMCHD1 RBBP8,CC,5,5 of 47,1.35,10.64,0.000321,0.004856
GO:0019901,protein kinase binding,E1BMK9(Evidence code:IEA/Database source:UniProtKB:Q9NXG0|ens)G3N0U2(Evidence code:IEA/Database source:InterPro:IPR015452)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P12036|ens)Q0P5H6(Evidence code:IEA/Database source:UniProtKB:Q9Y4P3|ens)F1MS60(Evidence code:IEA/Database source:UniProtKB:O14559|ens), CNTLN CCNB3 PTPRK DPYSL2 NEFH TBL2 ARHGAP33,MF,7,7 of 106,1.89,6.6,0.0003414,0.005118
GO:0016798,"hydrolase activity, acting on glycosyl bonds",Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)F2X047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q29444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q9MYY0(Evidence code:IEA/Database source:InterPro:IPR005199), CHIA LYZ MANBA GAA HPSE,MF,5,5 of 48,1.35,10.42,0.0003511,0.005216
GO:0018108,peptidyl-tyrosine phosphorylation,F1MS00(Evidence code:IEA/Database source:GO:0004713)Q769I5(Evidence code:IEA/Database source:GO:0004713)F1N780(Evidence code:IEA/Database source:GO:0004713), RET MET EPHA7,BP,3,3 of 10,0.81,30,0.000387,0.005236
GO:0001540,amyloid-beta binding,G3N0A1(Evidence code:IEA/Database source:UniProtKB:Q8BUY8|ens)F1MD95(Evidence code:IEA/Database source:UniProtKB:O94985|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens), GPRASP2 CLSTN1 LDLR,MF,3,3 of 10,0.81,30,0.000387,0.005236
GO:0060666,dichotomous subdivision of terminal units involved in salivary gland branching,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens)A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens), SEMA3A SEMA3C,BP,2,2 of 1,0.54,200,0.0003847,0.005236
GO:1901223,negative regulation of NIK/NF-kappaB signaling,O62829(Evidence code:ISS/Database source:UniProtKB:P35813)O62830(Evidence code:ISS/Database source:UniProtKB:O75688), PPM1A PPM1B,BP,2,2 of 1,0.54,200,0.0003847,0.005236
GO:0043931,ossification involved in bone maturation,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens), SEMA4D DCHS1,BP,2,2 of 1,0.54,200,0.0003847,0.005236
GO:0045499,chemorepellent activity,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), EPHA7 SEMA3A,MF,2,2 of 1,0.54,200,0.0003847,0.005236
GO:0018243,protein O-linked glycosylation via threonine,E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens)Q07537(Evidence code:IEA/Database source:UniProtKB:Q10472|ens), GALNT3 GALNT1,BP,2,2 of 1,0.54,200,0.0003847,0.005236
GO:0009052,"pentose-phosphate shunt, non-oxidative branch",Q3T186(Evidence code:IEA/Database source:InterPro:IPR004788|I)Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens), RPIA CARKL,BP,2,2 of 1,0.54,200,0.0003847,0.005236
GO:0004558,"alpha-1,4-glucosidase activity",Q9MYM4(Evidence code:IEA/Database source:EC:3.2.1.20)G3MY87(Evidence code:IEA/Database source:UniProtKB:B5THE2|ens), GAA MGAM,MF,2,2 of 1,0.54,200,0.0003847,0.005236
GO:0048846,axon extension involved in axon guidance,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens)E1BEL6(Evidence code:IEA/Database source:UniProtKB:O35375|ens), SEMA3A NRP2,BP,2,2 of 1,0.54,200,0.0003847,0.005236
GO:0043569,negative regulation of insulin-like growth factor receptor signaling pathway,E1BIR5(Evidence code:IEA/Database source:UniProtKB:O75339|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens), CILP IGFBP5,BP,2,2 of 1,0.54,200,0.0003847,0.005236
GO:0043025,neuronal cell body,F1MME1(Evidence code:IEA/Database source:UniProtKB:P35822|ens)E1BCA5(Evidence code:IEA/Database source:UniProtKB:O35684|ens)Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens), PTPRK SERPINI1 CRIPT DPYSL2 CNTN2,CC,5,5 of 50,1.35,10,0.0004176,0.005604
GO:0004930,G-protein coupled receptor activity,E1BEC6(Evidence code:IEA/Database source:InterPro:IPR000832|I)A2VDS6(Evidence code:IEA/Database source:InterPro:IPR000832|I)F1MUU8(Evidence code:IEA/Database source:InterPro:IPR000276)O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394)F1MJV6(Evidence code:IEA/Database source:InterPro:IPR000832|I)E1B7L5(Evidence code:IEA/Database source:InterPro:IPR000276)F1ME33(Evidence code:IEA/Database source:InterPro:IPR000276), ADGRF1 VIPR1 OR8D4 SFRP1 ADGRG6 OR6C75 LOC788438,MF,7,7 of 110,1.89,6.36,0.0004213,0.005609
GO:0043169,cation binding,O62829(Evidence code:IEA/Database source:InterPro:IPR000222)O62830(Evidence code:IEA/Database source:InterPro:IPR000222), PPM1A PPM1B,MF,2,2 of 1145,0.54,0.17,0.0004485,0.005924
GO:0000139,Golgi membrane,Q2HJD1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5EA01(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VC16(Evidence code:IEA/Database source:GO:0090110)E1BKQ9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BAU6(Evidence code:IEA/Database source:UniProtKB:Q9JII1|ens)E1BBP1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2TBU3(Evidence code:IEA/Database source:InterPro:IPR023601), LMAN2L ST8SIA1 B4GAT1  MIA3 GALNT5 INPP5E GALNT3 GOSR1,CC,8,8 of 147,2.16,5.44,0.0004539,0.005947
GO:0045599,negative regulation of fat cell differentiation,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848), ENPP1 SORT1 ADIPOQ,BP,3,3 of 11,0.81,27.27,0.0004884,0.006349
GO:0004519,endonuclease activity,P39873(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)A6QNQ6(Evidence code:IEA/Database source:InterPro:IPR033594)Q29RY4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)E1BIJ5(Evidence code:IEA/Database source:UniProtKB:Q86UW6|ens), BRN RBBP8 ELAC1 ANG2 N4BP2,MF,5,5 of 53,1.35,9.43,0.0005347,0.006791
GO:0008234,cysteine-type peptidase activity,P25975(Evidence code:IEA/Database source:InterPro:IPR000668|I)A5PJS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)Q0VCU3(Evidence code:IEA/Database source:InterPro:IPR000668|I)A4IFS7(Evidence code:IEA/Database source:InterPro:IPR000668|I)Q95M12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788), CTSL USP10 CTSF CTSL1 LGMN,MF,5,5 of 53,1.35,9.43,0.0005347,0.006791
GO:0019838,growth factor binding,P13384(Evidence code:IEA/Database source:UniProtKB-KW:KW-0340)Q28019(Evidence code:IEA/Database source:UniProtKB-KW:KW-0340)Q05718(Evidence code:IEA/Database source:UniProtKB-KW:KW-0340)Q05717(Evidence code:IEA/Database source:UniProtKB-KW:KW-0340), IGFBP2 LTBP2 IGFBP6 IGFBP5,MF,4,4 of 29,1.08,13.79,0.0005293,0.006791
GO:0045454,cell redox homeostasis,E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR004099)E1BAG3(Evidence code:IEA/Database source:InterPro:IPR013766)A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens)F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens), GSR TXNDC16 ERO1A  ERO1B,BP,4,4 of 30,1.08,13.33,0.0005945,0.007406
GO:0005507,copper ion binding,E1BM13(Evidence code:IBA/Database source:PANTHER:PTN001255556)Q9TTK6(Evidence code:IEA/Database source:InterPro:IPR000269|I)Q8MJ24(Evidence code:IEA/Database source:InterPro:IPR001695|I)A3KLR9(Evidence code:IBA/Database source:PANTHER:PTN000000113), LACC1 AOC3 LOXL4 ECSOD,MF,4,4 of 30,1.08,13.33,0.0005945,0.007406
GO:0005801,cis-Golgi network,Q3T086(Evidence code:IBA/Database source:PANTHER:PTN000302156)F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens)Q2TBU3(Evidence code:IEA/Database source:InterPro:IPR023601), TRAPPC6A AKAP9 GOSR1,CC,3,3 of 12,0.81,25,0.0006053,0.007406
GO:0050840,extracellular matrix binding,P21793(Evidence code:IEA/Database source:UniProtKB:P28654|ens)P55906(Evidence code:IEA/Database source:InterPro:IPR032954)Q3SYW7(Evidence code:IBA/Database source:PANTHER:PTN001015480), DCN TGFBI SPARCL1,MF,3,3 of 12,0.81,25,0.0006053,0.007406
GO:0043171,peptide catabolic process,A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164249)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646)Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773), ERAP2 CPQ TPP1,BP,3,3 of 12,0.81,25,0.0006053,0.007406
GO:0019221,cytokine-mediated signaling pathway,F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens)O77482(Evidence code:IBA/Database source:PANTHER:PTN000008570)Q08DU4(Evidence code:IEA/Database source:GO:0004920)Q0VC51(Evidence code:IEA/Database source:GO:0004908)P21793(Evidence code:IBA/Database source:PANTHER:PTN000043893)F1MMI6(Evidence code:IBA/Database source:PANTHER:PTN000043893), IL1R1 IL1RN IL10RB IL1RAP DCN LRRC15,BP,6,6 of 86,1.62,6.98,0.0006818,0.008282
GO:0042802,identical protein binding,A6QLR1(Evidence code:IEA/Database source:UniProtKB:Q96NY8|ens)A6QNQ6(Evidence code:IEA/Database source:UniProtKB:Q99708|ens)P62964(Evidence code:IDA/Database source:)A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens)Q05JF3(Evidence code:IEA/Database source:UniProtKB:P31415|ens)A6QQK5(Evidence code:IEA/Database source:UniProtKB:Q8IVH4|ens)Q58DK5(Evidence code:IEA/Database source:UniProtKB:P10518|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)Q3Y5Z3(Evidence code:IEA/Database source:UniProtKB:Q60994|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)P00514(Evidence code:IPI/Database source:UniProtKB:P00514)Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens)E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens), PVRL4 RBBP8 CRABP1 EIF2AK3 casq1 MMAA ALAD LDLR ADIPOQ CAT PRKAR1A APCS IFIH1,MF,13,13 of 379,3.51,3.43,0.0007305,0.008414
GO:0007507,heart development,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens)P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens)P02192(Evidence code:IEA/Database source:UniProtKB:P04247|ens)E1BEL6(Evidence code:ISS/Database source:UniProtKB:O35375), SEMA3C PRKAR1A MB NRP2,BP,4,4 of 32,1.08,12.5,0.0007414,0.008414
GO:0035690,cellular response to drug,P80109(Evidence code:ISS/Database source:UniProtKB:P80108)E1BE60(Evidence code:IEA/Database source:UniProtKB:Q91VC7|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994), GPLD1 PPP1R14A ADIPOQ,BP,3,3 of 13,0.81,23.08,0.0007386,0.008414
GO:0003148,outflow tract septum morphogenesis,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens)E1BEL6(Evidence code:IEA/Database source:UniProtKB:O35375|ens), SEMA3C NRP2,BP,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0010875,positive regulation of cholesterol efflux,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848)Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens), ADIPOQ PLTP,BP,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0018242,protein O-linked glycosylation via serine,E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens)Q07537(Evidence code:IEA/Database source:UniProtKB:Q10472|ens), GALNT3 GALNT1,BP,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0061549,sympathetic ganglion development,E1BEL6(Evidence code:IEA/Database source:UniProtKB:O35375|ens)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), NRP2 SEMA3A,BP,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0033018,sarcoplasmic reticulum lumen,Q05JF3(Evidence code:IEA/Database source:UniProtKB:O09165|ens)Q3T0K1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), casq1 CALU,CC,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0005549,odorant binding,F1MUU8(Evidence code:IBA/Database source:PANTHER:PTN001241937)F1ME33(Evidence code:IBA/Database source:PANTHER:PTN001241937), OR8D4 LOC788438,MF,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0004528,phosphodiesterase I activity,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881)F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens), ENPP2 ENPP1,MF,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0007413,axonal fasciculation,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), CNTN2 SEMA3A,BP,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0019894,kinesin binding,A7MB48(Evidence code:IEA/Database source:InterPro:IPR024854)F1MD95(Evidence code:IEA/Database source:UniProtKB:O94985|ens), KTN1 CLSTN1,MF,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0046007,negative regulation of activated T cell proliferation,Q2KJ64(Evidence code:IEA/Database source:UniProtKB:Q61176|ens)P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens), ARG1 PRKAR1A,BP,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0010792,DNA double-strand break processing involved in repair via single-strand annealing,F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens)A6QNQ6(Evidence code:IEA/Database source:InterPro:IPR033594), SLX4 RBBP8,BP,2,2 of 2,0.54,100,0.0007635,0.008414
GO:0005789,endoplasmic reticulum membrane,Q3T0K1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P40682(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QPT7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q58DR2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6)Q2HJD1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801)A5PJN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MW08(Evidence code:IBA/Database source:PANTHER:PTN000289179)Q3T083(Evidence code:IBA/Database source:PANTHER:PTN000006098), CALU ATP6AP1 ERAP2 DNAJB12 MIA3 LMAN2L ATF6 ERO1A  ERO1B SDF2L1,CC,10,10 of 244,2.7,4.1,0.0007979,0.008735
GO:0003779,actin binding,E1BF59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)A2VDX0(Evidence code:IEA/Database source:InterPro:IPR002108|I)Q9TS87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)P21752(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)P62326(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q3SYU6(Evidence code:IEA/Database source:InterPro:IPR001997|I)Q8SQ24(Evidence code:IBA/Database source:PANTHER:PTN000409135), PLEC TWF2 TAGLN TMSB10 TMSB4 CNN2 MYOZ1,MF,7,7 of 124,1.89,5.65,0.0008251,0.008858
GO:0002020,protease binding,P16368(Evidence code:IBA/Database source:PANTHER:PTN000931945)F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens)A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q16610|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens), TIMP2 IL1R1 ECM1 LDLR,MF,4,4 of 33,1.08,12.12,0.0008238,0.008858
GO:0042593,glucose homeostasis,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994)E1BQ21(Evidence code:IEA/Database source:InterPro:IPR039214)F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), ADIPOQ FAM3B ERO1B IGFBP5,BP,4,4 of 33,1.08,12.12,0.0008238,0.008858
GO:0004713,protein tyrosine kinase activity,F1N780(Evidence code:IEA/Database source:InterPro:IPR020635)F1MS00(Evidence code:IEA/Database source:InterPro:IPR020635)Q769I5(Evidence code:IEA/Database source:InterPro:IPR020635), EPHA7 RET MET,MF,3,3 of 14,0.81,21.43,0.0008892,0.009425
GO:0009749,response to glucose,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994)P80109(Evidence code:ISS/Database source:UniProtKB:P80108), FKBP1B ADIPOQ GPLD1,BP,3,3 of 14,0.81,21.43,0.0008892,0.009425
GO:0008083,growth factor activity,A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339)P19879(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339)P22444(Evidence code:IEA/Database source:InterPro:IPR001839|I)Q3SWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339)Q9XSK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339), IL34 OGN BMP3 THBS4 HDGF,MF,5,5 of 60,1.35,8.33,0.000902,0.009489
GO:0006260,DNA replication,Q58DC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0235)Q2T9V8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0235)Q1RMH9(Evidence code:IEA/Database source:UniProtKB:P54103|ens)F1N7Q0(Evidence code:IEA/Database source:InterPro:IPR018574), ORC1 DTD1 DNAJC2 SLX4,BP,4,4 of 34,1.08,11.76,0.0009124,0.009489
GO:0006139,nucleobase-containing compound metabolic process,A4IFD0(Evidence code:IEA/Database source:InterPro:IPR000850)P00570(Evidence code:IEA/Database source:InterPro:IPR000850), Ak5 AK1,BP,2,2 of 1068,0.54,0.19,0.0009091,0.009489
GO:0032991,protein-containing complex,F1MS60(Evidence code:IEA/Database source:UniProtKB:O14559|ens)E1BI98(Evidence code:IEA/Database source:UniProtKB:P12109|ens)P62964(Evidence code:IDA/Database source:)P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens)A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694)E1BCN3(Evidence code:IEA/Database source:UniProtKB:Q9UM07|ens), ARHGAP33 COL6A1 CRABP1 PRKAR1A USP10 PADI4,CC,6,6 of 1693,1.62,0.35,0.001087,0.01123
GO:0032869,cellular response to insulin stimulus,P80109(Evidence code:ISS/Database source:UniProtKB:P80108)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994)F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens), GPLD1 ADIPOQ ENPP1,BP,3,3 of 16,0.81,18.75,0.001246,0.01194
GO:0005579,membrane attack complex,Q2KIH5(Evidence code:IEA/Database source:InterPro:IPR001862|I)Q29RU4(Evidence code:IEA/Database source:InterPro:IPR001862|I), C8A C6,CC,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0006527,arginine catabolic process,P29473(Evidence code:IDA/Database source:)P56965(Evidence code:IEA/Database source:InterPro:IPR033197), NOS3 DDAH1,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0006910,"phagocytosis, recognition",A6QP79(Evidence code:ISS/Database source:UniProtKB:Q5KU26)G3N342(Evidence code:IBA/Database source:PANTHER:PTN001510949), COLEC12 IGHE,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0007042,lysosomal lumen acidification,P45478(Evidence code:ISS/Database source:UniProtKB:P50897)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503), PPT1 CLN5,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0030169,low-density lipoprotein particle binding,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)A6QP79(Evidence code:ISS/Database source:UniProtKB:Q5KU26), LDLR COLEC12,MF,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0070208,protein heterotrimerization,Q3Y5Z3(Evidence code:IEA/Database source:UniProtKB:Q60994|ens)E1BI98(Evidence code:IEA/Database source:UniProtKB:P12109|ens), ADIPOQ COL6A1,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0022417,protein maturation by protein folding,F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens), ERO1B ERO1A ,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0010839,negative regulation of keratinocyte proliferation,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens), PTPRK CTSL,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0006809,nitric oxide biosynthetic process,P56965(Evidence code:IDA/Database source:)P29473(Evidence code:IEA/Database source:InterPro:IPR004030|I), DDAH1 NOS3,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,Q05JF3(Evidence code:IEA/Database source:UniProtKB:O09165|ens)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens), casq1 FKBP1B,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0008484,sulfuric ester hydrolase activity,E1BIY5(Evidence code:IEA/Database source:InterPro:IPR000917|I)F1N2D5(Evidence code:IEA/Database source:InterPro:IPR000917), SULF2 IDS,MF,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0001867,"complement activation, lectin pathway",O02659(Evidence code:IEA/Database source:InterPro:IPR037570)I2E4T6(Evidence code:IEA/Database source:InterPro:IPR037571), MBL MASP2,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0007129,synapsis,E1BLN1(Evidence code:IEA/Database source:UniProtKB:Q62209|ens)F1N1D2(Evidence code:IEA/Database source:UniProtKB:Q61880|ens), SYCP1 DMC1,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0046597,negative regulation of viral entry into host cell,Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens)G3X823(Evidence code:IEA/Database source:UniProtKB:Q12899|ens), APCS TRIM26,BP,2,2 of 3,0.54,66.67,0.001263,0.01194
GO:0009897,external side of plasma membrane,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)G3N342(Evidence code:IBA/Database source:PANTHER:PTN001510949)F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens)E1BKZ1(Evidence code:IEA/Database source:UniProtKB:P47791|ens), LDLR IGHE IL1R1 GSR,CC,4,4 of 39,1.08,10.26,0.001458,0.01355
GO:0042393,histone binding,Q1RMH9(Evidence code:ISS/Database source:UniProtKB:Q99543)A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens)P51122(Evidence code:IBA/Database source:PANTHER:PTN000146830)P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens), DNAJC2 CTSL1 ANP32A CTSL,MF,4,4 of 39,1.08,10.26,0.001458,0.01355
GO:0016311,dephosphorylation,Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8)F1MFJ3(Evidence code:IEA/Database source:InterPro:IPR000387|I)Q0VD27(Evidence code:IEA/Database source:GO:0043874)F1MME1(Evidence code:IEA/Database source:InterPro:IPR000387|I), PGP PTPRG ENOPH1 PTPRK,BP,4,4 of 39,1.08,10.26,0.001458,0.01355
GO:0005515,protein binding,A7MAZ2(Evidence code:IPI/Database source:UniProtKB:Q08DU8)P00514(Evidence code:IPI/Database source:UniProtKB:P05132)G3MYZ3(Evidence code:IPI/Database source:UniProtKB:P27467)P21793(Evidence code:IPI/Database source:UniProtKB:O18977)P02639(Evidence code:IPI/Database source:UniProtKB:Q9CXW3)O02675(Evidence code:IPI/Database source:UniProtKB:Q8N3F8), STX12 PRKAR1A AFM DCN S100A1 DPYSL2,MF,6,6 of 1669,1.62,0.36,0.00152,0.01405
GO:0050661,NADP binding,E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR006322)P29473(Evidence code:IEA/Database source:InterPro:IPR012144)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens), GSR NOS3 CAT,MF,3,3 of 18,0.81,16.67,0.001681,0.01537
GO:0004725,protein tyrosine phosphatase activity,Q2T9S4(Evidence code:IEA/Database source:EC:3.1.3.48)F1MFJ3(Evidence code:IEA/Database source:InterPro:IPR000242|I)F1MME1(Evidence code:IEA/Database source:InterPro:IPR000242|I), PGP PTPRG PTPRK,MF,3,3 of 18,0.81,16.67,0.001681,0.01537
GO:0007131,reciprocal meiotic recombination,E1BLN1(Evidence code:IEA/Database source:UniProtKB:Q62209|ens)F1N1D2(Evidence code:IEA/Database source:InterPro:IPR011940), SYCP1 DMC1,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0034383,low-density lipoprotein particle clearance,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848)P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens), ADIPOQ LDLR,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0034115,negative regulation of heterotypic cell-cell adhesion,O77482(Evidence code:IEA/Database source:UniProtKB:P18510|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848), IL1RN ADIPOQ,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0000794,condensed nuclear chromosome,E1BLN1(Evidence code:IEA/Database source:UniProtKB:Q62209|ens)F1N1D2(Evidence code:IEA/Database source:UniProtKB:Q61880|ens), SYCP1 DMC1,CC,2,2 of 4,0.54,50,0.00188,0.01572
GO:0034375,high-density lipoprotein particle remodeling,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens), PLTP LCAT,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0006499,N-terminal protein myristoylation,O62830(Evidence code:ISS/Database source:UniProtKB:P36993)O62829(Evidence code:ISS/Database source:UniProtKB:P49443), PPM1B PPM1A,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0050918,positive chemotaxis,Q769I5(Evidence code:ISS/Database source:UniProtKB:P08581)P35541(Evidence code:IEA/Database source:GO:0042056), MET SAA1,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0021675,nerve development,E1BEL6(Evidence code:IEA/Database source:UniProtKB:O35375|ens)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), NRP2 SEMA3A,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0031982,vesicle,A7MAZ2(Evidence code:IEA/Database source:UniProtKB:Q86Y82|ens)O77482(Evidence code:IEA/Database source:UniProtKB:P25085|ens), STX12 IL1RN,CC,2,2 of 1000,0.54,0.2,0.00184,0.01572
GO:0030513,positive regulation of BMP signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024), GPC3 NEO1,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0010575,positive regulation of vascular endothelial growth factor production,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens)A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens), SULF2 EIF2AK3,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0042246,tissue regeneration,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens)Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q6IRK9), APOA5 CPQ,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0031953,negative regulation of protein autophosphorylation,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848), ENPP1 ADIPOQ,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0019471,4-hydroxyproline metabolic process,F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens)A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens), ERO1B ERO1A ,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0004568,chitinase activity,Q95M17(Evidence code:IEA/Database source:EC:3.2.1.14)E1BFD0(Evidence code:IBA/Database source:PANTHER:PTN000126635), CHIA CHI3L2,MF,2,2 of 4,0.54,50,0.00188,0.01572
GO:0006032,chitin catabolic process,E1BFD0(Evidence code:IBA/Database source:PANTHER:PTN000126635)Q95M17(Evidence code:ISS/Database source:UniProtKB:Q9BZP6), CHI3L2 CHIA,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0034372,very-low-density lipoprotein particle remodeling,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens), APOA5 LCAT,BP,2,2 of 4,0.54,50,0.00188,0.01572
GO:0006956,complement activation,Q2KIH5(Evidence code:IEA/Database source:InterPro:IPR037565)Q29RU4(Evidence code:IEA/Database source:InterPro:IPR037563)Q3SYW2(Evidence code:IEA/Database source:InterPro:IPR011360), C8A C6 C2,BP,3,3 of 19,0.81,15.79,0.00193,0.01598
GO:0042632,cholesterol homeostasis,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens)A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens), LCAT APOA5 LDLR,BP,3,3 of 19,0.81,15.79,0.00193,0.01598
GO:0008289,lipid binding,Q5PXY7(Evidence code:IEA/Database source:InterPro:IPR000463|I)A4FUZ9(Evidence code:IEA/Database source:InterPro:IPR000074)P62964(Evidence code:IEA/Database source:InterPro:IPR000463|I)E1BF81(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q0PH99(Evidence code:IEA/Database source:InterPro:IPR017942|I)Q8SPF8(Evidence code:IEA/Database source:InterPro:IPR001124|I)Q58DL9(Evidence code:IEA/Database source:InterPro:IPR001124|I)P17453(Evidence code:IEA/Database source:InterPro:IPR001124|I), CRABP2 APOA5 CRABP1 SERPINA6 BSP30C BPIFB1 PLTP BPI,MF,8,8 of 190,2.16,4.21,0.002175,0.01792
GO:0001822,kidney development,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens), DCHS1 GPC3 SULF2,BP,3,3 of 20,0.81,15,0.0022,0.01795
GO:0000724,double-strand break repair via homologous recombination,A6QNQ6(Evidence code:IEA/Database source:InterPro:IPR033594)F1MSA4(Evidence code:IEA/Database source:UniProtKB:Q6PFE3|ens)F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens), RBBP8 RAD54B SLX4,BP,3,3 of 20,0.81,15,0.0022,0.01795
GO:0050896,response to stimulus,F1ME33(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)E1B7L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)F1MUU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716), LOC788438 OR6C75 OR8D4,BP,3,3 of 1151,0.81,0.26,0.002238,0.01817
GO:0007189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens)F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q6F3F9|ens)P58073(Evidence code:IEA/Database source:UniProtKB:P12272|ens), ADGRF1 ADGRG6 PTHLH,BP,3,3 of 21,0.81,14.29,0.002493,0.01985
GO:0002244,hematopoietic progenitor cell differentiation,P50291(Evidence code:IEA/Database source:UniProtKB:P19883|ens)F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens)F1MIX6(Evidence code:IEA/Database source:UniProtKB:Q8BUR4|ens), FST PLEK DOCK1,BP,3,3 of 21,0.81,14.29,0.002493,0.01985
GO:0051897,positive regulation of protein kinase B signaling,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens)P00743(Evidence code:IEA/Database source:UniProtKB:P00742|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), RET F10 IGFBP5,BP,3,3 of 21,0.81,14.29,0.002493,0.01985
GO:0071360,cellular response to exogenous dsRNA,A6QP79(Evidence code:IEA/Database source:UniProtKB:Q5KU26|ens)E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens), COLEC12 IFIH1,BP,2,2 of 5,0.54,40,0.002612,0.01985
GO:0003007,heart morphogenesis,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens)E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens), GAA DCHS1,BP,2,2 of 5,0.54,40,0.002612,0.01985
GO:0001972,retinoic acid binding,P62964(Evidence code:IEA/Database source:InterPro:IPR031279)Q5PXY7(Evidence code:IEA/Database source:InterPro:IPR031281), CRABP1 CRABP2,MF,2,2 of 5,0.54,40,0.002612,0.01985
GO:0008061,chitin binding,Q95M17(Evidence code:IEA/Database source:InterPro:IPR002557|I)E1BFD0(Evidence code:IEA/Database source:InterPro:IPR011583|I), CHIA CHI3L2,MF,2,2 of 5,0.54,40,0.002612,0.01985
GO:0016671,"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor",A5PJN2(Evidence code:IEA/Database source:InterPro:IPR007266|I)F1MW08(Evidence code:IEA/Database source:InterPro:IPR007266|I), ERO1A  ERO1B,MF,2,2 of 5,0.54,40,0.002612,0.01985
GO:0042130,negative regulation of T cell proliferation,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens)Q2KJ64(Evidence code:IEA/Database source:UniProtKB:P05089|ens), TNFRSF21 ARG1,BP,2,2 of 5,0.54,40,0.002612,0.01985
GO:0021915,neural tube development,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens), DCHS1 SEMA3C,BP,2,2 of 5,0.54,40,0.002612,0.01985
GO:0004714,transmembrane receptor protein tyrosine kinase activity,Q769I5(Evidence code:IEA/Database source:InterPro:IPR016244)F1MS00(Evidence code:IEA/Database source:EC:2.7.10.1), MET RET,MF,2,2 of 5,0.54,40,0.002612,0.01985
GO:0098869,cellular oxidant detoxification,E1BKZ1(Evidence code:IEA/Database source:GO:0004362)P00432(Evidence code:IEA/Database source:GO:0004096), GSR CAT,BP,2,2 of 5,0.54,40,0.002612,0.01985
GO:0034975,protein folding in endoplasmic reticulum,F1MW08(Evidence code:IBA/Database source:PANTHER:PTN000289179)A5PJN2(Evidence code:IBA/Database source:PANTHER:PTN000289179), ERO1B ERO1A ,BP,2,2 of 5,0.54,40,0.002612,0.01985
GO:0043691,reverse cholesterol transport,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens), APOA5 LCAT,BP,2,2 of 5,0.54,40,0.002612,0.01985
GO:0004672,protein kinase activity,F1MS00(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q769I5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N780(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B902(Evidence code:IEA/Database source:InterPro:IPR000719)A5D791(Evidence code:IEA/Database source:InterPro:IPR000719|I)A0JN97(Evidence code:IEA/Database source:InterPro:IPR000719|I), RET MET EPHA7 MAP4K2 EIF2AK3 PRKCD,MF,6,6 of 116,1.62,5.17,0.002891,0.02187
GO:0008152,metabolic process,Q29444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)P46446(Evidence code:IEA/Database source:InterPro:IPR007036)F1N2D5(Evidence code:IEA/Database source:InterPro:IPR000917|I)Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)F1MCG9(Evidence code:IEA/Database source:InterPro:IPR017438)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR000917|I)Q0VD27(Evidence code:IEA/Database source:InterPro:IPR006439)Q2T9S4(Evidence code:IEA/Database source:InterPro:IPR006349)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR017849|I)Q3MHK8(Evidence code:IEA/Database source:InterPro:IPR013216)F1MNS5(Evidence code:IEA/Database source:InterPro:IPR017849|I)F2X047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q58DK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021), MANBA ASPA IDS CHIA DGKK SULF2 ENOPH1 PGP ENPP2 METTL7A ENPP1 LYZ GAA ALAD,BP,14,14 of 2613,3.78,0.54,0.003136,0.0236
GO:0015629,actin cytoskeleton,P68138(Evidence code:IEA/Database source:UniProtKB:P68133|ens)F1MS60(Evidence code:IBA/Database source:PANTHER:PTN000404766)Q8SQ24(Evidence code:IBA/Database source:PANTHER:PTN000409135), ACTA1 ARHGAP33 MYOZ1,CC,3,3 of 23,0.81,13.04,0.003149,0.0236
GO:0008285,negative regulation of cell proliferation,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)P80109(Evidence code:ISS/Database source:UniProtKB:P80108)Q0P5D6(Evidence code:IEA/Database source:InterPro:IPR027261)P56965(Evidence code:IEA/Database source:UniProtKB:O94760|ens)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens), GPC3 GPLD1 RARRES1 DDAH1 PTPRK AIMP2,BP,6,6 of 119,1.62,5.04,0.003259,0.02432
GO:0030425,dendrite,G5E5W4(Evidence code:IEA/Database source:UniProtKB:Q99P47|ens)Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)F1MME1(Evidence code:IEA/Database source:UniProtKB:P35822|ens), CNTNAP4 CRIPT DPYSL2 PTPRK,CC,4,4 of 50,1.08,8,0.003382,0.02512
GO:0035269,protein O-linked mannosylation,Q5EA01(Evidence code:ISS/Database source:UniProtKB:O43505)Q3T083(Evidence code:IEA/Database source:GO:0004169), B4GAT1  SDF2L1,BP,2,2 of 6,0.54,33.33,0.003456,0.02534
GO:0010867,positive regulation of triglyceride biosynthetic process,P80109(Evidence code:ISS/Database source:UniProtKB:O70362)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens), GPLD1 LDLR,BP,2,2 of 6,0.54,33.33,0.003456,0.02534
GO:0004017,adenylate kinase activity,A4IFD0(Evidence code:IEA/Database source:InterPro:IPR006267)P00570(Evidence code:IEA/Database source:InterPro:IPR006267|I), Ak5 AK1,MF,2,2 of 6,0.54,33.33,0.003456,0.02534
GO:0044325,ion channel binding,A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694)F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens)P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens), USP10 AKAP9 FKBP1B,MF,3,3 of 24,0.81,12.5,0.003513,0.02564
GO:0008237,metallopeptidase activity,P52176(Evidence code:IEA/Database source:InterPro:IPR006026|I)Q9GLE5(Evidence code:IEA/Database source:InterPro:IPR006026|I)A6QPT7(Evidence code:IEA/Database source:InterPro:IPR014782)Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482), MMP9 MMP2 ERAP2 CPQ,MF,4,4 of 51,1.08,7.84,0.003614,0.02626
GO:0002250,adaptive immune response,Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064)Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064)A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens), SEMA4A TNFRSF21 ERAP2 CTSL1,BP,4,4 of 52,1.08,7.69,0.003857,0.02791
GO:0006468,protein phosphorylation,E1B902(Evidence code:IEA/Database source:InterPro:IPR000719)Q769I5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N780(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MS00(Evidence code:IEA/Database source:InterPro:IPR000719|I)A0JN97(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5D791(Evidence code:IEA/Database source:InterPro:IPR000719|I), MAP4K2 MET EPHA7 RET PRKCD EIF2AK3,BP,6,6 of 125,1.62,4.8,0.004099,0.02953
GO:0042157,lipoprotein metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)A4FUZ9(Evidence code:IEA/Database source:InterPro:IPR000074), LDLR APOA5,BP,2,2 of 7,0.54,28.57,0.00441,0.03071
GO:0050885,neuromuscular process controlling balance,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens)E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens), GAA GM2A,BP,2,2 of 7,0.54,28.57,0.00441,0.03071
GO:0003785,actin monomer binding,P62326(Evidence code:IEA/Database source:InterPro:IPR001152)P21752(Evidence code:IEA/Database source:InterPro:IPR001152), TMSB4 TMSB10,MF,2,2 of 7,0.54,28.57,0.00441,0.03071
GO:0050766,positive regulation of phagocytosis,O02659(Evidence code:IEA/Database source:UniProtKB:P41317|ens)A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens), MBL LMAN2,BP,2,2 of 7,0.54,28.57,0.00441,0.03071
GO:0071353,cellular response to interleukin-4,Q58DK5(Evidence code:IEA/Database source:UniProtKB:P10518|ens)Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens), ALAD CARKL,BP,2,2 of 7,0.54,28.57,0.00441,0.03071
GO:0051085,chaperone cofactor-dependent protein refolding,Q58DR2(Evidence code:ISS/Database source:UniProtKB:Q9NXW2)A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q96HE7|ens), DNAJB12 ERO1A ,BP,2,2 of 7,0.54,28.57,0.00441,0.03071
GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024)E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens), CADM1 DCHS1,BP,2,2 of 7,0.54,28.57,0.00441,0.03071
GO:0031210,phosphatidylcholine binding,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens)A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens), PLTP APOA5,MF,2,2 of 7,0.54,28.57,0.00441,0.03071
GO:0048471,perinuclear region of cytoplasm,E1BBP1(Evidence code:IEA/Database source:UniProtKB:Q14435|ens)P51122(Evidence code:ISS/Database source:UniProtKB:P39687)Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)Q07537(Evidence code:IEA/Database source:UniProtKB:Q10472|ens)A0JN97(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q9JHI8)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens), GALNT3 ANP32A CLN5 GALNT1 PRKCD ADIPOQ SORT1,CC,7,7 of 170,1.89,4.12,0.004499,0.0312
GO:0008017,microtubule binding,O02675(Evidence code:IEA/Database source:InterPro:IPR030615)F1MX00(Evidence code:IEA/Database source:UniProtKB:Q0VFX2|ens)Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4)Q3MHK0(Evidence code:IEA/Database source:InterPro:IPR001752), DPYSL2 CFAP157 CRIPT KIF3A,MF,4,4 of 55,1.08,7.27,0.004652,0.03212
GO:0050728,negative regulation of inflammatory response,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994)G3X6G7(Evidence code:IEA/Database source:InterPro:IPR039224)P62326(Evidence code:IMP/Database source:), ADIPOQ METRNL TMSB4,BP,3,3 of 27,0.81,11.11,0.004753,0.03268
GO:0014069,postsynaptic density,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens)Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4), CLSTN1 NEFH CRIPT,CC,3,3 of 28,0.81,10.71,0.005218,0.03502
GO:2000279,negative regulation of DNA biosynthetic process,Q1RMH9(Evidence code:IEA/Database source:UniProtKB:P54103|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848), DNAJC2 ADIPOQ,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0032515,negative regulation of phosphoprotein phosphatase activity,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)F1N1Q9(Evidence code:IEA/Database source:GO:0004864), FKBP1B PPP1R17,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0030212,hyaluronan metabolic process,P56652(Evidence code:IEA/Database source:InterPro:IPR010600)A2VE29(Evidence code:IEA/Database source:InterPro:IPR010600), ITIH3 ITIH5,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0048741,skeletal muscle fiber development,Q08DY1(Evidence code:IEA/Database source:UniProtKB:Q9JI08|ens)P68138(Evidence code:ISS/Database source:UniProtKB:P68134), BIN3 ACTA1,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0016918,retinal binding,P62964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0845)Q5PXY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0845), CRABP1 CRABP2,MF,2,2 of 8,0.54,25,0.005471,0.03502
GO:0046326,positive regulation of glucose import,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994), GPC3 ADIPOQ,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0019841,retinol binding,P62964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0683)Q5PXY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0683), CRABP1 CRABP2,MF,2,2 of 8,0.54,25,0.005471,0.03502
GO:0001658,branching involved in ureteric bud morphogenesis,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens), DCHS1 GPC3,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0045776,negative regulation of blood pressure,P29473(Evidence code:IBA/Database source:PANTHER:PTN000453988)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848), NOS3 ADIPOQ,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0045668,negative regulation of osteoblast differentiation,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), SEMA4D IGFBP5,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0031069,hair follicle morphogenesis,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), CTSL IGFBP5,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0030282,bone mineralization,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)P58073(Evidence code:IEA/Database source:InterPro:IPR003626), GPC3 PTHLH,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0046658,anchored component of plasma membrane,Q3ZBZ6(Evidence code:IEA/Database source:InterPro:IPR001863)E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens), GPC3 MELTF,CC,2,2 of 8,0.54,25,0.005471,0.03502
GO:0004550,nucleoside diphosphate kinase activity,A4IFD0(Evidence code:IEA/Database source:EC:2.7.4.6)P00570(Evidence code:IEA/Database source:InterPro:IPR028582), Ak5 AK1,MF,2,2 of 8,0.54,25,0.005471,0.03502
GO:0003756,protein disulfide isomerase activity,F1MW08(Evidence code:IEA/Database source:InterPro:IPR007266|I)A5PJN2(Evidence code:IEA/Database source:InterPro:IPR007266|I), ERO1B ERO1A ,MF,2,2 of 8,0.54,25,0.005471,0.03502
GO:0008191,metalloendopeptidase inhibitor activity,P16368(Evidence code:IEA/Database source:InterPro:IPR001820|I)Q58D62(Evidence code:ISS/Database source:UniProtKB:Q9QXC1), TIMP2 FETUB,MF,2,2 of 8,0.54,25,0.005471,0.03502
GO:0022008,neurogenesis,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens), CLN5 DCHS1,BP,2,2 of 8,0.54,25,0.005471,0.03502
GO:0045944,positive regulation of transcription by RNA polymerase II,A4IFN7(Evidence code:IEA/Database source:UniProtKB:O08759|ens)E1BNP7(Evidence code:IEA/Database source:UniProtKB:Q91ZK0|ens)P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens)Q05443(Evidence code:IEA/Database source:UniProtKB:P51885|ens)E1BD99(Evidence code:IEA/Database source:UniProtKB:Q6N021|ens)Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801)E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens), UBE3A TFAP2D DCN LUM TET2 ATF6 SIX3,BP,7,7 of 177,1.89,3.95,0.005537,0.0353
GO:0001764,neuron migration,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens)E1BEL6(Evidence code:IEA/Database source:UniProtKB:O35375|ens)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens), SEMA3A NRP2 CNTN2,BP,3,3 of 29,0.81,10.34,0.005709,0.03626
GO:0006281,DNA repair,A6QNQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)A5PJS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)Q3SZL4(Evidence code:IEA/Database source:InterPro:IPR016592)E1BKG4(Evidence code:IBA/Database source:PANTHER:PTN000292173)F1N1D2(Evidence code:IEA/Database source:InterPro:IPR020588)F1N7Q0(Evidence code:IEA/Database source:InterPro:IPR018574), RBBP8 USP10 NBN PDS5A DMC1 SLX4,BP,6,6 of 136,1.62,4.41,0.006037,0.0382
GO:0015035,protein disulfide oxidoreductase activity,A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens)F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens), ERO1A  ERO1B,MF,2,2 of 9,0.54,22.22,0.006637,0.04136
GO:0004551,nucleotide diphosphatase activity,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881)F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens), ENPP2 ENPP1,MF,2,2 of 9,0.54,22.22,0.006637,0.04136
GO:0045214,sarcomere organization,Q05JF3(Evidence code:IEA/Database source:UniProtKB:O09165|ens)P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens), casq1 PRKAR1A,BP,2,2 of 9,0.54,22.22,0.006637,0.04136
GO:0033344,cholesterol efflux,A7MAZ2(Evidence code:IEA/Database source:UniProtKB:Q86Y82|ens)A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006), STX12 APOA5,BP,2,2 of 9,0.54,22.22,0.006637,0.04136
GO:0002376,immune system process,Q3T0A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q2KIV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q29RU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3SYW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)O02659(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q8SPF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391), CFD C1QB SEMA4A ERAP2 C6 IL34 C2 CHIA MBL BPIFB1,BP,10,10 of 334,2.7,2.99,0.006919,0.04296
GO:0006888,ER to Golgi vesicle-mediated transport,Q2TBU3(Evidence code:IEA/Database source:InterPro:IPR023601)Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6)Q3T086(Evidence code:IBA/Database source:PANTHER:PTN000302156), GOSR1 MIA3 TRAPPC6A,BP,3,3 of 32,0.81,9.38,0.007345,0.04526
GO:0050660,flavin adenine dinucleotide binding,P29473(Evidence code:IEA/Database source:InterPro:IPR012144)E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR006322|I)E1BBX5(Evidence code:IEA/Database source:InterPro:IPR036318), NOS3 GSR AOX2,MF,3,3 of 32,0.81,9.38,0.007345,0.04526
GO:0010468,regulation of gene expression,P58073(Evidence code:IEA/Database source:UniProtKB:P12272|ens)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens), PTHLH SORT1,BP,2,2 of 870,0.54,0.23,0.00756,0.04642
GO:0051216,cartilage development,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0891), SULF2 BMP3,BP,2,2 of 10,0.54,20,0.007904,0.04783
GO:0042730,fibrinolysis,Q2KJ63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0280)P98140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0280), KLKB1 F12,BP,2,2 of 10,0.54,20,0.007904,0.04783
GO:0045669,positive regulation of osteoblast differentiation,F1MS76(Evidence code:IEA/Database source:UniProtKB:Q8C341|ens)P40682(Evidence code:IEA/Database source:UniProtKB:Q9R1Q9|ens), SUCO ATP6AP1,BP,2,2 of 10,0.54,20,0.007904,0.04783
GO:0032330,regulation of chondrocyte differentiation,P58073(Evidence code:IBA/Database source:PANTHER:PTN000425409)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens), PTHLH CTGF,BP,2,2 of 10,0.54,20,0.007904,0.04783
GO:0008203,cholesterol metabolic process,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0153), LCAT CAT LDLR,BP,3,3 of 33,0.81,9.09,0.007945,0.0479
GO:0097190,apoptotic signaling pathway,A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849)A5D7R1(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q5EAE6(Evidence code:IBA/Database source:PANTHER:PTN000323543), TNFRSF6B TNFRSF21 TNFRSF11B DAP,BP,4,4 of 67,1.08,5.97,0.008917,0.05357
GO:0000149,SNARE binding,E1B9K5(Evidence code:IBA/Database source:PANTHER:PTN000480155)A7MAZ2(Evidence code:IBA/Database source:PANTHER:PTN000461349)Q2TBU3(Evidence code:IBA/Database source:PANTHER:PTN000473329), EXOC3L4 STX12 GOSR1,MF,3,3 of 35,0.81,8.57,0.00923,0.05432
GO:0051209,release of sequestered calcium ion into cytosol,A5PJN2(Evidence code:ISS/Database source:UniProtKB:Q8R180)P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens), ERO1A  FKBP1B,BP,2,2 of 11,0.54,18.18,0.00927,0.05432
GO:0042149,cellular response to glucose starvation,A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens)Q0P5H6(Evidence code:IEA/Database source:UniProtKB:Q9Y4P3|ens), EIF2AK3 TBL2,BP,2,2 of 11,0.54,18.18,0.00927,0.05432
GO:0071320,cellular response to cAMP,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens), AKAP9 IGFBP5,BP,2,2 of 11,0.54,18.18,0.00927,0.05432
GO:0007040,lysosome organization,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P10253|ens)Q1ZYR0(Evidence code:IEA/Database source:UniProtKB:Q3UMW8|ens), GAA CLN5,BP,2,2 of 11,0.54,18.18,0.00927,0.05432
GO:0005791,rough endoplasmic reticulum,F1ME65(Evidence code:IEA/Database source:UniProtKB:Q07065|ens)F1MS76(Evidence code:IEA/Database source:UniProtKB:Q8C341|ens), CKAP4 SUCO,CC,2,2 of 11,0.54,18.18,0.00927,0.05432
GO:0030324,lung development,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens), GPC3 CTGF,BP,2,2 of 11,0.54,18.18,0.00927,0.05432
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)A1A4K5(Evidence code:IEA/Database source:UniProtKB:Q13822|ens), THBS4 SEMA4D ENPP2,BP,3,3 of 36,0.81,8.33,0.009915,0.05789
GO:0043209,myelin sheath,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)P63048(Evidence code:IEA/Database source:UniProtKB:P62984|ens)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens), CNTN2 UBA52 DPYSL2 NEFH,CC,4,4 of 71,1.08,5.63,0.01076,0.06092
GO:0016810,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",A7MBC0(Evidence code:IEA/Database source:InterPro:IPR011059)A6QQ07(Evidence code:IBA/Database source:PANTHER:PTN000064607)O02675(Evidence code:IEA/Database source:InterPro:IPR011059), AMDHD2 BTD DPYSL2,MF,3,3 of 37,0.81,8.11,0.01063,0.06092
GO:0005913,cell-cell adherens junction,A6QLR1(Evidence code:IEA/Database source:UniProtKB:Q96NY8|ens)Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024), PVRL4 CADM1,CC,2,2 of 12,0.54,16.67,0.01073,0.06092
GO:0007029,endoplasmic reticulum organization,Q05JF3(Evidence code:IEA/Database source:UniProtKB:O09165|ens)A5PKH0(Evidence code:IEA/Database source:UniProtKB:Q8NFQ8|ens), casq1 TOR1AIP2,BP,2,2 of 12,0.54,16.67,0.01073,0.06092
GO:0001541,ovarian follicle development,A4IFN7(Evidence code:IEA/Database source:UniProtKB:O08759|ens)F1N1D2(Evidence code:IEA/Database source:UniProtKB:Q61880|ens), UBE3A DMC1,BP,2,2 of 12,0.54,16.67,0.01073,0.06092
GO:0034198,cellular response to amino acid starvation,Q5EAE6(Evidence code:IBA/Database source:PANTHER:PTN000323543)A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens), DAP EIF2AK3,BP,2,2 of 12,0.54,16.67,0.01073,0.06092
GO:0051496,positive regulation of stress fiber assembly,O19116(Evidence code:IDA/Database source:)O18739(Evidence code:IEA/Database source:UniProtKB:P29279|ens), SFRP1 CTGF,BP,2,2 of 12,0.54,16.67,0.01073,0.06092
GO:0032947,protein-containing complex scaffold activity,Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens)F1MXF5(Evidence code:IEA/Database source:InterPro:IPR028745), AIMP2 AKAP9,MF,2,2 of 12,0.54,16.67,0.01073,0.06092
GO:0006493,protein O-linked glycosylation,E1BD99(Evidence code:IEA/Database source:UniProtKB:Q6N021|ens)Q07537(Evidence code:IEA/Database source:UniProtKB:O08912|ens), TET2 GALNT1,BP,2,2 of 12,0.54,16.67,0.01073,0.06092
GO:0016491,oxidoreductase activity,Q3MHX0(Evidence code:IEA/Database source:InterPro:IPR005066|I)E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR016156|I)P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q08DD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P29473(Evidence code:IEA/Database source:InterPro:IPR001433|I)E1BBX5(Evidence code:IEA/Database source:InterPro:IPR002346|I)A3KLR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q9TTK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q8MJ24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A5PJN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560), SUOX GSR CAT CYP46A1 NOS3 AOX2 ECSOD AOC3 LOXL4 ERO1A ,MF,10,10 of 361,2.7,2.77,0.01132,0.06383
GO:0005905,clathrin-coated pit,P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens), LDLR SORT1,CC,2,2 of 13,0.54,15.38,0.01229,0.06887
GO:0090502,"RNA phosphodiester bond hydrolysis, endonucleolytic",Q29RY4(Evidence code:IEA/Database source:GO:0016891)Q0III8(Evidence code:IEA/Database source:GO:0033897), ELAC1 RNASET2,BP,2,2 of 13,0.54,15.38,0.01229,0.06887
GO:0043231,intracellular membrane-bounded organelle,Q3T186(Evidence code:IBA/Database source:PANTHER:PTN000232509)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)Q0VC12(Evidence code:IEA/Database source:UniProtKB:Q9GZM5|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:A0A024R7T2)A6QNQ6(Evidence code:IEA/Database source:UniProtKB:A0A024RC34)F1MX00(Evidence code:IEA/Database source:UniProtKB:Q5JU67|ens)P68107(Evidence code:ISA/Database source:UniProtKB:P97534)F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens)Q17QK3(Evidence code:IEA/Database source:UniProtKB:A0A024R9B8)P80109(Evidence code:ISS/Database source:UniProtKB:P80108), RPIA PTPRK CAT YIPF3 RET RBBP8 CFAP157 FKBP1B AKAP9 CPQ GPLD1,CC,11,11 of 1927,2.97,0.57,0.01801,0.07351
GO:0051260,protein homooligomerization,Q58DK5(Evidence code:IEA/Database source:UniProtKB:P13716|ens)P62964(Evidence code:IDA/Database source:)A5D791(Evidence code:ISS/Database source:UniProtKB:Q9NZJ5)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994), ALAD CRABP1 EIF2AK3 ADIPOQ,BP,4,4 of 88,1.08,4.55,0.02127,0.07351
GO:0005179,hormone activity,P58073(Evidence code:IEA/Database source:InterPro:IPR001415|I)P19159(Evidence code:IEA/Database source:InterPro:IPR001400|I)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848)G3X6G7(Evidence code:IEA/Database source:UniProtKB:Q8VE43|ens), PTHLH CSH2 ADIPOQ METRNL,MF,4,4 of 82,1.08,4.88,0.01705,0.07351
GO:0007267,cell-cell signaling,O18739(Evidence code:IBA/Database source:PANTHER:PTN000142748)A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164501)E1BJP8(Evidence code:IBA/Database source:PANTHER:PTN001932250)E1BD40(Evidence code:IBA/Database source:PANTHER:PTN001932250), CTGF ERAP2 PCDHGA7 PCDHGB2,BP,4,4 of 83,1.08,4.82,0.01771,0.07351
GO:0004518,nuclease activity,P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q29RY4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)A6QNQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)P39873(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540), ANG2 ELAC1 RBBP8 BRN,MF,4,4 of 79,1.08,5.06,0.01515,0.07351
GO:0008033,tRNA processing,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)Q29RY4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0819)Q5E9U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0819), SSB ELAC1 TYW3,BP,3,3 of 43,0.81,6.98,0.01553,0.07351
GO:0030336,negative regulation of cell migration,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994), PTPRK IGFBP5 ADIPOQ,BP,3,3 of 48,0.81,6.25,0.02043,0.07351
GO:0072659,protein localization to plasma membrane,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848)E1BMC6(Evidence code:IEA/Database source:UniProtKB:Q14BN4|ens), DCHS1 ADIPOQ SLMAP,BP,3,3 of 44,0.81,6.82,0.01645,0.07351
GO:0032729,positive regulation of interferon-gamma production,F1ML75(Evidence code:IEA/Database source:UniProtKB:P14778|ens)A5D7S4(Evidence code:IEA/Database source:UniProtKB:O70394|ens), IL1R1 IL27RA,BP,2,2 of 16,0.54,12.5,0.01751,0.07351
GO:0046426,negative regulation of JAK-STAT cascade,F1MMI6(Evidence code:IBA/Database source:PANTHER:PTN000043893)P21793(Evidence code:IBA/Database source:PANTHER:PTN000043893), LRRC15 DCN,BP,2,2 of 14,0.54,14.29,0.01394,0.07351
GO:0002027,regulation of heart rate,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens), FKBP1B SEMA3A,BP,2,2 of 17,0.54,11.76,0.01943,0.07351
GO:0046330,positive regulation of JNK cascade,O18739(Evidence code:IEA/Database source:UniProtKB:P29279|ens)E1B902(Evidence code:IEA/Database source:UniProtKB:Q12851|ens), CTGF MAP4K2,BP,2,2 of 16,0.54,12.5,0.01751,0.07351
GO:0030301,cholesterol transport,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens), LDLR LCAT,BP,2,2 of 14,0.54,14.29,0.01394,0.07351
GO:0000187,activation of MAPK activity,F1MNT5(Evidence code:IBA/Database source:PANTHER:PTN002204522)F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens), MUC20 RET,BP,2,2 of 18,0.54,11.11,0.02142,0.07351
GO:0007160,cell-matrix adhesion,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)A6QLI0(Evidence code:IEA/Database source:InterPro:IPR001299), CTGF EPDR1,BP,2,2 of 14,0.54,14.29,0.01394,0.07351
GO:0042542,response to hydrogen peroxide,P68107(Evidence code:ISA/Database source:UniProtKB:P97534)P00432(Evidence code:IBA/Database source:PANTHER:PTN000157250), FKBP1B CAT,BP,2,2 of 17,0.54,11.76,0.01943,0.07351
GO:0019835,cytolysis,F2X047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081)Q29RU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0204), LYZ C6,BP,2,2 of 17,0.54,11.76,0.01943,0.07351
GO:0005930,axoneme,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens)E1BAU6(Evidence code:IEA/Database source:UniProtKB:Q9JII1|ens), PRKAR1A INPP5E,CC,2,2 of 17,0.54,11.76,0.01943,0.07351
GO:0007417,central nervous system development,Q0V8B6(Evidence code:IBA/Database source:PANTHER:PTN001022357)A6QQ07(Evidence code:IBA/Database source:PANTHER:PTN000064610), TPP1 BTD,BP,2,2 of 18,0.54,11.11,0.02142,0.07351
GO:0030165,PDZ domain binding,Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4)F1MW38(Evidence code:IEA/Database source:UniProtKB:Q9NZV1|ens), CRIPT CRIM1,MF,2,2 of 15,0.54,13.33,0.01568,0.07351
GO:0006289,nucleotide-excision repair,F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens)A6QNQ6(Evidence code:IEA/Database source:UniProtKB:Q99708|ens), SLX4 RBBP8,BP,2,2 of 16,0.54,12.5,0.01751,0.07351
GO:0019205,nucleobase-containing compound kinase activity,A4IFD0(Evidence code:IEA/Database source:InterPro:IPR000850)P00570(Evidence code:IEA/Database source:InterPro:IPR000850), Ak5 AK1,MF,2,2 of 18,0.54,11.11,0.02142,0.07351
GO:0090263,positive regulation of canonical Wnt signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:P51654|ens)E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens), GPC3 SULF2,BP,2,2 of 16,0.54,12.5,0.01751,0.07351
GO:0042552,myelination,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens)F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q86SQ4|ens), TNFRSF21 ADGRG6,BP,2,2 of 14,0.54,14.29,0.01394,0.07351
GO:0009060,aerobic respiration,Q58CR1(Evidence code:IEA/Database source:UniProtKB:Q8VED8|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens), MTFR2 CAT,BP,2,2 of 17,0.54,11.76,0.01943,0.07351
GO:0015914,phospholipid transport,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens), LDLR PLTP,BP,2,2 of 16,0.54,12.5,0.01751,0.07351
GO:0008076,voltage-gated potassium channel complex,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens), CNTN2 AKAP9,CC,2,2 of 16,0.54,12.5,0.01751,0.07351
GO:0000049,tRNA binding,Q2T9V8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens), DTD1 SSB,MF,2,2 of 14,0.54,14.29,0.01394,0.07351
GO:0004722,protein serine/threonine phosphatase activity,O62830(Evidence code:IEA/Database source:InterPro:IPR015655)O62829(Evidence code:IEA/Database source:InterPro:IPR015655), PPM1B PPM1A,MF,2,2 of 15,0.54,13.33,0.01568,0.07351
GO:0001938,positive regulation of endothelial cell proliferation,A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q16610|ens)Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens), ECM1 THBS4,BP,2,2 of 17,0.54,11.76,0.01943,0.07351
GO:0007229,integrin-mediated signaling pathway,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens), CTGF PLEK,BP,2,2 of 16,0.54,12.5,0.01751,0.07351
GO:0006641,triglyceride metabolic process,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens), APOA5 CAT,BP,2,2 of 18,0.54,11.11,0.02142,0.07351
GO:0007597,"blood coagulation, intrinsic pathway",Q2KJ63(Evidence code:IEA/Database source:InterPro:IPR034813),KLKB1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0042954,lipoprotein transporter activity,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6),MIA3,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0045793,positive regulation of cell size,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0045352,interleukin-1 type I receptor antagonist activity,O77482(Evidence code:IEA/Database source:UniProtKB:P18510|ens),IL1RN,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0090599,alpha-glucosidase activity,Q9MYM4(Evidence code:IEA/Database source:EC:3.2.1.20),GAA,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0043874,acireductone synthase activity,Q0VD27(Evidence code:IEA/Database source:InterPro:IPR023943),ENOPH1,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0032688,negative regulation of interferon-beta production,O62830(Evidence code:ISS/Database source:UniProtKB:O75688),PPM1B,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0019807,aspartoacylase activity,P46446(Evidence code:IEA/Database source:EC:3.5.1.15),ASPA,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0034057,RNA strand-exchange activity,A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859),WBSCR1,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0010983,positive regulation of high-density lipoprotein particle clearance,P80109(Evidence code:ISS/Database source:UniProtKB:O70362),GPLD1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0000801,central element,E1BLN1(Evidence code:IEA/Database source:UniProtKB:Q62209|ens),SYCP1,CC,1,1 of 1,0.27,100,0.02258,0.07351
GO:0051500,D-tyrosyl-tRNA(Tyr) deacylase activity,Q2T9V8(Evidence code:IBA/Database source:PANTHER:PTN000049487),DTD1,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:2000467,positive regulation of glycogen (starch) synthase activity,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q8K3R4),ADIPOQ,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0097286,iron ion import,E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens),MELTF,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0000711,meiotic DNA repair synthesis,E1BLN1(Evidence code:IEA/Database source:UniProtKB:Q62209|ens),SYCP1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0003350,pulmonary myocardium development,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0048671,negative regulation of collateral sprouting,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0003094,glomerular filtration,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0032450,maltose alpha-glucosidase activity,Q9MYM4(Evidence code:IEA/Database source:EC:3.2.1.20),GAA,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:1902513,regulation of organelle transport along microtubule,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P12036|ens),NEFH,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0044871,negative regulation by host of viral glycoprotein metabolic process,Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens),APCS,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0033693,neurofilament bundle assembly,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P12036|ens),NEFH,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0042781,3-tRNA processing endoribonuclease activity,Q29RY4(Evidence code:IBA/Database source:PANTHER:PTN000284960),ELAC1,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:1904706,negative regulation of vascular smooth muscle cell proliferation,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0097010,eukaryotic translation initiation factor 4F complex assembly,A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859),WBSCR1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0010899,regulation of phosphatidylcholine catabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0043181,vacuolar sequestering,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P10253|ens),GAA,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:1903232,melanosome assembly,Q3T086(Evidence code:IEA/Database source:UniProtKB:Q78XR0|ens),TRAPPC6A,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0030889,negative regulation of B cell proliferation,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0004382,guanosine-diphosphatase activity,E1BPW0(Evidence code:IEA/Database source:EC:3.6.1.42),ENTPD5,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0032793,positive regulation of CREB transcription factor activity,E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens),ADGRF1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0030299,intestinal cholesterol absorption,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0034186,apolipoprotein A-I binding,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens),LCAT,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0008448,N-acetylglucosamine-6-phosphate deacetylase activity,A7MBC0(Evidence code:IEA/Database source:InterPro:IPR003764),AMDHD2,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0060235,lens induction in camera-type eye,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0043584,nose development,F6RF21(Evidence code:IEA/Database source:UniProtKB:A6NHR9|ens),SMCHD1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0060384,innervation,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0051661,maintenance of centrosome location,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0060736,prostate gland growth,A4IFN7(Evidence code:IEA/Database source:UniProtKB:O08759|ens),UBE3A,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0046709,IDP catabolic process,A7MBI8(Evidence code:IEA/Database source:UniProtKB:Q8BVU5|ens),NUDT9,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0021978,telencephalon regionalization,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0001783,B cell apoptotic process,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0004046,aminoacylase activity,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0051499,D-aminoacyl-tRNA deacylase activity,Q2T9V8(Evidence code:IEA/Database source:InterPro:IPR003732),DTD1,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0035924,cellular response to vascular endothelial growth factor stimulus,G3MXM5(Evidence code:IEA/Database source:UniProtKB:P54826|ens),GAS1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:2000478,positive regulation of metanephric glomerular visceral epithelial cell development,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994),ADIPOQ,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0003183,mitral valve morphogenesis,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0072178,nephric duct morphogenesis,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0017040,N-acylsphingosine amidohydrolase activity,Q17QB3(Evidence code:IEA/Database source:EC:3.5.1.23),ASAH1,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0017110,nucleoside-diphosphatase activity,E1BPW0(Evidence code:IEA/Database source:EC:3.6.1.6),ENTPD5,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0098909,regulation of cardiac muscle cell action potential involved in regulation of contraction,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0033197,response to vitamin E,P68107(Evidence code:ISA/Database source:UniProtKB:P97534),FKBP1B,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0021797,forebrain anterior/posterior pattern specification,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0006409,tRNA export from nucleus,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:2000590,negative regulation of metanephric mesenchymal cell migration,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994),ADIPOQ,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0035963,cellular response to interleukin-13,Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens),CARKL,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0002086,diaphragm contraction,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P10253|ens),GAA,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0030056,hemidesmosome,E1BF59(Evidence code:IEA/Database source:UniProtKB:Q15149|ens),PLEC,CC,1,1 of 1,0.27,100,0.02258,0.07351
GO:1900825,regulation of membrane depolarization during cardiac muscle cell action potential,E1BMC6(Evidence code:IEA/Database source:UniProtKB:Q14BN4|ens),SLMAP,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0005041,low-density lipoprotein particle receptor activity,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:1904707,positive regulation of vascular smooth muscle cell proliferation,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0098633,collagen fibril binding,P21793(Evidence code:IDA/Database source:),DCN,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0045353,interleukin-1 type II receptor antagonist activity,O77482(Evidence code:IEA/Database source:UniProtKB:P18510|ens),IL1RN,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0005161,platelet-derived growth factor receptor binding,F1ML75(Evidence code:IEA/Database source:UniProtKB:P14778|ens),IL1R1,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0042489,negative regulation of odontogenesis of dentin-containing tooth,A5D7R1(Evidence code:IEA/Database source:UniProtKB:O08712|ens),TNFRSF11B,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0039706,co-receptor binding,F1MNL4(Evidence code:IEA/Database source:UniProtKB:Q92859|ens),NEO1,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0001682,tRNA 5-leader removal,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0004439,"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity",E1BAU6(Evidence code:IEA/Database source:UniProtKB:Q9JII1|ens),INPP5E,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0046404,ATP-dependent polydeoxyribonucleotide 5-hydroxyl-kinase activity,E1BIJ5(Evidence code:IEA/Database source:UniProtKB:Q86UW6|ens),N4BP2,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0006014,D-ribose metabolic process,Q3T186(Evidence code:IBA/Database source:PANTHER:PTN000232507),RPIA,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0045880,positive regulation of smoothened signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0044206,UMP salvage,A5PJH9(Evidence code:IEA/Database source:UniPathway:UPA00574),UPP1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0021798,forebrain dorsal/ventral pattern formation,E1BMT1(Evidence code:IEA/Database source:UniProtKB:O95343|ens),SIX3,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0060336,negative regulation of interferon-gamma-mediated signaling pathway,Q2KJ64(Evidence code:IEA/Database source:UniProtKB:P05089|ens),ARG1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0006768,biotin metabolic process,A6QQ07(Evidence code:IBA/Database source:PANTHER:PTN000064610),BTD,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0060392,negative regulation of SMAD protein signal transduction,E1BIR5(Evidence code:IEA/Database source:UniProtKB:O75339|ens),CILP,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0004621,glycosylphosphatidylinositol phospholipase D activity,P80109(Evidence code:IEA/Database source:InterPro:IPR001028),GPLD1,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0004143,diacylglycerol kinase activity,F1MCG9(Evidence code:IEA/Database source:InterPro:IPR000756|I),DGKK,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0005157,macrophage colony-stimulating factor receptor binding,A6QL48(Evidence code:IEA/Database source:InterPro:IPR020415),IL34,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0051026,chiasma assembly,E1BLN1(Evidence code:IEA/Database source:UniProtKB:Q62209|ens),SYCP1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0022010,central nervous system myelination,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0019862,IgA binding,P00978(Evidence code:ISS/Database source:UniProtKB:P02760),AMBP,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0003823,antigen binding,G3N342(Evidence code:IBA/Database source:PANTHER:PTN001510949),IGHE,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0003951,NAD+ kinase activity,F1MCG9(Evidence code:IEA/Database source:InterPro:IPR017438),DGKK,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0046813,receptor-mediated virion attachment to host cell,F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens),LRRC15,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0008449,N-acetylglucosamine-6-sulfatase activity,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0048209,"regulation of vesicle targeting, to, from or within Golgi",Q2TBU3(Evidence code:IBA/Database source:PANTHER:PTN000473329),GOSR1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0045134,uridine-diphosphatase activity,E1BPW0(Evidence code:IEA/Database source:EC:3.6.1.6),ENTPD5,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0004920,interleukin-10 receptor activity,Q08DU4(Evidence code:IBA/Database source:PANTHER:PTN001074511),IL10RB,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:1904205,negative regulation of skeletal muscle hypertrophy,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:1901341,positive regulation of store-operated calcium channel activity,Q05JF3(Evidence code:IEA/Database source:UniProtKB:P31415|ens),casq1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0045715,negative regulation of low-density lipoprotein particle receptor biosynthetic process,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0009048,dosage compensation by inactivation of X chromosome,F6RF21(Evidence code:IEA/Database source:UniProtKB:A6NHR9|ens),SMCHD1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0004999,vasoactive intestinal polypeptide receptor activity,A2VDS6(Evidence code:IEA/Database source:InterPro:IPR001571|I),VIPR1,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:2001224,positive regulation of neuron migration,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0001556,oocyte maturation,F1N1D2(Evidence code:IEA/Database source:UniProtKB:Q61880|ens),DMC1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0070522,ERCC4-ERCC1 complex,F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens),SLX4,CC,1,1 of 1,0.27,100,0.02258,0.07351
GO:0050847,progesterone receptor signaling pathway,A4IFN7(Evidence code:IEA/Database source:UniProtKB:Q05086|ens),UBE3A,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0090024,negative regulation of neutrophil chemotaxis,P62326(Evidence code:IMP/Database source:),TMSB4,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0003273,cell migration involved in endocardial cushion formation,E1B969(Evidence code:IEA/Database source:UniProtKB:Q96JQ0|ens),DCHS1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0031642,negative regulation of myelination,Q08DN1(Evidence code:IEA/Database source:UniProtKB:O75509|ens),TNFRSF21,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0044224,juxtaparanode region of axon,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,CC,1,1 of 1,0.27,100,0.02258,0.07351
GO:0033557,Slx1-Slx4 complex,F1N7Q0(Evidence code:IEA/Database source:InterPro:IPR018574),SLX4,CC,1,1 of 1,0.27,100,0.02258,0.07351
GO:2000042,negative regulation of double-strand break repair via homologous recombination,F6RF21(Evidence code:IEA/Database source:UniProtKB:A6NHR9|ens),SMCHD1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0045650,negative regulation of macrophage differentiation,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0031435,mitogen-activated protein kinase kinase kinase binding,E1B902(Evidence code:IEA/Database source:UniProtKB:Q12851|ens),MAP4K2,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0070994,detection of oxidative stress,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994),ADIPOQ,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0097252,oligodendrocyte apoptotic process,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0060230,lipoprotein lipase activator activity,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0000121,glycerol-1-phosphatase activity,Q2T9S4(Evidence code:IEA/Database source:EC:3.1.3.21),PGP,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0008349,MAP kinase kinase kinase kinase activity,E1B902(Evidence code:IEA/Database source:InterPro:IPR021160),MAP4K2,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0034618,arginine binding,E1BCN3(Evidence code:IEA/Database source:UniProtKB:Q9UM07|ens),PADI4,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0048672,positive regulation of collateral sprouting,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0043403,skeletal muscle tissue regeneration,Q08DY1(Evidence code:IEA/Database source:UniProtKB:Q9JI08|ens),BIN3,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0030502,negative regulation of bone mineralization,A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q16610|ens),ECM1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0043136,glycerol-3-phosphatase activity,Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8),PGP,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0050436,microfibril binding,Q28019(Evidence code:IDA/Database source:),LTBP2,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0031581,hemidesmosome assembly,E1BF59(Evidence code:IEA/Database source:UniProtKB:Q15149|ens),PLEC,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0032596,protein transport into membrane raft,E1BKZ9(Evidence code:IMP/Database source:),SORT1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:2000584,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994),ADIPOQ,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0044869,negative regulation by host of viral exo-alpha-sialidase activity,Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens),APCS,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0061649,ubiquitin modification-dependent histone binding,Q1RMH9(Evidence code:ISS/Database source:UniProtKB:Q99543),DNAJC2,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:1902897,regulation of postsynaptic density protein 95 clustering,Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4),CRIPT,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0005151,"interleukin-1, type II receptor binding",O77482(Evidence code:IEA/Database source:UniProtKB:P18510|ens),IL1RN,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0007257,activation of JUN kinase activity,E1B902(Evidence code:IEA/Database source:UniProtKB:Q12851|ens),MAP4K2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0031133,regulation of axon diameter,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0033691,sialic acid binding,Q3Y5Z3(Evidence code:IEA/Database source:UniProtKB:Q15848|ens),ADIPOQ,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0060024,rhythmic synaptic transmission,F1MX37(Evidence code:IEA/Database source:UniProtKB:Q6PHS9|ens),CACNA2D2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0046855,inositol phosphate dephosphorylation,E1BAU6(Evidence code:IEA/Database source:UniProtKB:Q9JII1|ens),INPP5E,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0050427,3-phosphoadenosine 5-phosphosulfate metabolic process,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0004655,porphobilinogen synthase activity,Q58DK5(Evidence code:IEA/Database source:InterPro:IPR001731),ALAD,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0006507,GPI anchor release,P80109(Evidence code:IDA/Database source:),GPLD1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0071401,cellular response to triglyceride,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0048680,positive regulation of axon regeneration,P68107(Evidence code:ISA/Database source:UniProtKB:P97534),FKBP1B,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:1903358,regulation of Golgi organization,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:1905907,negative regulation of amyloid fibril formation,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:2000534,positive regulation of renal albumin absorption,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0006172,ADP biosynthetic process,P00570(Evidence code:IEA/Database source:UniRule:UR000166136),AK1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:1904426,positive regulation of GTP binding,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503),CLN5,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0005854,nascent polypeptide-associated complex,Q5E9A1(Evidence code:IEA/Database source:InterPro:IPR016641),NACA,CC,1,1 of 1,0.27,100,0.02258,0.07351
GO:0030305,heparanase activity,Q9MYY0(Evidence code:ISS/Database source:UniProtKB:Q9Y251),HPSE,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:1904027,negative regulation of collagen fibril organization,P21793(Evidence code:IDA/Database source:),DCN,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0030853,negative regulation of granulocyte differentiation,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0034722,gamma-glutamyl-peptidase activity,A7YWG4(Evidence code:IEA/Database source:EC:3.4.19.9),GGH,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0003956,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,Q95KW3(Evidence code:IEA/Database source:InterPro:IPR000768),ART3,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0035799,ureter maturation,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0002430,complement receptor mediated signaling pathway,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0005152,interleukin-1 receptor antagonist activity,O77482(Evidence code:IEA/Database source:InterPro:IPR039348),IL1RN,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0004567,beta-mannosidase activity,Q29444(Evidence code:IEA/Database source:EC:3.2.1.25),MANBA,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0032914,positive regulation of transforming growth factor beta1 production,Q05443(Evidence code:IEA/Database source:UniProtKB:P51885|ens),LUM,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0030870,Mre11 complex,Q3SZL4(Evidence code:IEA/Database source:InterPro:IPR016592),NBN,CC,1,1 of 1,0.27,100,0.02258,0.07351
GO:0048936,peripheral nervous system neuron axonogenesis,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens),NEFH,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0008429,phosphatidylethanolamine binding,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens),PLTP,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0046314,phosphocreatine biosynthetic process,Q9XSC6(Evidence code:ISS/Database source:UniProtKB:P07310),CKM,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0071045,nuclear histone mRNA catabolic process,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0003404,optic vesicle morphogenesis,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0051919,positive regulation of fibrinolysis,Q2KJ63(Evidence code:IEA/Database source:UniProtKB:P03952|ens),KLKB1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0021772,olfactory bulb development,F1MEW1(Evidence code:IEA/Database source:UniProtKB:Q14563|ens),SEMA3A,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0038084,vascular endothelial growth factor signaling pathway,E1BEL6(Evidence code:IEA/Database source:InterPro:IPR014648|I),NRP2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0007158,neuron cell-cell adhesion,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:2000394,positive regulation of lamellipodium morphogenesis,A1A4K5(Evidence code:IEA/Database source:UniProtKB:Q13822|ens),ENPP2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0010572,positive regulation of platelet activation,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:Q9JHK5|ens),PLEK,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0008821,crossover junction endodeoxyribonuclease activity,F1N7Q0(Evidence code:IBA/Database source:PANTHER:PTN001853063),SLX4,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0006046,N-acetylglucosamine catabolic process,A7MBC0(Evidence code:IBA/Database source:PANTHER:PTN000121925),AMDHD2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0070560,protein secretion by platelet,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:Q9JHK5|ens),PLEK,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0008967,phosphoglycolate phosphatase activity,Q2T9S4(Evidence code:ISS/Database source:UniProtKB:A6NDG6),PGP,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0072138,mesenchymal cell proliferation involved in ureteric bud development,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0047391,alkylglycerophosphoethanolamine phosphodiesterase activity,A1A4K5(Evidence code:IEA/Database source:EC:3.1.4.39),ENPP2,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:1903016,negative regulation of exo-alpha-sialidase activity,Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens),APCS,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0042158,lipoprotein biosynthetic process,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P16301|ens),LCAT,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0004751,ribose-5-phosphate isomerase activity,Q3T186(Evidence code:IEA/Database source:InterPro:IPR004788|I),RPIA,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0046900,tetrahydrofolylpolyglutamate metabolic process,A7YWG4(Evidence code:IBA/Database source:PANTHER:PTN000140059),GGH,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0060168,positive regulation of adenosine receptor signaling pathway,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:1903632,positive regulation of aminoacyl-tRNA ligase activity,Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens),AIMP2,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0045295,gamma-catenin binding,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0031018,endocrine pancreas development,A5D791(Evidence code:ISS/Database source:UniProtKB:Q9NZJ5),EIF2AK3,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0042780,tRNA 3-end processing,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0005150,"interleukin-1, type I receptor binding",O77482(Evidence code:IEA/Database source:UniProtKB:P18510|ens),IL1RN,MF,1,1 of 1,0.27,100,0.02258,0.07351
GO:0071397,cellular response to cholesterol,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0002042,cell migration involved in sprouting angiogenesis,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0061179,negative regulation of insulin secretion involved in cellular response to glucose stimulus,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 1,0.27,100,0.02258,0.07351
GO:0045177,apical part of cell,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens), DCHS1 LDLR,CC,2,2 of 19,0.54,10.53,0.0235,0.07578
GO:0007409,axonogenesis,Q05443(Evidence code:IBA/Database source:PANTHER:PTN000689595)P19879(Evidence code:IBA/Database source:PANTHER:PTN000689992), LUM OGN,BP,2,2 of 19,0.54,10.53,0.0235,0.07578
GO:0005901,caveola,P29473(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P01131(Evidence code:IDA/Database source:), NOS3 LDLR,CC,2,2 of 19,0.54,10.53,0.0235,0.07578
GO:0005884,actin filament,P68138(Evidence code:ISS/Database source:UniProtKB:P68133)Q08DY1(Evidence code:IEA/Database source:UniProtKB:Q9JI08|ens), ACTA1 BIN3,CC,2,2 of 19,0.54,10.53,0.0235,0.07578
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000559028)A4IF78(Evidence code:IEA/Database source:GO:0043027), TNFRSF6B TNFAIP8,BP,2,2 of 19,0.54,10.53,0.0235,0.07578
GO:0006869,lipid transport,A4FUZ9(Evidence code:IEA/Database source:InterPro:IPR000074)Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445), APOA5 PLTP LDLR,BP,3,3 of 51,0.81,5.88,0.02373,0.07637
GO:0051246,regulation of protein metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 576,0.27,0.17,0.02474,0.07947
GO:0006469,negative regulation of protein kinase activity,F1MMI6(Evidence code:IBA/Database source:PANTHER:PTN000043893)P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens)P21793(Evidence code:IBA/Database source:PANTHER:PTN000043893), LRRC15 PRKAR1A DCN,BP,3,3 of 52,0.81,5.77,0.02489,0.0798
GO:0016811,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",A6QQ07(Evidence code:IEA/Database source:InterPro:IPR012101)P46446(Evidence code:IEA/Database source:InterPro:IPR016708), BTD ASPA,MF,2,2 of 20,0.54,10,0.02566,0.08195
GO:0010906,regulation of glucose metabolic process,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), ADIPOQ IGFBP5,BP,2,2 of 20,0.54,10,0.02566,0.08195
GO:0005813,centrosome,E1BMK9(Evidence code:IEA/Database source:UniProtKB:Q9NXG0|ens)E1BD35(Evidence code:IEA/Database source:UniProtKB:B7WPL0|ens)F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens)Q27965(Evidence code:ISS/Database source:UniProtKB:P0DMV9), CNTLN RIC8B AKAP9 HSPA1B,CC,4,4 of 99,1.08,4.04,0.03054,0.08463
GO:0006897,endocytosis,P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)O02675(Evidence code:ISS/Database source:UniProtKB:Q16555)P49259(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens), LDLR DPYSL2 PLA2R1 SORT1,BP,4,4 of 96,1.08,4.17,0.02781,0.08463
GO:0042470,melanosome,Q3T0K1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7YWG4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0V8B6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), CALU GGH TPP1,CC,3,3 of 56,0.81,5.36,0.02983,0.08463
GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,Q769I5(Evidence code:IEA/Database source:InterPro:IPR016244)F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens)F1N780(Evidence code:IEA/Database source:InterPro:IPR001426|I), MET RET EPHA7,BP,3,3 of 56,0.81,5.36,0.02983,0.08463
GO:0032496,response to lipopolysaccharide,A5D7R1(Evidence code:IBA/Database source:PANTHER:PTN000753849)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849)A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849), TNFRSF11B TNFRSF21 TNFRSF6B,BP,3,3 of 54,0.81,5.56,0.0273,0.08463
GO:0005506,iron ion binding,E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens)Q08DD0(Evidence code:IEA/Database source:InterPro:IPR001128|I)E1BBX5(Evidence code:IEA/Database source:InterPro:IPR016208), MELTF CYP46A1 AOX2,MF,3,3 of 57,0.81,5.26,0.03114,0.08463
GO:0005769,early endosome,P01131(Evidence code:ISS/Database source:UniProtKB:P01130)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens)A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694), LDLR SORT1 USP10,CC,3,3 of 55,0.81,5.45,0.02855,0.08463
GO:0005096,GTPase activator activity,F1MIX6(Evidence code:IEA/Database source:InterPro:IPR030717)E1BD35(Evidence code:IBA/Database source:PANTHER:PTN000965417)F1MS60(Evidence code:IEA/Database source:InterPro:IPR035510), DOCK1 RIC8B ARHGAP33,MF,3,3 of 54,0.81,5.56,0.0273,0.08463
GO:0005484,SNAP receptor activity,A7MAZ2(Evidence code:IEA/Database source:InterPro:IPR006012)Q2TBU3(Evidence code:IBA/Database source:PANTHER:PTN000473329), STX12 GOSR1,MF,2,2 of 23,0.54,8.7,0.03258,0.08463
GO:0000784,"nuclear chromosome, telomeric region",F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens)F6RF21(Evidence code:IEA/Database source:UniProtKB:A6NHR9|ens), SLX4 SMCHD1,CC,2,2 of 22,0.54,9.09,0.0302,0.08463
GO:0032580,Golgi cisterna membrane,Q07537(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VCH4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), GALNT1 GAL3ST3,CC,2,2 of 22,0.54,9.09,0.0302,0.08463
GO:0048525,negative regulation of viral process,O02659(Evidence code:IEA/Database source:UniProtKB:P11226|ens)Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens), MBL APCS,BP,2,2 of 21,0.54,9.52,0.02789,0.08463
GO:0006165,nucleoside diphosphate phosphorylation,A4IFD0(Evidence code:ISS/Database source:UniProtKB:Q9Y6K8)P00570(Evidence code:ISS/Database source:UniProtKB:P00568), Ak5 AK1,BP,2,2 of 21,0.54,9.52,0.02789,0.08463
GO:0051775,response to redox state,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens),FKBP1B,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0090110,cargo loading into COPII-coated vesicle,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6),MIA3,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0006098,pentose-phosphate shunt,Q3T186(Evidence code:IEA/Database source:UniPathway:UPA00115),RPIA,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0019966,interleukin-1 binding,F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens),IL1R1,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0048041,focal adhesion assembly,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0070306,lens fiber cell differentiation,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0042567,insulin-like growth factor ternary complex,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,CC,1,1 of 2,0.27,50,0.03367,0.08463
GO:0001222,transcription corepressor binding,E1BMT1(Evidence code:IEA/Database source:UniProtKB:O95343|ens),SIX3,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0010459,negative regulation of heart rate,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0051873,killing by host of symbiont cells,O02659(Evidence code:IEA/Database source:UniProtKB:P41317|ens),MBL,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0070493,thrombin-activated receptor signaling pathway,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0001835,blastocyst hatching,A6QNQ6(Evidence code:IEA/Database source:UniProtKB:Q80YR6|ens),RBBP8,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:1902187,negative regulation of viral release from host cell,G3X823(Evidence code:IEA/Database source:UniProtKB:Q12899|ens),TRIM26,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0008430,selenium binding,P49907(Evidence code:IEA/Database source:InterPro:IPR037941),SELENOP,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0071547,piP-body,F1MUI1(Evidence code:IEA/Database source:UniProtKB:Q80VL1|ens),TDRKH,CC,1,1 of 2,0.27,50,0.03367,0.08463
GO:0046790,virion binding,Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens),APCS,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0045919,positive regulation of cytolysis,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0048549,positive regulation of pinocytosis,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0060510,type II pneumocyte differentiation,Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens),AIMP2,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:2000391,positive regulation of neutrophil extravasation,F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens),IL1R1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0002829,negative regulation of type 2 immune response,A5D7S4(Evidence code:IEA/Database source:UniProtKB:O70394|ens),IL27RA,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0035252,UDP-xylosyltransferase activity,F1N283(Evidence code:IEA/Database source:UniProtKB:Q3U4G3|ens),XXYLT1,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:2000345,regulation of hepatocyte proliferation,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0045943,positive regulation of transcription by RNA polymerase I,A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens),EIF2AK3,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0001657,ureteric bud development,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0030070,insulin processing,F1MW08(Evidence code:IEA/Database source:UniProtKB:Q8R2E9|ens),ERO1B,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0021853,cerebral cortex GABAergic interneuron migration,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0008525,phosphatidylcholine transporter activity,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens),PLTP,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0006590,thyroid hormone generation,Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q6IRK9),CPQ,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0006903,vesicle targeting,E1B902(Evidence code:IEA/Database source:UniProtKB:Q61161|ens),MAP4K2,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:1903077,negative regulation of protein localization to plasma membrane,F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens),LRRC15,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0019227,neuronal action potential propagation,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0031290,retinal ganglion cell axon guidance,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0090238,positive regulation of arachidonic acid secretion,P49259(Evidence code:ISS/Database source:UniProtKB:Q62028),PLA2R1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0001205,"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding",E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0033034,positive regulation of myeloid cell apoptotic process,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0072300,positive regulation of metanephric glomerulus development,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0021846,cell proliferation in forebrain,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0004865,protein serine/threonine phosphatase inhibitor activity,F1N1Q9(Evidence code:IEA/Database source:UniProtKB:Q9Z2E4|ens),PPP1R17,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0002161,aminoacyl-tRNA editing activity,Q2T9V8(Evidence code:IEA/Database source:InterPro:IPR003732),DTD1,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0045657,positive regulation of monocyte differentiation,A6QL48(Evidence code:IEA/Database source:UniProtKB:Q6ZMJ4|ens),IL34,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0016403,dimethylargininase activity,P56965(Evidence code:IEA/Database source:InterPro:IPR033197),DDAH1,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0072006,nephron development,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0048713,regulation of oligodendrocyte differentiation,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:1990050,phosphatidic acid transporter activity,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens),PLTP,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0030200,heparan sulfate proteoglycan catabolic process,Q9MYY0(Evidence code:ISS/Database source:UniProtKB:Q9Y251),HPSE,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0002084,protein depalmitoylation,P45478(Evidence code:IEA/Database source:InterPro:IPR030294),PPT1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0001849,complement component C1q binding,Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens),APCS,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0030730,sequestering of triglyceride,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0007130,synaptonemal complex assembly,E1BLN1(Evidence code:IEA/Database source:InterPro:IPR008827),SYCP1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0004563,beta-N-acetylhexosaminidase activity,E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens),GM2A,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0009313,oligosaccharide catabolic process,E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens),GM2A,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0047708,biotinidase activity,A6QQ07(Evidence code:IEA/Database source:EC:3.5.1.12),BTD,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0004096,catalase activity,P00432(Evidence code:IEA/Database source:InterPro:IPR011614|I),CAT,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:1903608,protein localization to cytoplasmic stress granule,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0048227,plasma membrane to endosome transport,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0010693,negative regulation of alkaline phosphatase activity,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens),SEMA4D,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0022011,myelination in peripheral nervous system,F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q6F3F9|ens),ADGRG6,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0016290,palmitoyl-CoA hydrolase activity,P45478(Evidence code:IDA/Database source:),PPT1,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0034653,retinoic acid catabolic process,P62964(Evidence code:IEA/Database source:InterPro:IPR031279),CRABP1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0035497,cAMP response element binding,Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801),ATF6,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0036374,glutathione hydrolase activity,F1MYJ3(Evidence code:IEA/Database source:InterPro:IPR000101),GGT5,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0005797,Golgi medial cisterna,Q2TBU3(Evidence code:IBA/Database source:PANTHER:PTN000473329),GOSR1,CC,1,1 of 2,0.27,50,0.03367,0.08463
GO:0009115,xanthine catabolic process,E1BBX5(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX2,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:2000050,regulation of non-canonical Wnt signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:P51654|ens),GPC3,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0035372,protein localization to microtubule,Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4),CRIPT,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:2000481,positive regulation of cAMP-dependent protein kinase activity,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0070528,protein kinase C signaling,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:Q9JHK5|ens),PLEK,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0000712,resolution of meiotic recombination intermediates,F1N7Q0(Evidence code:IBA/Database source:PANTHER:PTN001853063),SLX4,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0019800,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,P21793(Evidence code:IEA/Database source:UniProtKB:P28654|ens),DCN,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:1900038,negative regulation of cellular response to hypoxia,P56965(Evidence code:IEA/Database source:UniProtKB:O94760|ens),DDAH1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0035620,ceramide transporter activity,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens),PLTP,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0030643,cellular phosphate ion homeostasis,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0090403,oxidative stress-induced premature senescence,P49259(Evidence code:ISS/Database source:UniProtKB:Q13018),PLA2R1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0090063,positive regulation of microtubule nucleation,Q27965(Evidence code:ISS/Database source:UniProtKB:P0DMV9),HSPA1B,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0008340,determination of adult lifespan,F1MSA4(Evidence code:IEA/Database source:UniProtKB:Q6PFE3|ens),RAD54B,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0033592,RNA strand annealing activity,A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859),WBSCR1,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0045110,intermediate filament bundle assembly,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens),NEFH,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",P49259(Evidence code:ISS/Database source:UniProtKB:Q13018),PLA2R1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0071639,positive regulation of monocyte chemotactic protein-1 production,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0071218,cellular response to misfolded protein,Q58DR2(Evidence code:ISS/Database source:UniProtKB:Q9NXW2),DNAJB12,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0004854,xanthine dehydrogenase activity,E1BBX5(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX2,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:1902741,positive regulation of interferon-alpha secretion,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens),IFIH1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0090399,replicative senescence,P49259(Evidence code:ISS/Database source:UniProtKB:Q13018),PLA2R1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0030506,ankyrin binding,E1BF59(Evidence code:IEA/Database source:UniProtKB:Q15149|ens),PLEC,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0005134,interleukin-2 receptor binding,A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q61508|ens),ECM1,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0070417,cellular response to cold,A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens),EIF2AK3,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0048011,neurotrophin TRK receptor signaling pathway,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0004517,nitric-oxide synthase activity,P29473(Evidence code:IEA/Database source:InterPro:IPR004030|I),NOS3,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0004784,superoxide dismutase activity,A3KLR9(Evidence code:IEA/Database source:InterPro:IPR018152),ECSOD,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0060174,limb bud formation,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0003828,"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity",Q6ZXD2(Evidence code:IEA/Database source:EC:2.4.99.8),ST8SIA1,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0003215,cardiac right ventricle morphogenesis,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0010986,positive regulation of lipoprotein particle clearance,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:1900747,negative regulation of vascular endothelial growth factor signaling pathway,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:2000660,negative regulation of interleukin-1-mediated signaling pathway,O77482(Evidence code:IEA/Database source:InterPro:IPR039348),IL1RN,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0036477,somatodendritic compartment,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,CC,1,1 of 2,0.27,50,0.03367,0.08463
GO:0034138,toll-like receptor 3 signaling pathway,A6QP79(Evidence code:IEA/Database source:UniProtKB:Q5KU26|ens),COLEC12,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0071712,ER-associated misfolded protein catabolic process,Q3T083(Evidence code:IBA/Database source:PANTHER:PTN000006098),SDF2L1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0071603,endothelial cell-cell adhesion,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens),THBS4,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:1990825,sequence-specific mRNA binding,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0070700,BMP receptor binding,P22444(Evidence code:IEA/Database source:UniProtKB:P12645|ens),BMP3,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0051005,negative regulation of lipoprotein lipase activity,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0032926,negative regulation of activin receptor signaling pathway,P50291(Evidence code:IEA/Database source:UniProtKB:P19883|ens),FST,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0070573,metallodipeptidase activity,Q17QK3(Evidence code:ISS/Database source:UniProtKB:Q9Y646),CPQ,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0035473,lipase binding,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0010756,positive regulation of plasminogen activation,E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens),MELTF,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0090197,positive regulation of chemokine secretion,Q95M17(Evidence code:ISS/Database source:UniProtKB:Q9BZP6),CHIA,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0007095,mitotic G2 DNA damage checkpoint,Q3SZL4(Evidence code:ISS/Database source:UniProtKB:O60934),NBN,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0043353,enucleate erythrocyte differentiation,P02192(Evidence code:IEA/Database source:UniProtKB:P04247|ens),MB,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0001520,outer dense fiber,P00570(Evidence code:IEA/Database source:UniProtKB:Q9R0Y5|ens),AK1,CC,1,1 of 2,0.27,50,0.03367,0.08463
GO:0043325,"phosphatidylinositol-3,4-bisphosphate binding",F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0010694,positive regulation of alkaline phosphatase activity,P80109(Evidence code:IDA/Database source:),GPLD1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0034638,phosphatidylcholine catabolic process,A1A4K5(Evidence code:ISS/Database source:UniProtKB:Q64610),ENPP2,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0010745,negative regulation of macrophage derived foam cell differentiation,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:2001206,positive regulation of osteoclast development,P40682(Evidence code:IEA/Database source:UniProtKB:Q9R1Q9|ens),ATP6AP1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0090102,cochlea development,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0006624,vacuolar protein processing,Q95M12(Evidence code:IBA/Database source:PANTHER:PTN000243183),LGMN,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0016540,protein autoprocessing,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0004053,arginase activity,Q2KJ64(Evidence code:IEA/Database source:InterPro:IPR014033),ARG1,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0008240,tripeptidyl-peptidase activity,Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773),TPP1,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0034774,secretory granule lumen,E1BCA5(Evidence code:IEA/Database source:UniProtKB:O35684|ens),SERPINI1,CC,1,1 of 2,0.27,50,0.03367,0.08463
GO:0016807,cysteine-type carboxypeptidase activity,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:0006114,glycerol biosynthetic process,Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8),PGP,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,A6QPT7(Evidence code:IEA/Database source:InterPro:IPR033528),ERAP2,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0008266,poly(U) RNA binding,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,MF,1,1 of 2,0.27,50,0.03367,0.08463
GO:2001028,positive regulation of endothelial cell chemotaxis,Q769I5(Evidence code:ISS/Database source:UniProtKB:P08581),MET,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0016266,O-glycan processing,F1N283(Evidence code:IEA/Database source:UniProtKB:Q3U4G3|ens),XXYLT1,BP,1,1 of 2,0.27,50,0.03367,0.08463
GO:0016525,negative regulation of angiogenesis,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens)Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens), DCN THBS4,BP,2,2 of 24,0.54,8.33,0.03503,0.08793
GO:0045202,synapse,P63048(Evidence code:IEA/Database source:UniProtKB:P62984|ens)Q3ZC66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens), UBA52 CRIPT PRKAR1A,CC,3,3 of 60,0.81,5,0.03525,0.08834
GO:0043235,receptor complex,P49259(Evidence code:IEA/Database source:UniProtKB:Q13018|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens), PLA2R1 LDLR RET,CC,3,3 of 61,0.81,4.92,0.03668,0.09178
GO:0004222,metalloendopeptidase activity,P52176(Evidence code:IEA/Database source:InterPro:IPR001818|I)Q9GLE5(Evidence code:IEA/Database source:InterPro:IPR001818|I), MMP9 MMP2,MF,2,2 of 25,0.54,8,0.03756,0.09355
GO:0032868,response to insulin,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens)P13384(Evidence code:IDA/Database source:), SORT1 IGFBP2,BP,2,2 of 25,0.54,8,0.03756,0.09355
GO:0045807,positive regulation of endocytosis,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens), GPC3 LDLR,BP,2,2 of 25,0.54,8,0.03756,0.09355
GO:0046034,ATP metabolic process,A4IFD0(Evidence code:IEA/Database source:InterPro:IPR006267)E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9)P00570(Evidence code:IEA/Database source:InterPro:IPR006267), Ak5 ENTPD5 AK1,BP,3,3 of 62,0.81,4.84,0.03813,0.09485
GO:0000981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",E1BMT1(Evidence code:IEA/Database source:InterPro:IPR032949)A4Z945(Evidence code:IBA/Database source:PANTHER:PTN000192346)E1BNP7(Evidence code:IEA/Database source:UniProtKB:Q91ZK0|ens)E1BN90(Evidence code:IBA/Database source:PANTHER:PTN000003381), SIX3 ZBED8 TFAP2D ZKSCAN2,MF,4,4 of 107,1.08,3.74,0.03855,0.09575
GO:0098609,cell-cell adhesion,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)Q9GKR2(Evidence code:IEA/Database source:InterPro:IPR003987|I)Q28161(Evidence code:IEA/Database source:InterPro:IPR028435), DCHS1 VCAM1 PKP1,BP,3,3 of 65,0.81,4.62,0.04268,0.09609
GO:0003713,transcription coactivator activity,Q5E9A1(Evidence code:ISS/Database source:UniProtKB:Q60817)E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens)A4IFN7(Evidence code:IEA/Database source:UniProtKB:O08759|ens), NACA SIX3 UBE3A,MF,3,3 of 65,0.81,4.62,0.04268,0.09609
GO:0036094,small molecule binding,G3X701(Evidence code:IEA/Database source:InterPro:IPR002345)G3MZU3(Evidence code:IEA/Database source:InterPro:IPR002345)Q0IIA2(Evidence code:IEA/Database source:InterPro:IPR002345), LOC100300091 LOC783399 MGC151921,MF,3,3 of 800,0.81,0.38,0.0395,0.09609
GO:0031201,SNARE complex,A7MAZ2(Evidence code:ISS/Database source:UniProtKB:Q86Y82)Q2TBU3(Evidence code:IBA/Database source:PANTHER:PTN000473329), STX12 GOSR1,CC,2,2 of 27,0.54,7.41,0.0428,0.09609
GO:0005840,ribosome,P63048(Evidence code:IEA/Database source:InterPro:IPR001975)Q56JZ1(Evidence code:IEA/Database source:InterPro:IPR001380|I), UBA52 RPL13,CC,2,2 of 26,0.54,7.69,0.04015,0.09609
GO:0031398,positive regulation of protein ubiquitination,A4IFN7(Evidence code:IEA/Database source:UniProtKB:Q05086|ens)Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens), UBE3A AIMP2,BP,2,2 of 26,0.54,7.69,0.04015,0.09609
GO:0004869,cysteine-type endopeptidase inhibitor activity,Q5DPW9(Evidence code:IEA/Database source:InterPro:IPR000010|I)Q58D62(Evidence code:IEA/Database source:InterPro:IPR000010), CST6 FETUB,MF,2,2 of 26,0.54,7.69,0.04015,0.09609
GO:0009408,response to heat,Q9XSC6(Evidence code:ISS/Database source:UniProtKB:P00565)Q05JF3(Evidence code:IEA/Database source:UniProtKB:O09165|ens), CKM casq1,BP,2,2 of 26,0.54,7.69,0.04015,0.09609
GO:0051781,positive regulation of cell division,Q3SWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0497)P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0497), THBS4 CAT,BP,2,2 of 27,0.54,7.41,0.0428,0.09609
GO:0044342,type B pancreatic cell proliferation,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0052593,tryptamine:oxygen oxidoreductase (deaminating) activity,Q9TTK6(Evidence code:IEA/Database source:EC:1.4.3.21),AOC3,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0045656,negative regulation of monocyte differentiation,Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens),APCS,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0036295,cellular response to increased oxygen levels,P40682(Evidence code:ISS/Database source:UniProtKB:Q15904),ATP6AP1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0001673,male germ cell nucleus,E1BLN1(Evidence code:IEA/Database source:UniProtKB:Q62209|ens),SYCP1,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0098599,palmitoyl hydrolase activity,P45478(Evidence code:IEA/Database source:InterPro:IPR002472),PPT1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:1900025,negative regulation of substrate adhesion-dependent cell spreading,E1BG25(Evidence code:IEA/Database source:UniProtKB:P08582|ens),MELTF,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0060205,cytoplasmic vesicle lumen,E1BCA5(Evidence code:IEA/Database source:UniProtKB:Q99574|ens),SERPINI1,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0035987,endodermal cell differentiation,E1BI98(Evidence code:IEA/Database source:UniProtKB:P12109|ens),COL6A1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:1904357,negative regulation of telomere maintenance via telomere lengthening,F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens),SLX4,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:1900121,negative regulation of receptor binding,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0060052,neurofilament cytoskeleton organization,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens),NEFH,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0047429,nucleoside-triphosphate diphosphatase activity,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:1902692,regulation of neuroblast proliferation,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0017108,5-flap endonuclease activity,F1N7Q0(Evidence code:IBA/Database source:PANTHER:PTN001853063),SLX4,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0017101,aminoacyl-tRNA synthetase multienzyme complex,Q0II26(Evidence code:ISS/Database source:UniProtKB:Q13155),AIMP2,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0000730,DNA recombinase assembly,F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001415033),DMC1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0097655,serpin family protein binding,A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens),CTSL1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0007288,sperm axoneme assembly,F1MX00(Evidence code:IEA/Database source:UniProtKB:Q0VFX2|ens),CFAP157,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0008474,palmitoyl-(protein) hydrolase activity,P45478(Evidence code:IEA/Database source:InterPro:IPR030294),PPT1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0048407,platelet-derived growth factor binding,E1BI98(Evidence code:IEA/Database source:UniProtKB:P12109|ens),COL6A1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0080182,histone H3-K4 trimethylation,E1BD99(Evidence code:IEA/Database source:UniProtKB:Q6N021|ens),TET2,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0060628,regulation of ER to Golgi vesicle-mediated transport,G3MXM5(Evidence code:IEA/Database source:UniProtKB:P54826|ens),GAS1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0042551,neuron maturation,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0060056,mammary gland involution,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0052595,aliphatic-amine oxidase activity,Q9TTK6(Evidence code:IEA/Database source:EC:1.4.3.21),AOC3,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0035627,ceramide transport,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens),PLTP,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0046325,negative regulation of glucose import,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0006656,phosphatidylcholine biosynthetic process,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens),LCAT,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0006689,ganglioside catabolic process,E1BI28(Evidence code:IEA/Database source:InterPro:IPR028996),GM2A,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0031433,telethonin binding,Q8SQ24(Evidence code:IBA/Database source:PANTHER:PTN000409135),MYOZ1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0030151,molybdenum ion binding,Q3MHX0(Evidence code:IEA/Database source:InterPro:IPR005066),SUOX,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0090656,t-circle formation,F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens),SLX4,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0060976,coronary vasculature development,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0002827,positive regulation of T-helper 1 type immune response,A5D7S4(Evidence code:IEA/Database source:UniProtKB:O70394|ens),IL27RA,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0030300,regulation of intestinal cholesterol absorption,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439034),APOA5,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0060038,cardiac muscle cell proliferation,P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens),PRKAR1A,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0035267,NuA4 histone acetyltransferase complex,E1BDZ8(Evidence code:IEA/Database source:InterPro:IPR024943),EPC2,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0030014,CCR4-NOT complex,A4IFB6(Evidence code:ISS/Database source:UniProtKB:Q9H9A5),CNOT10,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0010897,negative regulation of triglyceride catabolic process,P80109(Evidence code:ISS/Database source:UniProtKB:O70362),GPLD1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0071953,elastic fiber,Q28019(Evidence code:IDA/Database source:),LTBP2,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0052596,phenethylamine:oxygen oxidoreductase (deaminating) activity,Q9TTK6(Evidence code:IEA/Database source:EC:1.4.3.21),AOC3,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0008603,cAMP-dependent protein kinase regulator activity,P00514(Evidence code:IEA/Database source:InterPro:IPR012198),PRKAR1A,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0035988,chondrocyte proliferation,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0051044,positive regulation of membrane protein ectodomain proteolysis,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0035970,peptidyl-threonine dephosphorylation,O62830(Evidence code:IEA/Database source:UniProtKB:O75688|ens),PPM1B,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0097001,ceramide binding,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens),PLTP,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0052594,aminoacetone:oxygen oxidoreductase(deaminating) activity,Q9TTK6(Evidence code:IEA/Database source:EC:1.4.3.21),AOC3,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0045821,positive regulation of glycolytic process,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9),ENTPD5,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0045780,positive regulation of bone resorption,P40682(Evidence code:IEA/Database source:UniProtKB:Q9R1Q9|ens),ATP6AP1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0033630,positive regulation of cell adhesion mediated by integrin,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0007263,nitric oxide mediated signal transduction,P29473(Evidence code:IBA/Database source:PANTHER:PTN001066032),NOS3,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:2000020,positive regulation of male gonad development,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0042159,lipoprotein catabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0048302,regulation of isotype switching to IgG isotypes,A5D7S4(Evidence code:IEA/Database source:UniProtKB:O70394|ens),IL27RA,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0090128,regulation of synapse maturation,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens),CLSTN1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0097421,liver regeneration,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0016281,eukaryotic translation initiation factor 4F complex,A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859),WBSCR1,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0071546,pi-body,F1MUI1(Evidence code:IEA/Database source:UniProtKB:Q80VL1|ens),TDRKH,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0042405,nuclear inclusion body,Q3SZL4(Evidence code:ISS/Database source:UniProtKB:O60934),NBN,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0042813,Wnt-activated receptor activity,O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394),SFRP1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0051373,FATZ binding,Q8SQ24(Evidence code:IBA/Database source:PANTHER:PTN000409135),MYOZ1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0042989,sequestering of actin monomers,P62326(Evidence code:IDA/Database source:),TMSB4,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0051451,myoblast migration,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens),THBS4,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0048013,ephrin receptor signaling pathway,F1N780(Evidence code:IEA/Database source:UniProtKB:Q15375|ens),EPHA7,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0043116,negative regulation of vascular permeability,P56965(Evidence code:IEA/Database source:UniProtKB:O94760|ens),DDAH1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0090435,protein localization to nuclear envelope,A5PKH0(Evidence code:IEA/Database source:UniProtKB:Q8NFQ8|ens),TOR1AIP2,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0060355,positive regulation of cell adhesion molecule production,A6QP79(Evidence code:IEA/Database source:UniProtKB:Q5KU26|ens),COLEC12,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0004169,dolichyl-phosphate-mannose-protein mannosyltransferase activity,Q3T083(Evidence code:IBA/Database source:PANTHER:PTN000006098),SDF2L1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0000052,citrulline metabolic process,P56965(Evidence code:IEA/Database source:InterPro:IPR033197),DDAH1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0021983,pituitary gland development,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0050694,galactose 3-O-sulfotransferase activity,Q0VCH4(Evidence code:IEA/Database source:UniProtKB:Q96A11|ens),GAL3ST3,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0048385,regulation of retinoic acid receptor signaling pathway,Q5PXY7(Evidence code:IEA/Database source:InterPro:IPR031281),CRABP2,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0042148,strand invasion,F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001415033),DMC1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0033268,node of Ranvier,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0038180,nerve growth factor signaling pathway,E1BKZ9(Evidence code:IEA/Database source:GO:0010465),SORT1,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0072111,cell proliferation involved in kidney development,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0048266,behavioral response to pain,Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2),THBS4,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0004622,lysophospholipase activity,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881),ENPP2,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0070971,endoplasmic reticulum exit site,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6),MIA3,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0043030,regulation of macrophage activation,Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens),CARKL,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0048012,hepatocyte growth factor receptor signaling pathway,F1MNT5(Evidence code:IEA/Database source:InterPro:IPR034551),MUC20,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0005883,neurofilament,F1MSQ6(Evidence code:IEA/Database source:InterPro:IPR033183),NEFH,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0000795,synaptonemal complex,E1BLN1(Evidence code:IEA/Database source:InterPro:IPR008827),SYCP1,CC,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0006983,ER overload response,A5D791(Evidence code:ISS/Database source:UniProtKB:Q9NZJ5),EIF2AK3,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0001502,cartilage condensation,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0017147,Wnt-protein binding,O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394),SFRP1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0001733,galactosylceramide sulfotransferase activity,Q0VCH4(Evidence code:IEA/Database source:InterPro:IPR009729),GAL3ST3,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0000150,recombinase activity,F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001415033),DMC1,MF,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0006751,glutathione catabolic process,F1MYJ3(Evidence code:IEA/Database source:InterPro:IPR000101),GGT5,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,A7E335(Evidence code:IEA/Database source:InterPro:IPR030721),CDH16,BP,1,1 of 3,0.27,33.33,0.04464,0.09609
GO:0042383,sarcolemma,E1BF59(Evidence code:IEA/Database source:UniProtKB:Q15149|ens)E1BI98(Evidence code:IEA/Database source:UniProtKB:Q04857|ens), PLEC COL6A1,CC,2,2 of 28,0.54,7.14,0.04552,0.09773
GO:0000786,nucleosome,Q2M2T1(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1MSQ6(Evidence code:IEA/Database source:InterPro:IPR005819), HIST1H2BK NEFH,CC,2,2 of 28,0.54,7.14,0.04552,0.09773
GO:0046488,phosphatidylinositol metabolic process,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens)E1BAU6(Evidence code:IEA/Database source:UniProtKB:Q9JII1|ens), PLEK INPP5E,BP,2,2 of 29,0.54,6.9,0.0483,0.1032
GO:0072593,reactive oxygen species metabolic process,P49259(Evidence code:ISS/Database source:UniProtKB:Q13018)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens), PLA2R1 CTGF,BP,2,2 of 29,0.54,6.9,0.0483,0.1032
GO:0045665,negative regulation of neuron differentiation,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens)E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens), SIX3 CNTN2,BP,2,2 of 29,0.54,6.9,0.0483,0.1032
GO:0001649,osteoblast differentiation,P22444(Evidence code:IEA/Database source:InterPro:IPR017197)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), BMP3 IGFBP5,BP,2,2 of 29,0.54,6.9,0.0483,0.1032
GO:0045121,membrane raft,F1MS00(Evidence code:IEA/Database source:UniRule:UR000380777)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)A7MAZ2(Evidence code:IEA/Database source:UniProtKB:Q86Y82|ens), RET PPT1 STX12,CC,3,3 of 71,0.81,4.23,0.05254,0.1043
GO:0034976,response to endoplasmic reticulum stress,Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2)A5PJN2(Evidence code:ISS/Database source:UniProtKB:Q8R180)A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens), THBS4 ERO1A  EIF2AK3,BP,3,3 of 70,0.81,4.29,0.05083,0.1043
GO:0000785,chromatin,E1BKG4(Evidence code:IEA/Database source:UniProtKB:Q29RF7|ens)P02316(Evidence code:IEA/Database source:InterPro:IPR000079)F1N685(Evidence code:IBA/Database source:PANTHER:PTN000284569), PDS5A HMGN1 JMJD1C,CC,3,3 of 70,0.81,4.29,0.05083,0.1043
GO:0007283,spermatogenesis,F1N1D2(Evidence code:IEA/Database source:UniProtKB:Q61880|ens)E1BLN1(Evidence code:IEA/Database source:UniProtKB:Q62209|ens)F1MUI1(Evidence code:IEA/Database source:UniProtKB:Q80VL1|ens), DMC1 SYCP1 TDRKH,BP,3,3 of 72,0.81,4.17,0.05428,0.1043
GO:0050830,defense response to Gram-positive bacterium,A5D7S4(Evidence code:IEA/Database source:UniProtKB:O70394|ens)O02659(Evidence code:IEA/Database source:UniProtKB:P11226|ens), IL27RA MBL,BP,2,2 of 31,0.54,6.45,0.05403,0.1043
GO:0043524,negative regulation of neuron apoptotic process,P45478(Evidence code:ISS/Database source:UniProtKB:P50897)E1BNP7(Evidence code:IEA/Database source:UniProtKB:Q91ZK0|ens), PPT1 TFAP2D,BP,2,2 of 30,0.54,6.67,0.05114,0.1043
GO:0003743,translation initiation factor activity,A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859)Q2YDE1(Evidence code:IEA/Database source:InterPro:IPR037585), WBSCR1 EIF4G3,MF,2,2 of 31,0.54,6.45,0.05403,0.1043
GO:0072562,blood microparticle,G3N342(Evidence code:IBA/Database source:PANTHER:PTN001510949)A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006), IGHE APOA5,CC,2,2 of 31,0.54,6.45,0.05403,0.1043
GO:0048856,anatomical structure development,Q3SYW7(Evidence code:IBA/Database source:PANTHER:PTN001015480)E1BNP7(Evidence code:IBA/Database source:PANTHER:PTN000087637), SPARCL1 TFAP2D,BP,2,2 of 617,0.54,0.32,0.05285,0.1043
GO:0030308,negative regulation of cell growth,P45478(Evidence code:ISS/Database source:UniProtKB:P50897)F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens), PPT1 ENPP1,BP,2,2 of 31,0.54,6.45,0.05403,0.1043
GO:0008021,synaptic vesicle,P45478(Evidence code:ISS/Database source:UniProtKB:P50897)Q0VC68(Evidence code:IEA/Database source:InterPro:IPR030647), PPT1 SEPT5,CC,2,2 of 31,0.54,6.45,0.05403,0.1043
GO:0006906,vesicle fusion,Q2TBU3(Evidence code:IBA/Database source:PANTHER:PTN000473329)A7MAZ2(Evidence code:IBA/Database source:PANTHER:PTN000461349), GOSR1 STX12,BP,2,2 of 31,0.54,6.45,0.05403,0.1043
GO:0060228,phosphatidylcholine-sterol O-acyltransferase activator activity,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006),APOA5,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:0005080,protein kinase C binding,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:1903019,negative regulation of glycoprotein metabolic process,Q3T004(Evidence code:IEA/Database source:UniProtKB:P02743|ens),APCS,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0034380,high-density lipoprotein particle assembly,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006),APOA5,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0006030,chitin metabolic process,Q95M17(Evidence code:IEA/Database source:InterPro:IPR002557|I),CHIA,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,F1MY06(Evidence code:IEA/Database source:UniProtKB:Q9UPQ9|ens),TNRC6B,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens),CADM1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0002070,epithelial cell maturation,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0031529,ruffle organization,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0019430,removal of superoxide radicals,A3KLR9(Evidence code:IEA/Database source:GO:0004784),ECSOD,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0006911,"phagocytosis, engulfment",G3N342(Evidence code:IBA/Database source:PANTHER:PTN001510949),IGHE,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:2000480,negative regulation of cAMP-dependent protein kinase activity,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0008104,protein localization,Q08DY1(Evidence code:IEA/Database source:UniProtKB:Q9NQY0|ens),BIN3,BP,1,1 of 497,0.27,0.2,0.04934,0.1043
GO:0003151,outflow tract morphogenesis,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0075522,IRES-dependent viral translational initiation,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0004862,cAMP-dependent protein kinase inhibitor activity,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:0008156,negative regulation of DNA replication,E1BKG4(Evidence code:IEA/Database source:UniProtKB:Q29RF7|ens),PDS5A,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0005775,vacuolar lumen,Q1ZYR0(Evidence code:IEA/Database source:UniProtKB:Q3UMW8|ens),CLN5,CC,1,1 of 4,0.27,25,0.05548,0.1043
GO:0031284,positive regulation of guanylate cyclase activity,P29473(Evidence code:IMP/Database source:),NOS3,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0060347,heart trabecula formation,F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q6F3F9|ens),ADGRG6,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0032727,positive regulation of interferon-alpha production,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens),IFIH1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0048706,embryonic skeletal system development,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0005865,striated muscle thin filament,P68138(Evidence code:ISS/Database source:UniProtKB:P68133),ACTA1,CC,1,1 of 4,0.27,25,0.05548,0.1043
GO:2001256,regulation of store-operated calcium entry,Q05JF3(Evidence code:IEA/Database source:UniProtKB:P31415|ens),casq1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0035116,embryonic hindlimb morphogenesis,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0045651,positive regulation of macrophage differentiation,A6QL48(Evidence code:IEA/Database source:UniProtKB:Q6ZMJ4|ens),IL34,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0071437,invadopodium,A6QQV9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),AFAP1L1,CC,1,1 of 4,0.27,25,0.05548,0.1043
GO:0090131,mesenchyme migration,P68138(Evidence code:ISS/Database source:UniProtKB:P08023),ACTA1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0051280,negative regulation of release of sequestered calcium ion into cytosol,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens),FKBP1B,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0042953,lipoprotein transport,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6),MIA3,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0002076,osteoblast development,P58073(Evidence code:IBA/Database source:PANTHER:PTN000425409),PTHLH,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0000185,activation of MAPKKK activity,E1B902(Evidence code:IEA/Database source:GO:0008349),MAP4K2,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0051601,exocyst localization,E1B9K5(Evidence code:IBA/Database source:PANTHER:PTN000480155),EXOC3L4,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0030521,androgen receptor signaling pathway,A4IFN7(Evidence code:IEA/Database source:UniProtKB:O08759|ens),UBE3A,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0051901,positive regulation of mitochondrial depolarization,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0019262,N-acetylneuraminate catabolic process,A7MBC0(Evidence code:IEA/Database source:UniPathway:UPA00629),AMDHD2,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0019953,sexual reproduction,A7MBG9(Evidence code:IEA/Database source:UniProtKB:Q9WUK2|ens),WBSCR1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0001838,embryonic epithelial tube formation,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0010739,positive regulation of protein kinase A signaling,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0001660,fever generation,O77482(Evidence code:IBA/Database source:PANTHER:PTN000008646),IL1RN,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0071499,cellular response to laminar fluid shear stress,P29473(Evidence code:IMP/Database source:),NOS3,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0043274,phospholipase binding,P49259(Evidence code:ISS/Database source:UniProtKB:Q13018-1),PLA2R1,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:0070513,death domain binding,Q5EAE6(Evidence code:IBA/Database source:PANTHER:PTN000323543),DAP,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:0007616,long-term memory,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0048185,activin binding,P50291(Evidence code:IEA/Database source:UniProtKB:P19883|ens),FST,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:0090503,"RNA phosphodiester bond hydrolysis, exonucleolytic",A3KN06(Evidence code:IEA/Database source:InterPro:IPR038838),C7H19ORF43,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0031639,plasminogen activation,Q2KJ63(Evidence code:IEA/Database source:UniProtKB:P03952|ens),KLKB1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0007020,microtubule nucleation,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:1901018,positive regulation of potassium ion transmembrane transporter activity,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0009650,UV protection,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0060315,negative regulation of ryanodine-sensitive calcium-release channel activity,P68107(Evidence code:ISA/Database source:UniProtKB:P68106),FKBP1B,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0014850,response to muscle activity,G3X6G7(Evidence code:IEA/Database source:InterPro:IPR039224),METRNL,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0034362,low-density lipoprotein particle,P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0427),LDLR,CC,1,1 of 4,0.27,25,0.05548,0.1043
GO:0003958,NADPH-hemoprotein reductase activity,P29473(Evidence code:IBA/Database source:PANTHER:PTN000453822),NOS3,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:0008045,motor neuron axon guidance,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0050853,B cell receptor signaling pathway,G3N342(Evidence code:IBA/Database source:PANTHER:PTN001510949),IGHE,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0006895,Golgi to endosome transport,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0007205,protein kinase C-activating G-protein coupled receptor signaling pathway,F1MCG9(Evidence code:IEA/Database source:InterPro:IPR000756),DGKK,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0051284,positive regulation of sequestering of calcium ion,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens),FKBP1B,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0070486,leukocyte aggregation,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0008131,primary amine oxidase activity,Q9TTK6(Evidence code:IEA/Database source:InterPro:IPR000269|I),AOC3,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:0030517,negative regulation of axon extension,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0048265,response to pain,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0010642,negative regulation of platelet-derived growth factor receptor signaling pathway,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0035329,hippo signaling,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0004111,creatine kinase activity,Q9XSC6(Evidence code:IEA/Database source:EC:2.7.3.2),CKM,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:0002063,chondrocyte development,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0010873,positive regulation of cholesterol esterification,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006),APOA5,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0030240,skeletal muscle thin filament assembly,P68138(Evidence code:ISS/Database source:UniProtKB:P68133),ACTA1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0032225,"regulation of synaptic transmission, dopaminergic",G5E5W4(Evidence code:IEA/Database source:UniProtKB:Q99P47|ens),CNTNAP4,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0005583,fibrillar collagen trimer,Q05443(Evidence code:IEA/Database source:UniProtKB:P51884|ens),LUM,CC,1,1 of 4,0.27,25,0.05548,0.1043
GO:0002532,production of molecular mediator involved in inflammatory response,Q95M17(Evidence code:ISS/Database source:UniProtKB:Q9BZP6),CHIA,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0048168,regulation of neuronal synaptic plasticity,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0051006,positive regulation of lipoprotein lipase activity,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0070508,cholesterol import,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0048484,enteric nervous system development,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0001103,RNA polymerase II repressing transcription factor binding,A6QNQ6(Evidence code:IEA/Database source:UniProtKB:Q99708|ens),RBBP8,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0015020,glucuronosyltransferase activity,Q5EA01(Evidence code:ISS/Database source:UniProtKB:O43505),B4GAT1 ,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:1901611,phosphatidylglycerol binding,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens),PLTP,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",F1MY06(Evidence code:IEA/Database source:UniProtKB:Q9UPQ9|ens),TNRC6B,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0006907,pinocytosis,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0050884,neuromuscular process controlling posture,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0034663,endoplasmic reticulum chaperone complex,Q3T083(Evidence code:IEA/Database source:UniProtKB:Q9ESP1|ens),SDF2L1,CC,1,1 of 4,0.27,25,0.05548,0.1043
GO:0060055,angiogenesis involved in wound healing,Q9MYY0(Evidence code:IBA/Database source:PANTHER:PTN000372531),HPSE,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0005952,cAMP-dependent protein kinase complex,P00514(Evidence code:IEA/Database source:InterPro:IPR012198),PRKAR1A,CC,1,1 of 4,0.27,25,0.05548,0.1043
GO:0005109,frizzled binding,O19116(Evidence code:IPI/Database source:UniProtKB:Q61088),SFRP1,MF,1,1 of 4,0.27,25,0.05548,0.1043
GO:1902742,apoptotic process involved in development,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0050765,negative regulation of phagocytosis,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0001731,formation of translation preinitiation complex,A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859),WBSCR1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:2000778,positive regulation of interleukin-6 secretion,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens),IFIH1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0009948,anterior/posterior axis specification,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0035567,non-canonical Wnt signaling pathway,O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394),SFRP1,BP,1,1 of 4,0.27,25,0.05548,0.1043
GO:0004860,protein kinase inhibitor activity,F1MMI6(Evidence code:IBA/Database source:PANTHER:PTN000043893)P21793(Evidence code:IBA/Database source:PANTHER:PTN000043893), LRRC15 DCN,MF,2,2 of 32,0.54,6.25,0.05699,0.1069
GO:0017148,negative regulation of translation,P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0652)Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens), ANG2 IGFBP5,BP,2,2 of 32,0.54,6.25,0.05699,0.1069
GO:0003824,catalytic activity,G3MY87(Evidence code:IEA/Database source:InterPro:IPR011013)E1BIY5(Evidence code:IEA/Database source:InterPro:IPR017849|I)F2X047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081)A5PJH9(Evidence code:IEA/Database source:InterPro:IPR000845|I)P62958(Evidence code:IEA/Database source:InterPro:IPR011146)Q9MYM4(Evidence code:IEA/Database source:InterPro:IPR011013)F1MNS5(Evidence code:IEA/Database source:InterPro:IPR002591|I)F1N2D5(Evidence code:IEA/Database source:InterPro:IPR017849|I)Q9XSC6(Evidence code:IEA/Database source:InterPro:IPR014746)O62829(Evidence code:IEA/Database source:InterPro:IPR001932)Q58DK5(Evidence code:IEA/Database source:InterPro:IPR013785)O62830(Evidence code:IEA/Database source:InterPro:IPR001932)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR002591|I), MGAM SULF2 LYZ UPP1 HINT1 GAA ENPP1 IDS CKM PPM1A ALAD PPM1B ENPP2,MF,13,13 of 1952,3.51,0.67,0.05779,0.1083
GO:0004888,transmembrane signaling receptor activity,F1MJV6(Evidence code:IEA/Database source:InterPro:IPR017981)E1BEC6(Evidence code:IEA/Database source:InterPro:IPR017981)A2VDS6(Evidence code:IEA/Database source:InterPro:IPR017981)A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens)P49259(Evidence code:IBA/Database source:PANTHER:PTN000177070), ADGRG6 ADGRF1 VIPR1 SEMA4D PLA2R1,MF,5,5 of 178,1.35,2.81,0.05936,0.1111
GO:0016791,phosphatase activity,F1MFJ3(Evidence code:IEA/Database source:InterPro:IPR000387)F1MME1(Evidence code:IEA/Database source:InterPro:IPR000387)Q2T9S4(Evidence code:IEA/Database source:InterPro:IPR006349), PTPRG PTPRK PGP,MF,3,3 of 75,0.81,4,0.05967,0.1116
GO:0006629,lipid metabolic process,Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q58DL9(Evidence code:IEA/Database source:InterPro:IPR030179)A1A4K5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)O77482(Evidence code:IEA/Database source:UniProtKB:P25085|ens)Q17QB3(Evidence code:IEA/Database source:InterPro:IPR016699)Q2TBM9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q2KIW4(Evidence code:IEA/Database source:InterPro:IPR003386)P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443), ST8SIA1 PLTP ENPP2 IL1RN ASAH1 SERAC1 LCAT LDLR,BP,8,8 of 325,2.16,2.46,0.06019,0.1124
GO:0005758,mitochondrial intermembrane space,Q0VD31(Evidence code:ISS/Database source:UniProtKB:Q9UKA2)Q3SZT9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), FBXL4 CYCT,CC,2,2 of 35,0.54,5.71,0.06617,0.1142
GO:0010212,response to ionizing radiation,F1MSA4(Evidence code:IEA/Database source:UniProtKB:Q6PFE3|ens)F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001415033), RAD54B DMC1,BP,2,2 of 35,0.54,5.71,0.06617,0.1142
GO:0030018,Z disc,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)Q8SQ24(Evidence code:IBA/Database source:PANTHER:PTN000409135), FKBP1B MYOZ1,CC,2,2 of 34,0.54,5.88,0.06306,0.1142
GO:0000781,"chromosome, telomeric region",F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens)F1N1D2(Evidence code:IEA/Database source:UniProtKB:Q61880|ens), SLX4 DMC1,CC,2,2 of 35,0.54,5.71,0.06617,0.1142
GO:0031225,anchored component of membrane,Q5E9X0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0336)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0336), GFRA2 GPC3,CC,2,2 of 34,0.54,5.88,0.06306,0.1142
GO:0005788,endoplasmic reticulum lumen,Q3T083(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BAG3(Evidence code:IEA/Database source:UniProtKB:Q9P2K2|ens), SDF2L1 TXNDC16,CC,2,2 of 34,0.54,5.88,0.06306,0.1142
GO:0042626,"ATPase activity, coupled to transmembrane movement of substances",G5E626(Evidence code:IEA/Database source:InterPro:IPR011527|I)F1MIP7(Evidence code:IEA/Database source:InterPro:IPR011527|I), ABCC6 ABCC2,MF,2,2 of 35,0.54,5.71,0.06617,0.1142
GO:0090501,RNA phosphodiester bond hydrolysis,P80929(Evidence code:IEA/Database source:GO:0004540)P39873(Evidence code:IEA/Database source:GO:0004540), ANG2 BRN,BP,2,2 of 35,0.54,5.71,0.06617,0.1142
GO:0010907,positive regulation of glucose metabolic process,P80109(Evidence code:ISS/Database source:UniProtKB:O70362),GPLD1,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0006465,signal peptide processing,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503),CLN5,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0071300,cellular response to retinoic acid,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0046856,phosphatidylinositol dephosphorylation,E1BAU6(Evidence code:IEA/Database source:InterPro:IPR000300),INPP5E,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0010591,regulation of lamellipodium assembly,Q08DY1(Evidence code:IEA/Database source:UniProtKB:Q9JI08|ens),BIN3,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0097009,energy homeostasis,G3X6G7(Evidence code:IEA/Database source:UniProtKB:Q8VE43|ens),METRNL,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0032331,negative regulation of chondrocyte differentiation,P58073(Evidence code:IEA/Database source:UniProtKB:P12272|ens),PTHLH,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0000050,urea cycle,Q2KJ64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0835),ARG1,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0000145,exocyst,E1B9K5(Evidence code:IEA/Database source:InterPro:IPR010326),EXOC3L4,CC,1,1 of 5,0.27,20,0.0662,0.1142
GO:0050772,positive regulation of axonogenesis,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens),SEMA4D,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0030008,TRAPP complex,Q3T086(Evidence code:IBA/Database source:PANTHER:PTN000302156),TRAPPC6A,CC,1,1 of 5,0.27,20,0.0662,0.1142
GO:0008409,5-3 exonuclease activity,A3KN06(Evidence code:IEA/Database source:InterPro:IPR038838),C7H19ORF43,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0042744,hydrogen peroxide catabolic process,P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0376),CAT,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0030836,positive regulation of actin filament depolymerization,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0034237,protein kinase A regulatory subunit binding,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0034370,triglyceride-rich lipoprotein particle remodeling,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q8C7G5|ens),APOA5,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0006782,protoporphyrinogen IX biosynthetic process,Q58DK5(Evidence code:IEA/Database source:UniPathway:UPA00251),ALAD,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0019509,L-methionine salvage from methylthioadenosine,Q0VD27(Evidence code:IEA/Database source:InterPro:IPR023943|I),ENOPH1,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0034236,protein kinase A catalytic subunit binding,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0045879,negative regulation of smoothened signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0003351,epithelial cilium movement,E1BA36(Evidence code:IEA/Database source:UniProtKB:Q5S003|ens),SPAG17,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0006471,protein ADP-ribosylation,Q95KW3(Evidence code:IEA/Database source:InterPro:IPR000768),ART3,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0009143,nucleoside triphosphate catabolic process,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0004697,protein kinase C activity,A0JN97(Evidence code:IEA/Database source:InterPro:IPR014376|I),PRKCD,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0060229,lipase activator activity,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0043198,dendritic shaft,Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4),CRIPT,CC,1,1 of 5,0.27,20,0.0662,0.1142
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,P68107(Evidence code:ISA/Database source:UniProtKB:P68106),FKBP1B,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0098519,"nucleotide phosphatase activity, acting on free nucleotides",Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8),PGP,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0000980,RNA polymerase II distal enhancer sequence-specific DNA binding,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0016813,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines",Q2KJ64(Evidence code:IEA/Database source:InterPro:IPR020855),ARG1,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0010898,positive regulation of triglyceride catabolic process,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0070412,R-SMAD binding,O62829(Evidence code:ISS/Database source:UniProtKB:P35813),PPM1A,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0007528,neuromuscular junction development,F1MX37(Evidence code:IEA/Database source:UniProtKB:Q6PHS9|ens),CACNA2D2,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0080111,DNA demethylation,E1BD99(Evidence code:IEA/Database source:UniProtKB:Q6N021|ens),TET2,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0017014,protein nitrosylation,P56965(Evidence code:IDA/Database source:),DDAH1,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0048710,regulation of astrocyte differentiation,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0008211,glucocorticoid metabolic process,E1BF81(Evidence code:IEA/Database source:UniProtKB:Q06770|ens),SERPINA6,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0018298,protein-chromophore linkage,P00978(Evidence code:IEA/Database source:UniProtKB-KW:KW-0157),AMBP,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0005664,nuclear origin of replication recognition complex,Q58DC8(Evidence code:ISS/Database source:UniProtKB:Q13415),ORC1,CC,1,1 of 5,0.27,20,0.0662,0.1142
GO:0070300,phosphatidic acid binding,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens),PLTP,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0046718,viral entry into host cell,A6QLR1(Evidence code:IEA/Database source:InterPro:IPR033320),PVRL4,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0014912,negative regulation of smooth muscle cell migration,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0046339,diacylglycerol metabolic process,F1MCG9(Evidence code:IEA/Database source:UniProtKB:Q5KSL6|ens),DGKK,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0030140,trans-Golgi network transport vesicle,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens),SORT1,CC,1,1 of 5,0.27,20,0.0662,0.1142
GO:0006044,N-acetylglucosamine metabolic process,A7MBC0(Evidence code:IEA/Database source:InterPro:IPR003764),AMDHD2,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0004089,carbonate dehydratase activity,P18915(Evidence code:IEA/Database source:InterPro:IPR018338|I),CA6,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0000023,maltose metabolic process,Q9MYM4(Evidence code:IEA/Database source:GO:0032450),GAA,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0097067,cellular response to thyroid hormone stimulus,A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens),CTSL1,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0070527,platelet aggregation,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:Q9JHK5|ens),PLEK,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0051045,negative regulation of membrane protein ectodomain proteolysis,P16368(Evidence code:IBA/Database source:PANTHER:PTN000931945),TIMP2,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0000407,phagophore assembly site,A7MAZ2(Evidence code:IEA/Database source:UniProtKB:Q86Y82|ens),STX12,CC,1,1 of 5,0.27,20,0.0662,0.1142
GO:0043394,proteoglycan binding,A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens),CTSL1,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0070633,transepithelial transport,P80109(Evidence code:ISS/Database source:UniProtKB:O70362),GPLD1,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0007140,male meiotic nuclear division,F1MUI1(Evidence code:IEA/Database source:UniProtKB:Q80VL1|ens),TDRKH,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0034587,piRNA metabolic process,F1MUI1(Evidence code:IEA/Database source:UniProtKB:Q80VL1|ens),TDRKH,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0090136,epithelial cell-cell adhesion,Q5BIR5(Evidence code:IEA/Database source:UniProtKB:P50452|ens),SERPINB8,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0001707,mesoderm formation,P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens),PRKAR1A,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0019855,calcium channel inhibitor activity,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens),FKBP1B,MF,1,1 of 5,0.27,20,0.0662,0.1142
GO:0000413,protein peptidyl-prolyl isomerization,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens),FKBP1B,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0046697,decidualization,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:1901673,regulation of mitotic spindle assembly,Q27965(Evidence code:ISS/Database source:UniProtKB:P0DMV9),HSPA1B,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0046627,negative regulation of insulin receptor signaling pathway,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0090141,positive regulation of mitochondrial fission,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0032801,receptor catabolic process,Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017),LGMN,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0016925,protein sumoylation,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens),IFIH1,BP,1,1 of 5,0.27,20,0.0662,0.1142
GO:0031588,nucleotide-activated protein kinase complex,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,CC,1,1 of 5,0.27,20,0.0662,0.1142
GO:0006412,translation,P63048(Evidence code:IEA/Database source:InterPro:IPR001975)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)F1MYJ3(Evidence code:IEA/Database source:GO:0000048)Q56JZ1(Evidence code:IEA/Database source:InterPro:IPR001380|I), UBA52 AIMP2 GGT5 RPL13,BP,4,4 of 130,1.08,3.08,0.06763,0.1165
GO:0005085,guanyl-nucleotide exchange factor activity,E1BD35(Evidence code:IBA/Database source:PANTHER:PTN000965417)F1MIX6(Evidence code:IEA/Database source:InterPro:IPR026791|I), RIC8B DOCK1,MF,2,2 of 36,0.54,5.56,0.06933,0.1191
GO:0001701,in utero embryonic development,Q3SZL4(Evidence code:ISS/Database source:UniProtKB:Q9R207)Q56JY8(Evidence code:IEA/Database source:UniProtKB:Q64152|ens), NBN BTF3,BP,2,2 of 36,0.54,5.56,0.06933,0.1191
GO:0030176,integral component of endoplasmic reticulum membrane,Q58DR2(Evidence code:ISS/Database source:UniProtKB:Q9NXW2)F1N283(Evidence code:IEA/Database source:UniProtKB:Q8NBI6|ens), DNAJB12 XXYLT1,CC,2,2 of 36,0.54,5.56,0.06933,0.1191
GO:0003700,DNA-binding transcription factor activity,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens)E1BN90(Evidence code:IEA/Database source:InterPro:IPR003309)E1BNP7(Evidence code:IEA/Database source:InterPro:IPR004979)E1BIL7(Evidence code:IEA/Database source:InterPro:IPR003309)Q0VC23(Evidence code:IEA/Database source:InterPro:IPR029801), SIX3 ZKSCAN2 TFAP2D ZKSCAN1 ATF6,MF,5,5 of 187,1.35,2.67,0.06977,0.1197
GO:0008022,protein C-terminus binding,A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q16610|ens)O18739(Evidence code:IEA/Database source:UniProtKB:P29279|ens), ECM1 CTGF,MF,2,2 of 37,0.54,5.41,0.07255,0.1243
GO:0009966,regulation of signal transduction,Q3ZBZ6(Evidence code:IEA/Database source:InterPro:IPR001863)F1MBN4(Evidence code:IBA/Database source:PANTHER:PTN001279849), GPC3 CXorf36,BP,2,2 of 593,0.54,0.34,0.0734,0.1257
GO:0006006,glucose metabolic process,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), ADIPOQ IGFBP5,BP,2,2 of 38,0.54,5.26,0.0758,0.1262
GO:0004540,ribonuclease activity,P39873(Evidence code:IBA/Database source:PANTHER:PTN001350296)P80929(Evidence code:IBA/Database source:PANTHER:PTN001350296), BRN ANG2,MF,2,2 of 38,0.54,5.26,0.0758,0.1262
GO:0042832,defense response to protozoan,Q2KJ64(Evidence code:IEA/Database source:UniProtKB:Q61176|ens),ARG1,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0044130,negative regulation of growth of symbiont in host,O02659(Evidence code:IEA/Database source:UniProtKB:P11226|ens),MBL,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0005158,insulin receptor binding,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,MF,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0030316,osteoclast differentiation,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0045190,isotype switching,Q3SZL4(Evidence code:ISS/Database source:UniProtKB:Q9R207),NBN,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0002040,sprouting angiogenesis,A5D7V3(Evidence code:IEA/Database source:UniProtKB:Q9NQ30|ens),ESM1,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0060760,positive regulation of response to cytokine stimulus,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens),IFIH1,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0071404,cellular response to low-density lipoprotein particle stimulus,P01131(Evidence code:IEA/Database source:UniProtKB:P01130|ens),LDLR,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0060416,response to growth hormone,Q05717(Evidence code:IDA/Database source:),IGFBP5,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0000339,RNA cap binding,Q2YDE1(Evidence code:IEA/Database source:InterPro:IPR037585),EIF4G3,MF,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0043024,ribosomal small subunit binding,A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859),WBSCR1,MF,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0017127,cholesterol transporter activity,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006),APOA5,MF,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0048512,circadian behavior,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0005980,glycogen catabolic process,Q9MYM4(Evidence code:ISS/Database source:UniProtKB:P10253),GAA,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0008373,sialyltransferase activity,Q6ZXD2(Evidence code:IEA/Database source:InterPro:IPR001675|I),ST8SIA1,MF,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0001527,microfibril,Q28019(Evidence code:IDA/Database source:),LTBP2,CC,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0032967,positive regulation of collagen biosynthetic process,F1MS76(Evidence code:IEA/Database source:UniProtKB:Q8C341|ens),SUCO,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:1901185,negative regulation of ERBB signaling pathway,Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017),LGMN,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0020027,hemoglobin metabolic process,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0007064,mitotic sister chromatid cohesion,E1BKG4(Evidence code:IEA/Database source:UniProtKB:Q29RF7|ens),PDS5A,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0031083,BLOC-1 complex,A7MAZ2(Evidence code:IDA/Database source:),STX12,CC,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0061564,axon development,F1MSQ6(Evidence code:IEA/Database source:InterPro:IPR033183),NEFH,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0034446,substrate adhesion-dependent cell spreading,O19116(Evidence code:IDA/Database source:),SFRP1,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0048813,dendrite morphogenesis,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0008242,omega peptidase activity,A7YWG4(Evidence code:IEA/Database source:InterPro:IPR015527),GGH,MF,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0048839,inner ear development,Q2KIV9(Evidence code:IEA/Database source:UniProtKB:P14106|ens),C1QB,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0001965,G-protein alpha-subunit binding,E1BD35(Evidence code:IBA/Database source:PANTHER:PTN000965417),RIC8B,MF,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0070006,metalloaminopeptidase activity,A6QPT7(Evidence code:IEA/Database source:InterPro:IPR033528),ERAP2,MF,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0035278,miRNA mediated inhibition of translation,F1MY06(Evidence code:IEA/Database source:InterPro:IPR033500),TNRC6B,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0010954,positive regulation of protein processing,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0051798,positive regulation of hair follicle development,P50291(Evidence code:IEA/Database source:UniProtKB:P19883|ens),FST,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,P80109(Evidence code:ISS/Database source:UniProtKB:O70362),GPLD1,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0031952,regulation of protein autophosphorylation,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0030552,cAMP binding,P00514(Evidence code:IEA/Database source:UniProtKB-KW:KW-0116),PRKAR1A,MF,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0046033,AMP metabolic process,P00570(Evidence code:IEA/Database source:UniRule:UR000166136),AK1,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0051181,cofactor transport,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0006312,mitotic recombination,F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001415033),DMC1,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:1901862,negative regulation of muscle tissue development,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0005795,Golgi stack,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,CC,1,1 of 6,0.27,16.67,0.0768,0.1262
GO:0005125,cytokine activity,A6QL48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)O77482(Evidence code:IEA/Database source:InterPro:IPR000975)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202), IL34 IL1RN BMP3,MF,3,3 of 84,0.81,3.57,0.07723,0.1266
GO:0016042,lipid catabolic process,P45478(Evidence code:ISS/Database source:UniProtKB:P50897)A1A4K5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)A6H713(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442), PPT1 ENPP2 LIPA,BP,3,3 of 84,0.81,3.57,0.07723,0.1266
GO:0009142,nucleoside triphosphate biosynthetic process,P00570(Evidence code:IEA/Database source:InterPro:IPR028582)A4IFD0(Evidence code:ISS/Database source:UniProtKB:Q9Y6K8), AK1 Ak5,BP,2,2 of 39,0.54,5.13,0.07911,0.1294
GO:0006302,double-strand break repair,Q3SZL4(Evidence code:ISS/Database source:UniProtKB:O60934)F6RF21(Evidence code:IEA/Database source:InterPro:IPR038892), NBN SMCHD1,BP,2,2 of 39,0.54,5.13,0.07911,0.1294
GO:0042742,defense response to bacterium,F2X047(Evidence code:IEA/Database source:InterPro:IPR030056)G3N342(Evidence code:IBA/Database source:PANTHER:PTN001510949)P17453(Evidence code:IEA/Database source:UniProtKB-KW:KW-0044), LYZ IGHE BPI,BP,3,3 of 86,0.81,3.49,0.08141,0.1331
GO:0006957,"complement activation, alternative pathway",Q3T0A3(Evidence code:IEA/Database source:InterPro:IPR037561),CFD,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0017025,TBP-class protein binding,Q5E9A1(Evidence code:ISS/Database source:UniProtKB:Q60817),NACA,MF,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0000272,polysaccharide catabolic process,Q95M17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0624),CHIA,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0034394,protein localization to cell surface,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0005891,voltage-gated calcium channel complex,F1MX37(Evidence code:IEA/Database source:UniProtKB:Q6PHS9|ens),CACNA2D2,CC,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0005149,interleukin-1 receptor binding,O77482(Evidence code:IEA/Database source:InterPro:IPR003297),IL1RN,MF,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0032509,endosome transport via multivesicular body sorting pathway,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0070498,interleukin-1-mediated signaling pathway,F1ML75(Evidence code:IEA/Database source:UniProtKB:P14778|ens),IL1R1,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0050687,negative regulation of defense response to virus,O62830(Evidence code:ISS/Database source:UniProtKB:O75688),PPM1B,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0050750,low-density lipoprotein particle receptor binding,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,MF,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0007416,synapse assembly,E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens),ADGRF1,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0031143,pseudopodium,Q8SQ24(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),MYOZ1,CC,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0043046,DNA methylation involved in gamete generation,F1MUI1(Evidence code:IEA/Database source:UniProtKB:Q80VL1|ens),TDRKH,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0048565,digestive tract development,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0008013,beta-catenin binding,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,MF,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0042627,chylomicron,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,CC,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0070997,neuron death,A6QQ95(Evidence code:IEA/Database source:UniProtKB:Q92876|ens),KLK6,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694),USP10,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0033180,"proton-transporting V-type ATPase, V1 domain",P40682(Evidence code:IEA/Database source:InterPro:IPR008388),ATP6AP1,CC,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0090181,regulation of cholesterol metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,P29473(Evidence code:IMP/Database source:),NOS3,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0030201,heparan sulfate proteoglycan metabolic process,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0086091,regulation of heart rate by cardiac conduction,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0031102,neuron projection regeneration,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006),APOA5,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0008329,signaling pattern recognition receptor activity,A6QP79(Evidence code:ISS/Database source:UniProtKB:Q5KU26),COLEC12,MF,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0019433,triglyceride catabolic process,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0051402,neuron apoptotic process,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0045453,bone resorption,Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773),TPP1,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0031116,positive regulation of microtubule polymerization,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0031369,translation initiation factor binding,Q0P5H6(Evidence code:IEA/Database source:UniProtKB:Q9Y4P3|ens),TBL2,MF,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0051180,vitamin transport,G3MYZ3(Evidence code:IEA/Database source:UniProtKB:P43652|ens),AFM,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0046323,glucose import,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens),SORT1,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0045723,positive regulation of fatty acid biosynthetic process,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,BP,1,1 of 7,0.27,14.29,0.08728,0.1382
GO:0016477,cell migration,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)F1MIX6(Evidence code:IEA/Database source:InterPro:IPR030717)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens), DCHS1 CTGF DOCK1 PTPRK,BP,4,4 of 143,1.08,2.8,0.0879,0.139
GO:0070374,positive regulation of ERK1 and ERK2 cascade,O18739(Evidence code:IEA/Database source:UniProtKB:P29279|ens)P40682(Evidence code:IEA/Database source:UniProtKB:Q9R1Q9|ens), CTGF ATP6AP1,BP,2,2 of 42,0.54,4.76,0.08928,0.1411
GO:0005739,mitochondrion,A7MBI8(Evidence code:IBA/Database source:PANTHER:PTN000315253)Q0VD31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q2TBM9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q3SZT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P00432(Evidence code:IBA/Database source:PANTHER:PTN000157252)Q58CR1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q5EA03(Evidence code:IEA/Database source:UniProtKB:Q96B77|ens)F1MUI1(Evidence code:IEA/Database source:UniProtKB:Q80VL1|ens), NUDT9 FBXL4 SERAC1 CYCT CAT MTFR2 TMEM186 TDRKH,CC,8,8 of 380,2.16,2.11,0.09023,0.1424
GO:0007165,signal transduction,F1MXF5(Evidence code:IEA/Database source:InterPro:IPR028745)Q3SYW7(Evidence code:IEA/Database source:InterPro:IPR016359)E1B7L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1ML75(Evidence code:IEA/Database source:InterPro:IPR000157)Q08DN1(Evidence code:IEA/Database source:InterPro:IPR000488)A5PJT7(Evidence code:IEA/Database source:InterPro:IPR008605)F1MS60(Evidence code:IEA/Database source:InterPro:IPR000198|I)A5D7R1(Evidence code:IEA/Database source:InterPro:IPR000488)F1MUU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1MCG9(Evidence code:IEA/Database source:InterPro:IPR037607)A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164501)A2VDS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1ME33(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)O18739(Evidence code:IBA/Database source:PANTHER:PTN000142748), AKAP9 SPARCL1 OR6C75 IL1R1 TNFRSF21 ECM1 ARHGAP33 TNFRSF11B OR8D4 DGKK ERAP2 VIPR1 LOC788438 PTPRK CTGF,BP,15,15 of 809,4.05,1.85,0.09385,0.148
GO:0005765,lysosomal membrane,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503)Q9MYY0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9MYM4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), CLN5 HPSE GAA,CC,3,3 of 92,0.81,3.26,0.0945,0.148
GO:0051428,peptide hormone receptor binding,P58073(Evidence code:ISS/Database source:UniProtKB:P12272),PTHLH,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0006904,vesicle docking involved in exocytosis,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:Q9JHK5|ens),PLEK,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0009086,methionine biosynthetic process,Q0VD27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0486),ENOPH1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0034361,very-low-density lipoprotein particle,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,CC,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0051146,striated muscle cell differentiation,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0050850,positive regulation of calcium-mediated signaling,P62958(Evidence code:IEA/Database source:UniProtKB:P70349|ens),HINT1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0051965,positive regulation of synapse assembly,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens),CLSTN1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0036297,interstrand cross-link repair,F1N7Q0(Evidence code:IBA/Database source:PANTHER:PTN001853063),SLX4,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0000060,"protein import into nucleus, translocation",E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0010033,response to organic substance,P68107(Evidence code:ISA/Database source:UniProtKB:P97534),FKBP1B,BP,1,1 of 408,0.27,0.25,0.09736,0.148
GO:0070192,chromosome organization involved in meiotic cell cycle,F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001489025),DMC1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0001671,ATPase activator activity,A5PKH0(Evidence code:IEA/Database source:UniProtKB:Q8NFQ8|ens),TOR1AIP2,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0060612,adipose tissue development,E1BKK9(Evidence code:IEA/Database source:UniProtKB:Q8VHC3|ens),SELENOM,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0030866,cortical actin cytoskeleton organization,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0005245,voltage-gated calcium channel activity,F1MX37(Evidence code:IEA/Database source:UniProtKB:Q6PHS9|ens),CACNA2D2,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0042098,T cell proliferation,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0006525,arginine metabolic process,Q2KJ64(Evidence code:IEA/Database source:InterPro:IPR014033),ARG1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0010955,negative regulation of protein processing,G3MXM5(Evidence code:IEA/Database source:UniProtKB:P54826|ens),GAS1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0004864,protein phosphatase inhibitor activity,F1N1Q9(Evidence code:IEA/Database source:InterPro:IPR033242),PPP1R17,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0001974,blood vessel remodeling,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0009154,purine ribonucleotide catabolic process,P62958(Evidence code:ISS/Database source:UniProtKB:P49773),HINT1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0001960,negative regulation of cytokine-mediated signaling pathway,A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q61508|ens),ECM1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,A4IFN7(Evidence code:IEA/Database source:UniProtKB:Q05086|ens),UBE3A,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0010181,FMN binding,P29473(Evidence code:IEA/Database source:InterPro:IPR001094|I),NOS3,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0060348,bone development,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0071467,cellular response to pH,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0045111,intermediate filament cytoskeleton,E1BF59(Evidence code:IEA/Database source:UniProtKB:Q15149|ens),PLEC,CC,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0060306,regulation of membrane repolarization,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0000400,four-way junction DNA binding,F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001415033),DMC1,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0002828,regulation of type 2 immune response,A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q61508|ens),ECM1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0019825,oxygen binding,P02192(Evidence code:IEA/Database source:InterPro:IPR002335|I),MB,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0033619,membrane protein proteolysis,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0030017,sarcomere,P68138(Evidence code:IEA/Database source:UniProtKB:P68133|ens),ACTA1,CC,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0071398,cellular response to fatty acid,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0051894,positive regulation of focal adhesion assembly,O19116(Evidence code:IDA/Database source:),SFRP1,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0016504,peptidase activator activity,A5D7S8(Evidence code:IEA/Database source:InterPro:IPR017048),FBLN1,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0000118,histone deacetylase complex,P62958(Evidence code:ISS/Database source:UniProtKB:P49773),HINT1,CC,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0004402,histone acetyltransferase activity,E1BDZ8(Evidence code:IBA/Database source:PANTHER:PTN000382618),EPC2,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0005344,oxygen carrier activity,P02192(Evidence code:IEA/Database source:UniProtKB-KW:KW-0561),MB,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0006783,heme biosynthetic process,Q58DK5(Evidence code:ISS/Database source:UniProtKB:P13716),ALAD,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0008543,fibroblast growth factor receptor signaling pathway,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0097110,scaffold protein binding,Q3ZC66(Evidence code:IEA/Database source:UniProtKB:Q9P021|ens),CRIPT,MF,1,1 of 8,0.27,12.5,0.09764,0.148
GO:0006796,phosphate-containing compound metabolic process,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,BP,1,1 of 417,0.27,0.24,0.09796,0.1482
GO:0045184,establishment of protein localization,Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4),CRIPT,BP,1,1 of 416,0.27,0.24,0.09786,0.1482
GO:0006464,cellular protein modification process,F1MW08(Evidence code:IBA/Database source:PANTHER:PTN000289179)A5PJN2(Evidence code:IBA/Database source:PANTHER:PTN000289179), ERO1B ERO1A ,BP,2,2 of 565,0.54,0.35,0.102,0.1541
GO:0009055,electron transfer activity,Q3SZT9(Evidence code:IEA/Database source:InterPro:IPR002327|I)E1BBX5(Evidence code:IEA/Database source:InterPro:IPR001041|I), CYCT AOX2,MF,2,2 of 46,0.54,4.35,0.1034,0.1561
GO:0030154,cell differentiation,A7MB70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)O19116(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)O02675(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BEL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P22444(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q5EA85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221), SEMA3C SFRP1 AIMP2 CTGF DPYSL2 NRP2 BMP3 ANG2 SEMA4A,BP,9,9 of 434,2.43,2.07,0.1068,0.1584
GO:0050821,protein stabilization,A7MAZ2(Evidence code:IEA/Database source:UniProtKB:Q86Y82|ens)G3MYZ3(Evidence code:IEA/Database source:UniProtKB:P43652|ens), STX12 AFM,BP,2,2 of 47,0.54,4.26,0.107,0.1584
GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens),EIF2AK3,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0019933,cAMP-mediated signaling,F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q86SQ4|ens),ADGRG6,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0043486,histone exchange,P51122(Evidence code:IBA/Database source:PANTHER:PTN000146837),ANP32A,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0001756,somitogenesis,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0033700,phospholipid efflux,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006),APOA5,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0048286,lung alveolus development,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0046850,regulation of bone remodeling,F1MS76(Evidence code:IEA/Database source:UniProtKB:Q8C341|ens),SUCO,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0032570,response to progesterone,A4IFN7(Evidence code:IEA/Database source:UniProtKB:Q05086|ens),UBE3A,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0030516,regulation of axon extension,O02675(Evidence code:IEA/Database source:InterPro:IPR030615),DPYSL2,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0032720,negative regulation of tumor necrosis factor production,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0061448,connective tissue development,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0006879,cellular iron ion homeostasis,P40682(Evidence code:ISS/Database source:UniProtKB:Q15904),ATP6AP1,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0005844,polysome,A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859),WBSCR1,CC,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:2000249,regulation of actin cytoskeleton reorganization,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0016849,phosphorus-oxygen lyase activity,L8B5P3(Evidence code:IEA/Database source:InterPro:IPR001054),ADCY10,MF,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0002088,lens development in camera-type eye,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0002026,regulation of the force of heart contraction,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0042734,presynaptic membrane,G5E5W4(Evidence code:IEA/Database source:UniProtKB:Q99P47|ens),CNTNAP4,CC,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0042743,hydrogen peroxide metabolic process,Q3SZT9(Evidence code:IEA/Database source:UniProtKB:P00015|ens),CYCT,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0005528,FK506 binding,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens),FKBP1B,MF,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0016239,positive regulation of macroautophagy,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0003777,microtubule motor activity,Q3MHK0(Evidence code:IEA/Database source:InterPro:IPR001752|I),KIF3A,MF,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0046716,muscle cell cellular homeostasis,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0042026,protein refolding,Q27965(Evidence code:ISS/Database source:UniProtKB:P0DMV9),HSPA1B,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0001954,positive regulation of cell-matrix adhesion,O19116(Evidence code:IDA/Database source:),SFRP1,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0031532,actin cytoskeleton reorganization,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0001530,lipopolysaccharide binding,P17453(Evidence code:IEA/Database source:InterPro:IPR030181),BPI,MF,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0046622,positive regulation of organ growth,F1MX37(Evidence code:IEA/Database source:UniProtKB:Q6PHS9|ens),CACNA2D2,BP,1,1 of 9,0.27,11.11,0.1079,0.1584
GO:0051603,proteolysis involved in cellular protein catabolic process,Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017)P25975(Evidence code:IBA/Database source:PANTHER:PTN000274640)A4IFS7(Evidence code:IEA/Database source:UniProtKB:P07711|ens)Q0VCU3(Evidence code:IBA/Database source:PANTHER:PTN000274640), LGMN CTSL CTSL1 CTSF,BP,4,4 of 157,1.08,2.55,0.1126,0.1652
GO:0030335,positive regulation of cell migration,F1MMI6(Evidence code:IEA/Database source:UniProtKB:Q8TF66|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens), LRRC15 RET SEMA4D,BP,3,3 of 100,0.81,3,0.1132,0.1659
GO:0006887,exocytosis,Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6)E1B9K5(Evidence code:IEA/Database source:InterPro:IPR010326), MIA3 EXOC3L4,BP,2,2 of 50,0.54,4,0.1181,0.1688
GO:0001666,response to hypoxia,P02192(Evidence code:IEA/Database source:UniProtKB:P04247|ens)A3KLR9(Evidence code:IEA/Database source:UniProtKB:O09164|ens), MB ECSOD,BP,2,2 of 50,0.54,4,0.1181,0.1688
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,A5PJN2(Evidence code:ISS/Database source:UniProtKB:Q8R180),ERO1A ,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0000266,mitochondrial fission,Q58CR1(Evidence code:IEA/Database source:UniProtKB:Q8VED8|ens),MTFR2,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0001772,immunological synapse,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,CC,1,1 of 10,0.27,10,0.118,0.1688
GO:0016641,"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor",Q8MJ24(Evidence code:IEA/Database source:InterPro:IPR001695|I),LOXL4,MF,1,1 of 10,0.27,10,0.118,0.1688
GO:0042056,chemoattractant activity,P35541(Evidence code:IBA/Database source:PANTHER:PTN000603423),SAA1,MF,1,1 of 10,0.27,10,0.118,0.1688
GO:0030239,myofibril assembly,Q8SQ24(Evidence code:IBA/Database source:PANTHER:PTN000409135),MYOZ1,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0046933,"proton-transporting ATP synthase activity, rotational mechanism",P40682(Evidence code:IEA/Database source:InterPro:IPR008388),ATP6AP1,MF,1,1 of 10,0.27,10,0.118,0.1688
GO:0090023,positive regulation of neutrophil chemotaxis,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens),THBS4,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0010389,regulation of G2/M transition of mitotic cell cycle,G3N0U2(Evidence code:IEA/Database source:InterPro:IPR015452),CCNB3,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0033017,sarcoplasmic reticulum membrane,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,CC,1,1 of 10,0.27,10,0.118,0.1688
GO:0002102,podosome,A6QQV9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),AFAP1L1,CC,1,1 of 10,0.27,10,0.118,0.1688
GO:0070469,respiratory chain,Q3SZT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679),CYCT,CC,1,1 of 10,0.27,10,0.118,0.1688
GO:0045429,positive regulation of nitric oxide biosynthetic process,P56965(Evidence code:IEA/Database source:InterPro:IPR033197),DDAH1,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0017080,sodium channel regulator activity,P80109(Evidence code:ISS/Database source:UniProtKB:O70362),GPLD1,MF,1,1 of 10,0.27,10,0.118,0.1688
GO:0008333,endosome to lysosome transport,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0007628,adult walking behavior,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0070325,lipoprotein particle receptor binding,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,MF,1,1 of 10,0.27,10,0.118,0.1688
GO:0036126,sperm flagellum,P00570(Evidence code:IEA/Database source:UniProtKB:Q9R0Y5|ens),AK1,CC,1,1 of 10,0.27,10,0.118,0.1688
GO:0060048,cardiac muscle contraction,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P10253|ens),GAA,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0035861,site of double-strand break,F6RF21(Evidence code:IEA/Database source:UniProtKB:A6NHR9|ens),SMCHD1,CC,1,1 of 10,0.27,10,0.118,0.1688
GO:0006801,superoxide metabolic process,A3KLR9(Evidence code:IEA/Database source:InterPro:IPR001424|I),ECSOD,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0043010,camera-type eye development,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0030057,desmosome,Q28161(Evidence code:IEA/Database source:InterPro:IPR028432),PKP1,CC,1,1 of 10,0.27,10,0.118,0.1688
GO:0045745,positive regulation of G-protein coupled receptor protein signaling pathway,A6QQ95(Evidence code:IEA/Database source:UniProtKB:Q92876|ens),KLK6,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0045923,positive regulation of fatty acid metabolic process,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994),ADIPOQ,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0045109,intermediate filament organization,A6QQQ9(Evidence code:ISS/Database source:UniProtKB:Q9D312),KRT20,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0035264,multicellular organism growth,E1BKK9(Evidence code:IEA/Database source:UniProtKB:Q8VHC3|ens),SELENOM,BP,1,1 of 10,0.27,10,0.118,0.1688
GO:0016607,nuclear speck,Q3T0I4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1ME65(Evidence code:IEA/Database source:UniProtKB:A0A024RBH2)F1MIX6(Evidence code:IEA/Database source:UniProtKB:A0A096LNH6), ALYREF CKAP4 DOCK1,CC,3,3 of 103,0.81,2.91,0.1205,0.1721
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994)O62829(Evidence code:ISS/Database source:UniProtKB:P35813), ADIPOQ PPM1A,BP,2,2 of 51,0.54,3.92,0.1218,0.1737
GO:0031175,neuron projection development,E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens)E1BPC9(Evidence code:IEA/Database source:InterPro:IPR032991), ADGRF1 CNTN2,BP,2,2 of 51,0.54,3.92,0.1218,0.1737
GO:0007005,mitochondrion organization,Q58CR1(Evidence code:IEA/Database source:UniProtKB:Q8VED8|ens)F1MJV6(Evidence code:IEA/Database source:UniProtKB:Q6F3F9|ens)P29473(Evidence code:IMP/Database source:), MTFR2 ADGRG6 NOS3,BP,3,3 of 104,0.81,2.88,0.123,0.1752
GO:0002062,chondrocyte differentiation,P80109(Evidence code:ISS/Database source:UniProtKB:O70362),GPLD1,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0009395,phospholipid catabolic process,A1A4K5(Evidence code:ISS/Database source:UniProtKB:Q13822),ENPP2,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:2000177,regulation of neural precursor cell proliferation,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens),SEMA4D,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0031122,cytoplasmic microtubule organization,Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4),CRIPT,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0042104,positive regulation of activated T cell proliferation,P13384(Evidence code:ISS/Database source:UniProtKB:P18065),IGFBP2,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0005548,phospholipid transporter activity,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens),PLTP,MF,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0008198,ferrous iron binding,E1BD99(Evidence code:IEA/Database source:UniProtKB:Q6N021|ens),TET2,MF,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0019915,lipid storage,E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens),GM2A,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0051219,phosphoprotein binding,Q0P5H6(Evidence code:IEA/Database source:UniProtKB:Q9Y4P3|ens),TBL2,MF,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0071949,FAD binding,E1BBX5(Evidence code:IEA/Database source:InterPro:IPR016166),AOX2,MF,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0048814,regulation of dendrite morphogenesis,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0050852,T cell receptor signaling pathway,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0071944,cell periphery,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q9JHI8),ADIPOQ,CC,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0032728,positive regulation of interferon-beta production,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens),IFIH1,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0043027,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,A4IF78(Evidence code:IEA/Database source:UniProtKB:O95379|ens),TNFAIP8,MF,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0006122,"mitochondrial electron transport, ubiquinol to cytochrome c",Q3SZT9(Evidence code:IBA/Database source:PANTHER:PTN000238899),CYCT,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0045335,phagocytic vesicle,A7MAZ2(Evidence code:IEA/Database source:UniProtKB:Q86Y82|ens),STX12,CC,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0008286,insulin receptor signaling pathway,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0048038,quinone binding,Q9TTK6(Evidence code:IEA/Database source:InterPro:IPR000269|I),AOC3,MF,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0007339,binding of sperm to zona pellucida,Q58D62(Evidence code:ISS/Database source:UniProtKB:Q9QXC1),FETUB,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0071560,cellular response to transforming growth factor beta stimulus,E1BIR5(Evidence code:IEA/Database source:UniProtKB:O75339|ens),CILP,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0005771,multivesicular body,P01131(Evidence code:IDA/Database source:),LDLR,CC,1,1 of 11,0.27,9.09,0.128,0.1784
GO:2000404,regulation of T cell migration,A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q61508|ens),ECM1,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0006123,"mitochondrial electron transport, cytochrome c to oxygen",Q3SZT9(Evidence code:IBA/Database source:PANTHER:PTN000238899),CYCT,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0006939,smooth muscle contraction,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 11,0.27,9.09,0.128,0.1784
GO:0045926,negative regulation of growth,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), GPC3 IGFBP5,BP,2,2 of 54,0.54,3.7,0.1332,0.1855
GO:0006355,"regulation of transcription, DNA-templated",E1BMT1(Evidence code:IEA/Database source:InterPro:IPR032949)P51122(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BN90(Evidence code:IEA/Database source:InterPro:IPR001909|I)Q9XSK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BDZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A2VE56(Evidence code:IEA/Database source:InterPro:IPR004092)P62958(Evidence code:ISS/Database source:UniProtKB:P49773)A7E3B5(Evidence code:IEA/Database source:InterPro:IPR028853)E1BIL7(Evidence code:IEA/Database source:InterPro:IPR001909|I)F1N685(Evidence code:IBA/Database source:PANTHER:PTN000284569)Q1RMH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BNP7(Evidence code:IEA/Database source:InterPro:IPR004979), SIX3 ANP32A ZKSCAN2 HDGF EPC2 PHF20L1 HINT1 ARID4B ZKSCAN1 JMJD1C DNAJC2 TFAP2D,BP,12,12 of 662,3.24,1.81,0.138,0.1888
GO:0000723,telomere maintenance,Q3SZL4(Evidence code:IEA/Database source:InterPro:IPR016592),NBN,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0034704,calcium channel complex,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens),FKBP1B,CC,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0045744,negative regulation of G-protein coupled receptor protein signaling pathway,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0015459,potassium channel regulator activity,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,MF,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0071385,cellular response to glucocorticoid stimulus,P62326(Evidence code:IDA/Database source:),TMSB4,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,P62958(Evidence code:ISS/Database source:UniProtKB:P49773),HINT1,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0016763,"transferase activity, transferring pentosyl groups",A5PJH9(Evidence code:IEA/Database source:InterPro:IPR018016),UPP1,MF,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0017053,transcriptional repressor complex,A6QNQ6(Evidence code:IEA/Database source:UniProtKB:Q99708|ens),RBBP8,CC,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:1902624,positive regulation of neutrophil migration,P62326(Evidence code:IMP/Database source:),TMSB4,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0043525,positive regulation of neuron apoptotic process,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0010596,negative regulation of endothelial cell migration,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,Q05JF3(Evidence code:IEA/Database source:UniProtKB:P31415|ens),casq1,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0030544,Hsp70 protein binding,Q1RMH9(Evidence code:IEA/Database source:UniProtKB:Q99543|ens),DNAJC2,MF,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0007613,memory,E1BEC6(Evidence code:IEA/Database source:UniProtKB:Q8VEC3|ens),ADGRF1,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0043473,pigmentation,Q3T086(Evidence code:IEA/Database source:UniProtKB:Q78XR0|ens),TRAPPC6A,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0000014,single-stranded DNA endodeoxyribonuclease activity,A6QNQ6(Evidence code:IEA/Database source:UniProtKB:Q99708|ens),RBBP8,MF,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0015485,cholesterol binding,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006),APOA5,MF,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0032757,positive regulation of interleukin-8 production,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0050996,positive regulation of lipid catabolic process,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0006779,porphyrin-containing compound biosynthetic process,Q58DK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0627),ALAD,BP,1,1 of 12,0.27,8.33,0.1379,0.1888
GO:0016887,ATPase activity,F6RF21(Evidence code:IEA/Database source:UniProtKB:Q6P5D8|ens)F1MIP7(Evidence code:IEA/Database source:InterPro:IPR003439|I)G5E626(Evidence code:IEA/Database source:InterPro:IPR003439|I), SMCHD1 ABCC2 ABCC6,MF,3,3 of 110,0.81,2.73,0.1383,0.1891
GO:0007018,microtubule-based movement,Q3MHK0(Evidence code:IEA/Database source:InterPro:IPR001752|I)A7MB48(Evidence code:IEA/Database source:InterPro:IPR024854), KIF3A KTN1,BP,2,2 of 56,0.54,3.57,0.1409,0.1925
GO:0065003,protein-containing complex assembly,Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens),AIMP2,BP,1,1 of 397,0.27,0.25,0.1421,0.194
GO:0003723,RNA binding,F1MUI1(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q3MHV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MXK2(Evidence code:IEA/Database source:InterPro:IPR032747)Q3T0I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q0III8(Evidence code:IEA/Database source:InterPro:IPR001568|I)Q2KIJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A7MBG9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)P10881(Evidence code:IEA/Database source:InterPro:IPR002344|I)Q2T9V8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q56JZ1(Evidence code:IBA/Database source:PANTHER:PTN000197497), TDRKH RBM15B NUFIP2 ALYREF RNASET2 NOL8 WBSCR1 SSB DTD1 RPL13,MF,10,10 of 520,2.7,1.92,0.1423,0.1941
GO:0006914,autophagy,Q5EAE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0072)A5PJS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0072), DAP USP10,BP,2,2 of 57,0.54,3.51,0.1448,0.1974
GO:0008047,enzyme activator activity,F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens)A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens)E1BI28(Evidence code:IEA/Database source:InterPro:IPR028996), SLX4 APOA5 GM2A,MF,3,3 of 113,0.81,2.65,0.1462,0.1977
GO:0007179,transforming growth factor beta receptor signaling pathway,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0050805,negative regulation of synaptic transmission,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0009791,post-embryonic development,A7MB70(Evidence code:IEA/Database source:UniProtKB:Q62181|ens),SEMA3C,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0032781,positive regulation of ATPase activity,A5PKH0(Evidence code:IEA/Database source:UniProtKB:Q8NFQ8|ens),TOR1AIP2,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0048662,negative regulation of smooth muscle cell proliferation,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0003073,regulation of systemic arterial blood pressure,P56965(Evidence code:IEA/Database source:UniProtKB:Q9CWS0|ens),DDAH1,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:1900076,regulation of cellular response to insulin stimulus,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0048260,positive regulation of receptor-mediated endocytosis,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0001654,eye development,E1BMT1(Evidence code:IEA/Database source:InterPro:IPR032949),SIX3,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0009409,response to cold,G3X6G7(Evidence code:IEA/Database source:InterPro:IPR039224),METRNL,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0010507,negative regulation of autophagy,Q5EAE6(Evidence code:IBA/Database source:PANTHER:PTN000323543),DAP,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0031638,zymogen activation,P00741(Evidence code:IEA/Database source:UniProtKB:P00740|ens),F9,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0031047,gene silencing by RNA,F1MY06(Evidence code:IEA/Database source:UniProtKB:Q9UPQ9|ens),TNRC6B,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0048145,regulation of fibroblast proliferation,Q3SZL4(Evidence code:ISS/Database source:UniProtKB:Q9JIL9),NBN,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0009190,cyclic nucleotide biosynthetic process,L8B5P3(Evidence code:IEA/Database source:InterPro:IPR001054),ADCY10,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0016891,"endoribonuclease activity, producing 5-phosphomonoesters",Q29RY4(Evidence code:IEA/Database source:InterPro:IPR013471),ELAC1,MF,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0030199,collagen fibril organization,Q05443(Evidence code:IEA/Database source:InterPro:IPR027219),LUM,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:1901799,negative regulation of proteasomal protein catabolic process,Q58DK5(Evidence code:IEA/Database source:UniProtKB:P13716|ens),ALAD,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0031579,membrane raft organization,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0031098,stress-activated protein kinase signaling cascade,E1B902(Evidence code:IBA/Database source:PANTHER:PTN000684825),MAP4K2,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0050807,regulation of synapse organization,G5E5W4(Evidence code:IEA/Database source:UniProtKB:Q99P47|ens),CNTNAP4,BP,1,1 of 13,0.27,7.69,0.1477,0.1977
GO:0032259,methylation,Q3MHK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)Q5E9U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489), METTL7A TYW3,BP,2,2 of 58,0.54,3.45,0.1487,0.199
GO:0005516,calmodulin binding,P29473(Evidence code:IEA/Database source:InterPro:IPR012144)Q3SYU6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112), NOS3 CNN2,MF,2,2 of 59,0.54,3.39,0.1527,0.2041
GO:0007601,visual perception,Q1ZYR0(Evidence code:IEA/Database source:UniProtKB:Q3UMW8|ens)Q05443(Evidence code:IEA/Database source:InterPro:IPR027219), CLN5 LUM,BP,2,2 of 60,0.54,3.33,0.1566,0.2077
GO:0070328,triglyceride homeostasis,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,BP,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0033014,tetrapyrrole biosynthetic process,Q58DK5(Evidence code:IEA/Database source:InterPro:IPR001731),ALAD,BP,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0031492,nucleosomal DNA binding,P02316(Evidence code:IEA/Database source:InterPro:IPR000079),HMGN1,MF,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0055090,acylglycerol homeostasis,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens),APOA5,BP,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0060070,canonical Wnt signaling pathway,O19116(Evidence code:IBA/Database source:PANTHER:PTN000139394),SFRP1,BP,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0031594,neuromuscular junction,P00514(Evidence code:IEA/Database source:UniProtKB:Q9DBC7|ens),PRKAR1A,CC,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0007565,female pregnancy,Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens),IGFBP5,BP,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0009166,nucleotide catabolic process,A5PJH9(Evidence code:IEA/Database source:InterPro:IPR010059),UPP1,BP,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0002039,p53 binding,A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694),USP10,MF,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0043197,dendritic spine,Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4),CRIPT,CC,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0043292,contractile fiber,E1BF59(Evidence code:IEA/Database source:UniProtKB:Q9QXS1|ens),PLEC,CC,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0001725,stress fiber,P68138(Evidence code:ISS/Database source:UniProtKB:P68133),ACTA1,CC,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0008374,O-acyltransferase activity,Q2KIW4(Evidence code:IEA/Database source:InterPro:IPR003386),LCAT,MF,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0033116,endoplasmic reticulum-Golgi intermediate compartment membrane,P40682(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),ATP6AP1,CC,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0008408,3-5 exonuclease activity,A3KN06(Evidence code:IEA/Database source:InterPro:IPR038838),C7H19ORF43,MF,1,1 of 14,0.27,7.14,0.1574,0.2077
GO:0045765,regulation of angiogenesis,O19116(Evidence code:IMP/Database source:)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881), SFRP1 ENPP2,BP,2,2 of 62,0.54,3.23,0.1646,0.2168
GO:0045104,intermediate filament cytoskeleton organization,F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens),NEFH,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0071230,cellular response to amino acid stimulus,E1BI98(Evidence code:IEA/Database source:UniProtKB:Q04857|ens),COL6A1,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0048306,calcium-dependent protein binding,O02659(Evidence code:IEA/Database source:UniProtKB:P11226|ens),MBL,MF,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0005160,transforming growth factor beta receptor binding,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063),BMP3,MF,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0030509,BMP signaling pathway,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218210),BMP3,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:1902305,regulation of sodium ion transmembrane transport,E1BMC6(Evidence code:IEA/Database source:UniProtKB:Q14BN4|ens),SLMAP,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0050806,positive regulation of synaptic transmission,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens),CLSTN1,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0006997,nucleus organization,E1BLA8(Evidence code:IEA/Database source:UniProtKB:Q91XA2|ens),GOLM1,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0090303,positive regulation of wound healing,P62326(Evidence code:IMP/Database source:),TMSB4,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0006730,one-carbon metabolic process,P18915(Evidence code:IEA/Database source:InterPro:IPR018428),CA6,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063),BMP3,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0001750,photoreceptor outer segment,F1MME1(Evidence code:IEA/Database source:UniProtKB:P35822|ens),PTPRK,CC,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0004177,aminopeptidase activity,A6QPT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0031),ERAP2,MF,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0010494,cytoplasmic stress granule,F1MXK2(Evidence code:IEA/Database source:UniProtKB:Q7Z417|ens),NUFIP2,CC,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0005604,basement membrane,Q3SWW8(Evidence code:IEA/Database source:UniProtKB:P35443|ens),THBS4,CC,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0032233,positive regulation of actin filament bundle assembly,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:1903038,negative regulation of leukocyte cell-cell adhesion,P29473(Evidence code:IMP/Database source:),NOS3,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens),LMAN2,CC,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0000082,G1/S transition of mitotic cell cycle,A6QNQ6(Evidence code:IEA/Database source:UniProtKB:Q80YR6|ens),RBBP8,BP,1,1 of 15,0.27,6.67,0.1669,0.2168
GO:0007015,actin filament organization,P21752(Evidence code:IEA/Database source:InterPro:IPR001152)P62326(Evidence code:IEA/Database source:InterPro:IPR001152), TMSB10 TMSB4,BP,2,2 of 63,0.54,3.17,0.1686,0.2189
GO:0007264,small GTPase mediated signal transduction,F1MIX6(Evidence code:IEA/Database source:InterPro:IPR026791|I)F1MS60(Evidence code:IBA/Database source:PANTHER:PTN001813090), DOCK1 ARHGAP33,BP,2,2 of 64,0.54,3.12,0.1727,0.2239
GO:0006351,"transcription, DNA-templated",E1BN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BIL7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BDZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P62958(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q9XSK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q1RMH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q5E9A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P51122(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804), ZKSCAN2 ZKSCAN1 EPC2 HINT1 HDGF DNAJC2 NACA ANP32A,BP,8,8 of 435,2.16,1.84,0.1736,0.2246
GO:0006974,cellular response to DNA damage stimulus,F1MSA4(Evidence code:IEA/Database source:UniProtKB:Q6PFE3|ens)A6QNQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)Q3SZL4(Evidence code:IEA/Database source:InterPro:IPR016592)A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694), RAD54B RBBP8 NBN USP10,BP,4,4 of 188,1.08,2.13,0.1762,0.2246
GO:0030551,cyclic nucleotide binding,P68107(Evidence code:ISA/Database source:UniProtKB:P97534),FKBP1B,MF,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0043621,protein self-association,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,MF,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0006953,acute-phase response,P35541(Evidence code:IEA/Database source:UniProtKB-KW:KW-0011),SAA1,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0003796,lysozyme activity,F2X047(Evidence code:IEA/Database source:InterPro:IPR000974|I),LYZ,MF,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0010633,negative regulation of epithelial cell migration,F1MEW1(Evidence code:IEA/Database source:UniProtKB:O08665|ens),SEMA3A,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0048747,muscle fiber development,F1MX37(Evidence code:IEA/Database source:UniProtKB:Q6PHS9|ens),CACNA2D2,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0043407,negative regulation of MAP kinase activity,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994),ADIPOQ,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0007612,learning,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0009308,amine metabolic process,Q9TTK6(Evidence code:IEA/Database source:InterPro:IPR000269|I),AOC3,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0000045,autophagosome assembly,A7MAZ2(Evidence code:IEA/Database source:UniProtKB:Q86Y82|ens),STX12,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0005778,peroxisomal membrane,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,CC,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0004180,carboxypeptidase activity,Q17QK3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0121),CPQ,MF,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0045851,pH reduction,P40682(Evidence code:IEA/Database source:UniProtKB:Q9R1Q9|ens),ATP6AP1,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0034103,regulation of tissue remodeling,Q3SWW8(Evidence code:ISS/Database source:UniProtKB:Q9Z1T2),THBS4,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0010508,positive regulation of autophagy,P21793(Evidence code:IEA/Database source:UniProtKB:P07585|ens),DCN,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0051321,meiotic cell cycle,A6QNQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0469),RBBP8,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0046961,"proton-transporting ATPase activity, rotational mechanism",P40682(Evidence code:IEA/Database source:InterPro:IPR008388),ATP6AP1,MF,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0051537,"2 iron, 2 sulfur cluster binding",E1BBX5(Evidence code:IEA/Database source:InterPro:IPR006058),AOX2,MF,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0033141,positive regulation of peptidyl-serine phosphorylation of STAT protein,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0005623,cell,Q3Y5Z3(Evidence code:IDA/Database source:),ADIPOQ,CC,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0071897,DNA biosynthetic process,O18739(Evidence code:IEA/Database source:UniProtKB-KW:KW-0237),CTGF,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0071456,cellular response to hypoxia,Q0P5H6(Evidence code:IEA/Database source:UniProtKB:Q9Y4P3|ens),TBL2,BP,1,1 of 16,0.27,6.25,0.1764,0.2246
GO:0050727,regulation of inflammatory response,Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens)F1ML75(Evidence code:IEA/Database source:UniProtKB:P13504|ens), CARKL IL1R1,BP,2,2 of 66,0.54,3.03,0.1808,0.23
GO:0006941,striated muscle contraction,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0006986,response to unfolded protein,Q3SWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0834),THBS4,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0030837,negative regulation of actin filament polymerization,A2VDX0(Evidence code:IEA/Database source:InterPro:IPR028458),TWF2,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0048278,vesicle docking,A7MAZ2(Evidence code:IBA/Database source:PANTHER:PTN000461349),STX12,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0019905,syntaxin binding,E1BGS4(Evidence code:IEA/Database source:InterPro:IPR026183),TXLNA,MF,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0003727,single-stranded RNA binding,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens),IFIH1,MF,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0001501,skeletal system development,P58073(Evidence code:IEA/Database source:UniProtKB:P12272|ens),PTHLH,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0003705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,MF,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0051084,de novo posttranslational protein folding,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9),ENTPD5,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0051117,ATPase binding,A5PKH0(Evidence code:IEA/Database source:UniProtKB:Q8NFQ8|ens),TOR1AIP2,MF,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0006891,intra-Golgi vesicle-mediated transport,Q2TBU3(Evidence code:IBA/Database source:PANTHER:PTN000473329),GOSR1,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0090090,negative regulation of canonical Wnt signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0003684,damaged DNA binding,A6QNQ6(Evidence code:IEA/Database source:UniProtKB:Q99708|ens),RBBP8,MF,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0045739,positive regulation of DNA repair,F6RF21(Evidence code:IEA/Database source:UniProtKB:A6NHR9|ens),SMCHD1,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0006695,cholesterol biosynthetic process,A4FUZ9(Evidence code:IBA/Database source:PANTHER:PTN000439006),APOA5,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0006890,"retrograde vesicle-mediated transport, Golgi to ER",A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens),LMAN2,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0008094,DNA-dependent ATPase activity,F1N1D2(Evidence code:IEA/Database source:InterPro:IPR011940|I),DMC1,MF,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0007286,spermatid development,F1N1D2(Evidence code:IEA/Database source:UniProtKB:Q61880|ens),DMC1,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0010811,positive regulation of cell-substrate adhesion,Q5E9C0(Evidence code:IEA/Database source:UniProtKB:Q15404|ens),RSU1,BP,1,1 of 17,0.27,5.88,0.1857,0.2329
GO:0042981,regulation of apoptotic process,E1B902(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5D7R1(Evidence code:IBA/Database source:PANTHER:PTN000753849)A4IF78(Evidence code:IEA/Database source:InterPro:IPR008477)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849)P51122(Evidence code:IBA/Database source:PANTHER:PTN000146830)P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063), MAP4K2 TNFRSF11B TNFAIP8 TNFRSF21 ANP32A BMP3,BP,6,6 of 317,1.62,1.89,0.1893,0.2372
GO:0042325,regulation of phosphorylation,E1BE60(Evidence code:IEA/Database source:InterPro:IPR008025|I),PPP1R14A,BP,1,1 of 330,0.27,0.3,0.1932,0.2419
GO:0030317,flagellated sperm motility,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55065|ens),PLTP,BP,1,1 of 18,0.27,5.56,0.195,0.2425
GO:0031623,receptor internalization,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 18,0.27,5.56,0.195,0.2425
GO:0030136,clathrin-coated vesicle,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,CC,1,1 of 18,0.27,5.56,0.195,0.2425
GO:0006635,fatty acid beta-oxidation,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994),ADIPOQ,BP,1,1 of 18,0.27,5.56,0.195,0.2425
GO:0004520,endodeoxyribonuclease activity,F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001415033),DMC1,MF,1,1 of 18,0.27,5.56,0.195,0.2425
GO:0070373,negative regulation of ERK1 and ERK2 cascade,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 18,0.27,5.56,0.195,0.2425
GO:0032088,negative regulation of NF-kappaB transcription factor activity,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,BP,1,1 of 18,0.27,5.56,0.195,0.2425
GO:0003725,double-stranded RNA binding,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens),IFIH1,MF,1,1 of 18,0.27,5.56,0.195,0.2425
GO:0005903,brush border,E1BF59(Evidence code:IEA/Database source:UniProtKB:Q9QXS1|ens),PLEC,CC,1,1 of 18,0.27,5.56,0.195,0.2425
GO:1990904,ribonucleoprotein complex,P10881(Evidence code:IEA/Database source:InterPro:IPR002344),SSB,CC,1,1 of 360,0.27,0.28,0.1994,0.2477
GO:0010595,positive regulation of endothelial cell migration,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:0009247,glycolipid biosynthetic process,Q0VCH4(Evidence code:IEA/Database source:InterPro:IPR009729),GAL3ST3,BP,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:0051384,response to glucocorticoid,O77482(Evidence code:IEA/Database source:UniProtKB:P18510|ens),IL1RN,BP,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:0016573,histone acetylation,E1BDZ8(Evidence code:IEA/Database source:GO:0004402),EPC2,BP,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:0050871,positive regulation of B cell activation,G3N342(Evidence code:IBA/Database source:PANTHER:PTN001510949),IGHE,BP,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:0050770,regulation of axonogenesis,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:0071277,cellular response to calcium ion,P80109(Evidence code:ISS/Database source:UniProtKB:P80108),GPLD1,BP,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:0019827,stem cell population maintenance,E1BCN3(Evidence code:IEA/Database source:UniProtKB:Q9Z183|ens),PADI4,BP,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:0048771,tissue remodeling,Q3SWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0797),THBS4,BP,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,Q3SZT9(Evidence code:IEA/Database source:UniProtKB:P00015|ens),CYCT,BP,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:0004601,peroxidase activity,P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0575),CAT,MF,1,1 of 19,0.27,5.26,0.2041,0.2516
GO:0042826,histone deacetylase binding,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,MF,1,1 of 20,0.27,5,0.2131,0.2598
GO:0005811,lipid droplet,F1ME65(Evidence code:IEA/Database source:UniProtKB:Q07065|ens),CKAP4,CC,1,1 of 20,0.27,5,0.2131,0.2598
GO:0070936,protein K48-linked ubiquitination,A4IFN7(Evidence code:IEA/Database source:UniProtKB:Q05086|ens),UBE3A,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0007338,single fertilization,Q58D62(Evidence code:ISS/Database source:UniProtKB:Q9QXC1),FETUB,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0032587,ruffle membrane,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,CC,1,1 of 20,0.27,5,0.2131,0.2598
GO:0030175,filopodium,P68138(Evidence code:ISS/Database source:UniProtKB:P08023),ACTA1,CC,1,1 of 20,0.27,5,0.2131,0.2598
GO:0060395,SMAD protein signal transduction,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063),BMP3,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0008037,cell recognition,Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens),CADM1,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0007093,mitotic cell cycle checkpoint,Q3SZL4(Evidence code:IEA/Database source:InterPro:IPR016592),NBN,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0051865,protein autoubiquitination,A4IFN7(Evidence code:IEA/Database source:UniProtKB:Q05086|ens),UBE3A,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0010977,negative regulation of neuron projection development,F1MEW1(Evidence code:IEA/Database source:UniProtKB:Q14563|ens),SEMA3A,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0071347,cellular response to interleukin-1,A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694),USP10,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0030177,positive regulation of Wnt signaling pathway,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8IWU5|ens),SULF2,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0006749,glutathione metabolic process,E1BKZ1(Evidence code:IEA/Database source:InterPro:IPR006322),GSR,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0015991,ATP hydrolysis coupled proton transport,P40682(Evidence code:IEA/Database source:InterPro:IPR008388),ATP6AP1,BP,1,1 of 20,0.27,5,0.2131,0.2598
GO:0016853,isomerase activity,P68107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3T186(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413), FKBP1B RPIA,MF,2,2 of 75,0.54,2.67,0.2179,0.265
GO:0031965,nuclear membrane,Q1RMH9(Evidence code:IEA/Database source:UniProtKB:Q99543|ens)Q58DR2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), DNAJC2 DNAJB12,CC,2,2 of 75,0.54,2.67,0.2179,0.265
GO:0008168,methyltransferase activity,Q5E9U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)Q3MHK8(Evidence code:IEA/Database source:InterPro:IPR013216), TYW3 METTL7A,MF,2,2 of 75,0.54,2.67,0.2179,0.265
GO:0004857,enzyme inhibitor activity,P16368(Evidence code:IEA/Database source:UniProtKB-KW:KW-0481)F1MW38(Evidence code:IEA/Database source:InterPro:IPR011061)Q58D62(Evidence code:IEA/Database source:UniProtKB-KW:KW-0481), TIMP2 CRIM1 FETUB,MF,3,3 of 139,0.81,2.16,0.2194,0.2667
GO:0098797,plasma membrane protein complex,F1MNL4(Evidence code:IEA/Database source:UniProtKB:Q92859|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens), NEO1 RET,CC,2,2 of 76,0.54,2.63,0.222,0.267
GO:0001650,fibrillar center,Q3ZC66(Evidence code:IEA/Database source:UniProtKB:Q9P021|ens),CRIPT,CC,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,MF,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0099003,vesicle-mediated transport in synapse,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens),CLSTN1,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0016363,nuclear matrix,P51122(Evidence code:IEA/Database source:UniProtKB:O35381|ens),ANP32A,CC,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0010976,positive regulation of neuron projection development,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0055072,iron ion homeostasis,F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024),NEO1,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0001816,cytokine production,P49259(Evidence code:ISS/Database source:UniProtKB:Q13018),PLA2R1,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0045921,positive regulation of exocytosis,P40682(Evidence code:IEA/Database source:UniProtKB:Q9R1Q9|ens),ATP6AP1,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0050715,positive regulation of cytokine secretion,Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens),CADM1,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0034614,cellular response to reactive oxygen species,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0009611,response to wounding,E1BIY5(Evidence code:IEA/Database source:UniProtKB:Q8CFG0|ens),SULF2,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0003014,renal system process,Q95M12(Evidence code:ISS/Database source:UniProtKB:O89017),LGMN,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,G3N0U2(Evidence code:IEA/Database source:InterPro:IPR015452),CCNB3,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0019395,fatty acid oxidation,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994),ADIPOQ,BP,1,1 of 21,0.27,4.76,0.2221,0.267
GO:0000226,microtubule cytoskeleton organization,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens)F1MSQ6(Evidence code:IEA/Database source:UniProtKB:P19246|ens), CNTN2 NEFH,BP,2,2 of 77,0.54,2.6,0.2262,0.2717
GO:0005977,glycogen metabolic process,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 22,0.27,4.55,0.2309,0.2758
GO:0006487,protein N-linked glycosylation,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9),ENTPD5,BP,1,1 of 22,0.27,4.55,0.2309,0.2758
GO:0034644,cellular response to UV,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 22,0.27,4.55,0.2309,0.2758
GO:0071356,cellular response to tumor necrosis factor,Q08DN1(Evidence code:IEA/Database source:UniProtKB:O75509|ens),TNFRSF21,BP,1,1 of 22,0.27,4.55,0.2309,0.2758
GO:0030178,negative regulation of Wnt signaling pathway,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 22,0.27,4.55,0.2309,0.2758
GO:0003697,single-stranded DNA binding,F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001415033),DMC1,MF,1,1 of 22,0.27,4.55,0.2309,0.2758
GO:0030426,growth cone,F1MCA2(Evidence code:IEA/Database source:UniProtKB:Q91XX8|ens),PCDHGB1,CC,1,1 of 22,0.27,4.55,0.2309,0.2758
GO:0042752,regulation of circadian rhythm,A4IFN7(Evidence code:IEA/Database source:UniProtKB:O08759|ens),UBE3A,BP,1,1 of 22,0.27,4.55,0.2309,0.2758
GO:0015031,protein transport,P45478(Evidence code:ISS/Database source:UniProtKB:P50897)Q2TBU3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0VC16(Evidence code:ISS/Database source:UniProtKB:Q5JRA6)F1MS60(Evidence code:IEA/Database source:InterPro:IPR035510)Q5E9A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q2HJD1(Evidence code:IEA/Database source:UniProtKB:Q9H0V9|ens)G3MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653), PPT1 GOSR1 MIA3 ARHGAP33 NACA LMAN2L AFM,BP,7,7 of 394,1.89,1.78,0.2315,0.2763
GO:0040008,regulation of growth,P13384(Evidence code:IEA/Database source:UniProtKB-KW:KW-0341)Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)Q05717(Evidence code:IEA/Database source:UniProtKB:Q07079|ens), IGFBP2 GPC3 IGFBP5,BP,3,3 of 145,0.81,2.07,0.2373,0.283
GO:0030674,"protein binding, bridging",E1BMK9(Evidence code:IEA/Database source:UniProtKB:Q9NXG0|ens),CNTLN,MF,1,1 of 23,0.27,4.35,0.2396,0.2846
GO:0047485,protein N-terminus binding,Q3SZL4(Evidence code:ISS/Database source:UniProtKB:O60934),NBN,MF,1,1 of 23,0.27,4.35,0.2396,0.2846
GO:0019903,protein phosphatase binding,A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens),EIF2AK3,MF,1,1 of 23,0.27,4.35,0.2396,0.2846
GO:0040014,regulation of multicellular organism growth,F1MX37(Evidence code:IEA/Database source:UniProtKB:Q6PHS9|ens),CACNA2D2,BP,1,1 of 23,0.27,4.35,0.2396,0.2846
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9),ENTPD5,BP,1,1 of 23,0.27,4.35,0.2396,0.2846
GO:0016903,"oxidoreductase activity, acting on the aldehyde or oxo group of donors",E1BBX5(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX2,MF,1,1 of 23,0.27,4.35,0.2396,0.2846
GO:0003755,peptidyl-prolyl cis-trans isomerase activity,P68107(Evidence code:IEA/Database source:EC:5.2.1.8),FKBP1B,MF,1,1 of 24,0.27,4.17,0.2482,0.2932
GO:0017137,Rab GTPase binding,P40682(Evidence code:IEA/Database source:UniProtKB:Q9R1Q9|ens),ATP6AP1,MF,1,1 of 24,0.27,4.17,0.2482,0.2932
GO:0042147,"retrograde transport, endosome to Golgi",Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503),CLN5,BP,1,1 of 24,0.27,4.17,0.2482,0.2932
GO:0036503,ERAD pathway,Q58DR2(Evidence code:ISS/Database source:UniProtKB:Q9NXW2),DNAJB12,BP,1,1 of 24,0.27,4.17,0.2482,0.2932
GO:0046777,protein autophosphorylation,A5D791(Evidence code:ISS/Database source:UniProtKB:Q9NZJ5),EIF2AK3,BP,1,1 of 24,0.27,4.17,0.2482,0.2932
GO:0044853,plasma membrane raft,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,CC,1,1 of 24,0.27,4.17,0.2482,0.2932
GO:0070555,response to interleukin-1,F1ML75(Evidence code:IEA/Database source:UniProtKB:P14778|ens),IL1R1,BP,1,1 of 24,0.27,4.17,0.2482,0.2932
GO:0051258,protein polymerization,Q05JF3(Evidence code:IEA/Database source:UniProtKB:P31415|ens),casq1,BP,1,1 of 24,0.27,4.17,0.2482,0.2932
GO:0016829,lyase activity,Q58DK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)P18915(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456), ALAD CA6,MF,2,2 of 83,0.54,2.41,0.2513,0.2966
GO:0035556,intracellular signal transduction,F1MCG9(Evidence code:IEA/Database source:InterPro:IPR002219)L8B5P3(Evidence code:IEA/Database source:InterPro:IPR001054)A0JN97(Evidence code:IEA/Database source:InterPro:IPR002219)F1MRZ8(Evidence code:IEA/Database source:InterPro:IPR000591)E1B902(Evidence code:IEA/Database source:UniProtKB:Q12851|ens), DGKK ADCY10 PRKCD PLEK MAP4K2,BP,5,5 of 275,1.35,1.82,0.2554,0.301
GO:0007049,cell cycle,Q0VC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A6QNQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A0JN97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131), SEPT5 RBBP8 PRKCD,BP,3,3 of 151,0.81,1.99,0.2553,0.301
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,Q3SZT9(Evidence code:IBA/Database source:PANTHER:PTN000943712),CYCT,BP,1,1 of 25,0.27,4,0.2568,0.3017
GO:0010921,regulation of phosphatase activity,F1N1Q9(Evidence code:IEA/Database source:InterPro:IPR033242),PPP1R17,BP,1,1 of 25,0.27,4,0.2568,0.3017
GO:0050729,positive regulation of inflammatory response,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 25,0.27,4,0.2568,0.3017
GO:0090317,negative regulation of intracellular protein transport,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 25,0.27,4,0.2568,0.3017
GO:0006979,response to oxidative stress,F1MCG9(Evidence code:IEA/Database source:UniProtKB:Q5KSL6|ens)P00432(Evidence code:IEA/Database source:InterPro:IPR018028|I), DGKK CAT,BP,2,2 of 86,0.54,2.33,0.2639,0.3099
GO:0034612,response to tumor necrosis factor,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 26,0.27,3.85,0.2652,0.3099
GO:0070588,calcium ion transmembrane transport,F1MX37(Evidence code:IEA/Database source:GO:0005245),CACNA2D2,BP,1,1 of 26,0.27,3.85,0.2652,0.3099
GO:0031072,heat shock protein binding,A6QP36(Evidence code:IEA/Database source:UniProtKB:Q12907|ens),LMAN2,MF,1,1 of 26,0.27,3.85,0.2652,0.3099
GO:0031256,leading edge membrane,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,CC,1,1 of 26,0.27,3.85,0.2652,0.3099
GO:0071222,cellular response to lipopolysaccharide,Q1JPE3(Evidence code:IEA/Database source:UniProtKB:Q9D5J6|ens),CARKL,BP,1,1 of 26,0.27,3.85,0.2652,0.3099
GO:0004527,exonuclease activity,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,MF,1,1 of 26,0.27,3.85,0.2652,0.3099
GO:0004843,thiol-dependent ubiquitin-specific protease activity,A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694),USP10,MF,1,1 of 26,0.27,3.85,0.2652,0.3099
GO:0001932,regulation of protein phosphorylation,P00514(Evidence code:IEA/Database source:InterPro:IPR012198),PRKAR1A,BP,1,1 of 304,0.27,0.33,0.2719,0.3172
GO:0009967,positive regulation of signal transduction,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994),ADIPOQ,BP,1,1 of 308,0.27,0.32,0.2728,0.3172
GO:0031490,chromatin DNA binding,F1N685(Evidence code:IBA/Database source:PANTHER:PTN000284569),JMJD1C,MF,1,1 of 27,0.27,3.7,0.2735,0.3172
GO:0007050,cell cycle arrest,P00570(Evidence code:IEA/Database source:UniProtKB:Q9R0Y5|ens),AK1,BP,1,1 of 27,0.27,3.7,0.2735,0.3172
GO:0009566,fertilization,F1MUI1(Evidence code:IEA/Database source:UniProtKB:Q80VL1|ens),TDRKH,BP,1,1 of 27,0.27,3.7,0.2735,0.3172
GO:0051287,NAD binding,E1BBX5(Evidence code:IEA/Database source:InterPro:IPR014313),AOX2,MF,1,1 of 27,0.27,3.7,0.2735,0.3172
GO:0001894,tissue homeostasis,O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens),CTGF,BP,1,1 of 27,0.27,3.7,0.2735,0.3172
GO:0031032,actomyosin structure organization,Q3SYU6(Evidence code:IEA/Database source:InterPro:IPR001997),CNN2,BP,1,1 of 27,0.27,3.7,0.2735,0.3172
GO:0050680,negative regulation of epithelial cell proliferation,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 27,0.27,3.7,0.2735,0.3172
GO:0005496,steroid binding,E1BF81(Evidence code:ISS/Database source:UniProtKB:P08185),SERPINA6,MF,1,1 of 27,0.27,3.7,0.2735,0.3172
GO:0005319,lipid transporter activity,Q58DL9(Evidence code:IEA/Database source:UniProtKB:P55058|ens),PLTP,MF,1,1 of 27,0.27,3.7,0.2735,0.3172
GO:0032270,positive regulation of cellular protein metabolic process,Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848),ADIPOQ,BP,1,1 of 322,0.27,0.31,0.2782,0.3223
GO:0004674,protein serine/threonine kinase activity,E1B902(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A0JN97(Evidence code:IEA/Database source:InterPro:IPR000961|I), MAP4K2 PRKCD,MF,2,2 of 90,0.54,2.22,0.2806,0.325
GO:0036064,ciliary basal body,F1MX00(Evidence code:IEA/Database source:UniProtKB:Q0VFX2|ens),CFAP157,CC,1,1 of 28,0.27,3.57,0.2818,0.3254
GO:0010634,positive regulation of epithelial cell migration,A1A4K5(Evidence code:IEA/Database source:UniProtKB:Q13822|ens),ENPP2,BP,1,1 of 28,0.27,3.57,0.2818,0.3254
GO:0007611,learning or memory,E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens),GM2A,BP,1,1 of 28,0.27,3.57,0.2818,0.3254
GO:0006606,protein import into nucleus,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 28,0.27,3.57,0.2818,0.3254
GO:0006644,phospholipid metabolic process,Q2KIW4(Evidence code:IEA/Database source:UniProtKB:P04180|ens)A1A4K5(Evidence code:IEA/Database source:UniProtKB:Q9R1E6|ens), LCAT ENPP2,BP,2,2 of 91,0.54,2.2,0.2848,0.3287
GO:0003676,nucleic acid binding,P39873(Evidence code:IEA/Database source:InterPro:IPR001427)Q3MHV8(Evidence code:IEA/Database source:InterPro:IPR000504|I)P10881(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MUI1(Evidence code:IEA/Database source:InterPro:IPR004087)P80929(Evidence code:IEA/Database source:InterPro:IPR001427)Q1LZB8(Evidence code:IEA/Database source:InterPro:IPR006572)Q2KIJ3(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MY06(Evidence code:IEA/Database source:InterPro:IPR035979)A7MBG9(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BIL7(Evidence code:IEA/Database source:InterPro:IPR001909|I)E1BN90(Evidence code:IEA/Database source:InterPro:IPR001909|I)F1MNS5(Evidence code:IEA/Database source:InterPro:IPR001604|I)A1A4K5(Evidence code:IEA/Database source:InterPro:IPR001604|I)F1MTJ4(Evidence code:IEA/Database source:InterPro:IPR001878|I)Q3T0I4(Evidence code:IEA/Database source:InterPro:IPR000504|I), BRN RBM15B SSB TDRKH ANG2 DBF4 NOL8 TNRC6B WBSCR1 ZKSCAN1 ZKSCAN2 ENPP1 ENPP2 PEG10 ALYREF,MF,15,15 of 989,4.05,1.52,0.2884,0.3326
GO:0009617,response to bacterium,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens)Q3Y5Z3(Evidence code:IEA/Database source:UniProtKB:Q60994|ens), GPC3 ADIPOQ,BP,2,2 of 92,0.54,2.17,0.289,0.333
GO:0036459,thiol-dependent ubiquitinyl hydrolase activity,A5PJS6(Evidence code:IEA/Database source:InterPro:IPR001394|I),USP10,MF,1,1 of 29,0.27,3.45,0.2899,0.3334
GO:0003774,motor activity,Q3MHK0(Evidence code:IEA/Database source:UniRule:UR000401007),KIF3A,MF,1,1 of 29,0.27,3.45,0.2899,0.3334
GO:0006338,chromatin remodeling,E1BCN3(Evidence code:IEA/Database source:UniProtKB:Q9Z183|ens),PADI4,BP,1,1 of 29,0.27,3.45,0.2899,0.3334
GO:0005543,phospholipid binding,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens)P00743(Evidence code:IEA/Database source:UniProtKB:P00742|ens), APOA5 F10,MF,2,2 of 94,0.54,2.13,0.2974,0.3417
GO:0012505,endomembrane system,A7MAZ2(Evidence code:IBA/Database source:PANTHER:PTN000461349),STX12,CC,1,1 of 30,0.27,3.33,0.298,0.3417
GO:0016579,protein deubiquitination,A5PJS6(Evidence code:IEA/Database source:InterPro:IPR001394),USP10,BP,1,1 of 30,0.27,3.33,0.298,0.3417
GO:0071482,cellular response to light stimulus,Q17QV5(Evidence code:IEA/Database source:InterPro:IPR029588),TRPM3,BP,1,1 of 30,0.27,3.33,0.298,0.3417
GO:0001934,positive regulation of protein phosphorylation,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848)A6QL48(Evidence code:IEA/Database source:InterPro:IPR020415)A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens), EPHA7 ADIPOQ IL34 SEMA4D,BP,4,4 of 205,1.08,1.95,0.3062,0.3487
GO:0038023,signaling receptor activity,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens)Q5E9X0(Evidence code:IEA/Database source:InterPro:IPR003438|I)F1MNL4(Evidence code:IEA/Database source:InterPro:IPR033024)P49259(Evidence code:ISS/Database source:UniProtKB:Q13018-1), SEMA4D GFRA2 NEO1 PLA2R1,MF,4,4 of 204,1.08,1.96,0.3048,0.3487
GO:0004497,monooxygenase activity,Q08DD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503),CYP46A1,MF,1,1 of 31,0.27,3.23,0.3059,0.3487
GO:0045766,positive regulation of angiogenesis,A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q16610|ens),ECM1,BP,1,1 of 31,0.27,3.23,0.3059,0.3487
GO:0051289,protein homotetramerization,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,BP,1,1 of 31,0.27,3.23,0.3059,0.3487
GO:0000165,MAPK cascade,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 31,0.27,3.23,0.3059,0.3487
GO:0000048,peptidyltransferase activity,F1MYJ3(Evidence code:IEA/Database source:UniProtKB:P36269|ens),GGT5,MF,1,1 of 31,0.27,3.23,0.3059,0.3487
GO:0043021,ribonucleoprotein complex binding,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens),IFIH1,MF,1,1 of 31,0.27,3.23,0.3059,0.3487
GO:0030182,neuron differentiation,F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens),RET,BP,1,1 of 31,0.27,3.23,0.3059,0.3487
GO:0005814,centriole,E1BMK9(Evidence code:IEA/Database source:UniProtKB:Q9NXG0|ens),CNTLN,CC,1,1 of 31,0.27,3.23,0.3059,0.3487
GO:0050829,defense response to Gram-negative bacterium,P17453(Evidence code:IEA/Database source:InterPro:IPR030181),BPI,BP,1,1 of 32,0.27,3.12,0.3138,0.3569
GO:0010952,positive regulation of peptidase activity,A5D7S8(Evidence code:IEA/Database source:GO:0016504),FBLN1,BP,1,1 of 32,0.27,3.12,0.3138,0.3569
GO:0045444,fat cell differentiation,G3X6G7(Evidence code:IEA/Database source:UniProtKB:Q8VE43|ens),METRNL,BP,1,1 of 33,0.27,3.03,0.3216,0.3653
GO:0003714,transcription corepressor activity,A6QNQ6(Evidence code:IEA/Database source:UniProtKB:Q99708|ens),RBBP8,MF,1,1 of 33,0.27,3.03,0.3216,0.3653
GO:0005938,cell cortex,F1MS60(Evidence code:IBA/Database source:PANTHER:PTN000404766),ARHGAP33,CC,1,1 of 34,0.27,2.94,0.3293,0.373
GO:0006366,transcription by RNA polymerase II,E1BMT1(Evidence code:IEA/Database source:GO:0001205),SIX3,BP,1,1 of 34,0.27,2.94,0.3293,0.373
GO:0060828,regulation of canonical Wnt signaling pathway,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:P51654|ens),GPC3,BP,1,1 of 34,0.27,2.94,0.3293,0.373
GO:0008652,cellular amino acid biosynthetic process,Q0VD27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0028),ENOPH1,BP,1,1 of 34,0.27,2.94,0.3293,0.373
GO:0005925,focal adhesion,Q5E9C0(Evidence code:IEA/Database source:UniProtKB:Q15404|ens)E1BF59(Evidence code:IEA/Database source:UniProtKB:Q15149|ens), RSU1 PLEC,CC,2,2 of 103,0.54,1.94,0.3348,0.3789
GO:0009267,cellular response to starvation,A6QQQ9(Evidence code:ISS/Database source:UniProtKB:Q9D312),KRT20,BP,1,1 of 35,0.27,2.86,0.3369,0.3808
GO:0051092,positive regulation of NF-kappaB transcription factor activity,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,BP,1,1 of 35,0.27,2.86,0.3369,0.3808
GO:0010008,endosome membrane,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens)Q28193(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), RET FURIN,CC,2,2 of 104,0.54,1.92,0.3389,0.3828
GO:0010769,regulation of cell morphogenesis involved in differentiation,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,BP,1,1 of 36,0.27,2.78,0.3444,0.3875
GO:0000302,response to reactive oxygen species,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,BP,1,1 of 36,0.27,2.78,0.3444,0.3875
GO:0005777,peroxisome,P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0576),CAT,CC,1,1 of 36,0.27,2.78,0.3444,0.3875
GO:0006665,sphingolipid metabolic process,Q6ZXD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0746),ST8SIA1,BP,1,1 of 36,0.27,2.78,0.3444,0.3875
GO:0005802,trans-Golgi network,Q3T086(Evidence code:IBA/Database source:PANTHER:PTN000302156),TRAPPC6A,CC,1,1 of 36,0.27,2.78,0.3444,0.3875
GO:0033138,positive regulation of peptidyl-serine phosphorylation,F1MXF5(Evidence code:IEA/Database source:UniProtKB:Q99996|ens),AKAP9,BP,1,1 of 36,0.27,2.78,0.3444,0.3875
GO:0005730,nucleolus,P80929(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens)Q3ZC66(Evidence code:IEA/Database source:UniProtKB:Q9P021|ens)O62830(Evidence code:IEA/Database source:UniProtKB:O75688|ens), ANG2 CTSL CRIPT PPM1B,CC,4,4 of 232,1.08,1.72,0.3479,0.3912
GO:0016209,antioxidant activity,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,MF,1,1 of 37,0.27,2.7,0.3518,0.395
GO:0042493,response to drug,F1MSA4(Evidence code:IEA/Database source:UniProtKB:Q6PFE3|ens),RAD54B,BP,1,1 of 37,0.27,2.7,0.3518,0.395
GO:0030099,myeloid cell differentiation,E1BD99(Evidence code:IEA/Database source:UniProtKB:Q6N021|ens),TET2,BP,1,1 of 38,0.27,2.63,0.3592,0.4022
GO:0045930,negative regulation of mitotic cell cycle,G3MXM5(Evidence code:IEA/Database source:UniProtKB:P54826|ens),GAS1,BP,1,1 of 38,0.27,2.63,0.3592,0.4022
GO:0061077,chaperone-mediated protein folding,P68107(Evidence code:IBA/Database source:PANTHER:PTN000054102),FKBP1B,BP,1,1 of 38,0.27,2.63,0.3592,0.4022
GO:0045732,positive regulation of protein catabolic process,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 38,0.27,2.63,0.3592,0.4022
GO:0007626,locomotory behavior,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 39,0.27,2.56,0.3664,0.4092
GO:0006936,muscle contraction,E1BMC6(Evidence code:IEA/Database source:InterPro:IPR030498),SLMAP,BP,1,1 of 39,0.27,2.56,0.3664,0.4092
GO:0042113,B cell activation,E1BGS4(Evidence code:IEA/Database source:UniProtKB:Q6PAM1|ens),TXLNA,BP,1,1 of 39,0.27,2.56,0.3664,0.4092
GO:0007162,negative regulation of cell adhesion,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 39,0.27,2.56,0.3664,0.4092
GO:0042594,response to starvation,Q58D84(Evidence code:IEA/Database source:UniProtKB:Q62356|ens),FSTL1,BP,1,1 of 40,0.27,2.5,0.3736,0.4161
GO:0051028,mRNA transport,Q3T0I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509),ALYREF,BP,1,1 of 40,0.27,2.5,0.3736,0.4161
GO:0042445,hormone metabolic process,E1BKK9(Evidence code:IEA/Database source:UniProtKB:Q8VHC3|ens),SELENOM,BP,1,1 of 40,0.27,2.5,0.3736,0.4161
GO:0051536,iron-sulfur cluster binding,E1BBX5(Evidence code:IEA/Database source:InterPro:IPR001041|I),AOX2,MF,1,1 of 40,0.27,2.5,0.3736,0.4161
GO:1903508,positive regulation of nucleic acid-templated transcription,Q5E9A1(Evidence code:IEA/Database source:GO:0003713),NACA,BP,1,1 of 255,0.27,0.39,0.3782,0.4209
GO:0005874,microtubule,Q3MHK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)O02675(Evidence code:ISS/Database source:UniProtKB:Q16555), KIF3A DPYSL2,CC,2,2 of 114,0.54,1.75,0.3796,0.4212
GO:0051606,detection of stimulus,Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens),CADM1,BP,1,1 of 41,0.27,2.44,0.3807,0.4212
GO:0034622,cellular protein-containing complex assembly,Q58DR2(Evidence code:ISS/Database source:UniProtKB:Q9NXW2),DNAJB12,BP,1,1 of 262,0.27,0.38,0.3787,0.4212
GO:0060326,cell chemotaxis,P35541(Evidence code:IBA/Database source:PANTHER:PTN000603423),SAA1,BP,1,1 of 41,0.27,2.44,0.3807,0.4212
GO:0005770,late endosome,P01131(Evidence code:ISS/Database source:UniProtKB:P01130),LDLR,CC,1,1 of 41,0.27,2.44,0.3807,0.4212
GO:0008016,regulation of heart contraction,P02639(Evidence code:IEA/Database source:InterPro:IPR028486),S100A1,BP,1,1 of 41,0.27,2.44,0.3807,0.4212
GO:0048589,developmental growth,A7MBG9(Evidence code:IEA/Database source:UniProtKB:Q9WUK2|ens),WBSCR1,BP,1,1 of 41,0.27,2.44,0.3807,0.4212
GO:0061630,ubiquitin protein ligase activity,A4IFN7(Evidence code:IEA/Database source:InterPro:IPR017134),UBE3A,MF,1,1 of 41,0.27,2.44,0.3807,0.4212
GO:0016323,basolateral plasma membrane,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,CC,1,1 of 41,0.27,2.44,0.3807,0.4212
GO:0000122,negative regulation of transcription by RNA polymerase II,P50291(Evidence code:IEA/Database source:UniProtKB:P19883|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens), FST SEMA4D,BP,2,2 of 115,0.54,1.74,0.3836,0.4239
GO:0006811,ion transport,P40682(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406),ATP6AP1,BP,1,1 of 278,0.27,0.36,0.3836,0.4239
GO:0002682,regulation of immune system process,Q5GN72(Evidence code:IEA/Database source:InterPro:IPR001500),agp,BP,1,1 of 279,0.27,0.36,0.3841,0.4241
GO:0003682,chromatin binding,Q1RMH9(Evidence code:ISS/Database source:UniProtKB:Q99543)Q58DC8(Evidence code:IEA/Database source:InterPro:IPR001025), DNAJC2 ORC1,MF,2,2 of 116,0.54,1.72,0.3876,0.4277
GO:0008360,regulation of cell shape,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 43,0.27,2.33,0.3947,0.4344
GO:0051262,protein tetramerization,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,BP,1,1 of 43,0.27,2.33,0.3947,0.4344
GO:0017157,regulation of exocytosis,Q0VC68(Evidence code:IEA/Database source:InterPro:IPR030647),SEPT5,BP,1,1 of 43,0.27,2.33,0.3947,0.4344
GO:0007218,neuropeptide signaling pathway,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens),SORT1,BP,1,1 of 43,0.27,2.33,0.3947,0.4344
GO:0000790,nuclear chromatin,F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens),SLX4,CC,1,1 of 44,0.27,2.27,0.4016,0.4405
GO:0030027,lamellipodium,P68138(Evidence code:ISS/Database source:UniProtKB:P08023),ACTA1,CC,1,1 of 44,0.27,2.27,0.4016,0.4405
GO:0007204,positive regulation of cytosolic calcium ion concentration,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 44,0.27,2.27,0.4016,0.4405
GO:0050900,leukocyte migration,P52176(Evidence code:IEA/Database source:InterPro:IPR028688),MMP9,BP,1,1 of 44,0.27,2.27,0.4016,0.4405
GO:0016485,protein processing,P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens),CTSL,BP,1,1 of 44,0.27,2.27,0.4016,0.4405
GO:0043065,positive regulation of apoptotic process,A4IF78(Evidence code:IEA/Database source:UniProtKB:O95379|ens)P80109(Evidence code:ISS/Database source:UniProtKB:P80108), TNFAIP8 GPLD1,BP,2,2 of 121,0.54,1.65,0.4074,0.4464
GO:0008217,regulation of blood pressure,A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000745637),ERAP2,BP,1,1 of 45,0.27,2.22,0.4083,0.4464
GO:0009116,nucleoside metabolic process,A5PJH9(Evidence code:IEA/Database source:InterPro:IPR000845|I),UPP1,BP,1,1 of 45,0.27,2.22,0.4083,0.4464
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 45,0.27,2.22,0.4083,0.4464
GO:0022625,cytosolic large ribosomal subunit,Q56JZ1(Evidence code:IBA/Database source:PANTHER:PTN000197497),RPL13,CC,1,1 of 45,0.27,2.22,0.4083,0.4464
GO:0042127,regulation of cell proliferation,A5D7R1(Evidence code:IBA/Database source:PANTHER:PTN000753849)E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens)A6QPW7(Evidence code:IBA/Database source:PANTHER:PTN000753849)E1BNP7(Evidence code:IBA/Database source:PANTHER:PTN000087637)Q08DN1(Evidence code:IBA/Database source:PANTHER:PTN000753849), TNFRSF11B SIX3 TNFRSF6B TFAP2D TNFRSF21,BP,5,5 of 309,1.35,1.62,0.4128,0.451
GO:0030054,cell junction,Q3ZC66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q28161(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1N7Q0(Evidence code:IEA/Database source:UniProtKB:Q8IY92|ens)F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)A6QQV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965), CRIPT PKP1 SLX4 PTPRK AFAP1L1,CC,5,5 of 315,1.35,1.59,0.4193,0.4578
GO:0010506,regulation of autophagy,A5PJS6(Evidence code:ISS/Database source:UniProtKB:Q14694),USP10,BP,1,1 of 47,0.27,2.13,0.4217,0.4598
GO:0043087,regulation of GTPase activity,Q3T086(Evidence code:IEA/Database source:InterPro:IPR037992),TRAPPC6A,BP,1,1 of 47,0.27,2.13,0.4217,0.4598
GO:0007389,pattern specification process,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 48,0.27,2.08,0.4282,0.4663
GO:0008654,phospholipid biosynthetic process,Q2TBM9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0594),SERAC1,BP,1,1 of 48,0.27,2.08,0.4282,0.4663
GO:0035091,phosphatidylinositol binding,F1MS60(Evidence code:IEA/Database source:InterPro:IPR036871),ARHGAP33,MF,1,1 of 49,0.27,2.04,0.4347,0.4728
GO:0007268,chemical synaptic transmission,P45478(Evidence code:IBA/Database source:PANTHER:PTN000133985),PPT1,BP,1,1 of 49,0.27,2.04,0.4347,0.4728
GO:0051015,actin filament binding,Q9TS87(Evidence code:IEA/Database source:InterPro:IPR029976),TAGLN,MF,1,1 of 50,0.27,2,0.4411,0.4794
GO:0005768,endosome,P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A5PJS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q28193(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967), LDLR USP10 FURIN,CC,3,3 of 165,0.81,1.82,0.4442,0.4825
GO:0045211,postsynaptic membrane,F1MD95(Evidence code:IEA/Database source:UniProtKB:Q9EPL2|ens),CLSTN1,CC,1,1 of 51,0.27,1.96,0.4475,0.4857
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,F1N780(Evidence code:IEA/Database source:UniProtKB:Q15375|ens),EPHA7,BP,1,1 of 52,0.27,1.92,0.4537,0.4918
GO:1901987,regulation of cell cycle phase transition,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,BP,1,1 of 52,0.27,1.92,0.4537,0.4918
GO:0007010,cytoskeleton organization,O02675(Evidence code:IEA/Database source:InterPro:IPR030615)F1MIX6(Evidence code:IEA/Database source:InterPro:IPR030717)Q3SYU6(Evidence code:IEA/Database source:InterPro:IPR029974), DPYSL2 DOCK1 CNN2,BP,3,3 of 174,0.81,1.72,0.4577,0.4958
GO:0031410,cytoplasmic vesicle,A5PKI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BLB8(Evidence code:IEA/Database source:UniProtKB:Q8C7U1|ens)P80929(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens)F1ML49(Evidence code:IEA/Database source:UniProtKB:Q8IZA0|ens)P25975(Evidence code:IEA/Database source:UniProtKB:P06797|ens), FAM3C N4BP3 ANG2 SORT1 KIAA0319L CTSL,CC,6,6 of 379,1.62,1.58,0.4596,0.4976
GO:0008514,organic anion transmembrane transporter activity,F1MIP7(Evidence code:IEA/Database source:InterPro:IPR030247),ABCC2,MF,1,1 of 53,0.27,1.89,0.4599,0.4976
GO:0005102,signaling receptor binding,Q2TBL2(Evidence code:IEA/Database source:UniProtKB:Q9BY67|ens)A5D7C8(Evidence code:IEA/Database source:UniProtKB:O09126|ens)O02659(Evidence code:IEA/Database source:UniProtKB:P11226|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q60994)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens), CADM1 SEMA4D MBL ADIPOQ FKBP1B CAT,MF,6,6 of 385,1.62,1.56,0.4632,0.5008
GO:0045892,"negative regulation of transcription, DNA-templated",F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens)E1BMT1(Evidence code:IEA/Database source:UniProtKB:O95343|ens)Q3Y5Z3(Evidence code:ISS/Database source:UniProtKB:Q15848), PTPRK SIX3 ADIPOQ,BP,3,3 of 178,0.81,1.69,0.4641,0.5015
GO:0036464,cytoplasmic ribonucleoprotein granule,F1ME65(Evidence code:IEA/Database source:UniProtKB:A0A024RBH2),CKAP4,CC,1,1 of 54,0.27,1.85,0.466,0.5032
GO:0016705,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",Q08DD0(Evidence code:IEA/Database source:InterPro:IPR001128|I),CYP46A1,MF,1,1 of 55,0.27,1.82,0.4721,0.5094
GO:0043066,negative regulation of apoptotic process,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)P45478(Evidence code:ISS/Database source:UniProtKB:P50897)F1MG91(Evidence code:IEA/Database source:InterPro:IPR015556), CAT PPT1 SERPINB2,BP,3,3 of 186,0.81,1.61,0.4777,0.5152
GO:0042277,peptide binding,A6QPT7(Evidence code:IBA/Database source:PANTHER:PTN000164249),ERAP2,MF,1,1 of 56,0.27,1.79,0.4781,0.5152
GO:0010975,regulation of neuron projection development,O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens),DPYSL2,BP,1,1 of 57,0.27,1.75,0.484,0.5202
GO:0051480,regulation of cytosolic calcium ion concentration,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens),FKBP1B,BP,1,1 of 57,0.27,1.75,0.484,0.5202
GO:0030141,secretory granule,A6QQ95(Evidence code:IBA/Database source:PANTHER:PTN001208501),KLK6,CC,1,1 of 57,0.27,1.75,0.484,0.5202
GO:0006959,humoral immune response,Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens),TNFRSF21,BP,1,1 of 57,0.27,1.75,0.484,0.5202
GO:0016055,Wnt signaling pathway,O19116(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879),SFRP1,BP,1,1 of 58,0.27,1.72,0.4898,0.5262
GO:0008202,steroid metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0753),LDLR,BP,1,1 of 59,0.27,1.69,0.4956,0.5307
GO:0022900,electron transport chain,E1BBX5(Evidence code:IEA/Database source:GO:0009055),AOX2,BP,1,1 of 59,0.27,1.69,0.4956,0.5307
GO:0051091,positive regulation of DNA-binding transcription factor activity,G3X823(Evidence code:IEA/Database source:UniProtKB:Q12899|ens),TRIM26,BP,1,1 of 59,0.27,1.69,0.4956,0.5307
GO:0032870,cellular response to hormone stimulus,F1MIP7(Evidence code:IBA/Database source:PANTHER:PTN002384111),ABCC2,BP,1,1 of 59,0.27,1.69,0.4956,0.5307
GO:0006650,glycerophospholipid metabolic process,Q2T9S4(Evidence code:ISS/Database source:UniProtKB:Q8CHP8),PGP,BP,1,1 of 59,0.27,1.69,0.4956,0.5307
GO:0070372,regulation of ERK1 and ERK2 cascade,F1N780(Evidence code:IEA/Database source:UniProtKB:Q15375|ens),EPHA7,BP,1,1 of 60,0.27,1.67,0.5013,0.5358
GO:0016324,apical plasma membrane,F1MIP7(Evidence code:IEA/Database source:UniProtKB:Q8VI47|ens),ABCC2,CC,1,1 of 60,0.27,1.67,0.5013,0.5358
GO:0009887,animal organ morphogenesis,Q3ZBZ6(Evidence code:IEA/Database source:UniProtKB:Q8CFZ4|ens),GPC3,BP,1,1 of 60,0.27,1.67,0.5013,0.5358
GO:0051607,defense response to virus,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q9BYX4|ens),IFIH1,BP,1,1 of 62,0.27,1.61,0.5126,0.5474
GO:0030855,epithelial cell differentiation,Q9TS87(Evidence code:IEA/Database source:UniProtKB:Q01995|ens),TAGLN,BP,1,1 of 63,0.27,1.59,0.5181,0.5526
GO:0030133,transport vesicle,Q0VC12(Evidence code:IEA/Database source:UniProtKB:Q9GZM5|ens),YIPF3,CC,1,1 of 63,0.27,1.59,0.5181,0.5526
GO:0005539,glycosaminoglycan binding,P21793(Evidence code:IEA/Database source:UniProtKB:P28654|ens),DCN,MF,1,1 of 64,0.27,1.56,0.5235,0.557
GO:0051276,chromosome organization,F6RF21(Evidence code:IEA/Database source:InterPro:IPR010935|I),SMCHD1,BP,1,1 of 64,0.27,1.56,0.5235,0.557
GO:0030036,actin cytoskeleton organization,O19116(Evidence code:IDA/Database source:),SFRP1,BP,1,1 of 64,0.27,1.56,0.5235,0.557
GO:0005261,cation channel activity,Q17QV5(Evidence code:IEA/Database source:InterPro:IPR029588),TRPM3,MF,1,1 of 64,0.27,1.56,0.5235,0.557
GO:0009653,anatomical structure morphogenesis,E1B969(Evidence code:IEA/Database source:UniProtKB:E9PVD3|ens),DCHS1,BP,1,1 of 217,0.27,0.46,0.5257,0.5586
GO:0006259,DNA metabolic process,F1N1D2(Evidence code:IEA/Database source:InterPro:IPR020587),DMC1,BP,1,1 of 217,0.27,0.46,0.5257,0.5586
GO:0051248,negative regulation of protein metabolic process,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens),LDLR,BP,1,1 of 225,0.27,0.44,0.5266,0.5592
GO:0006913,nucleocytoplasmic transport,P51122(Evidence code:ISS/Database source:UniProtKB:P39687),ANP32A,BP,1,1 of 65,0.27,1.54,0.5289,0.5613
GO:0016772,"transferase activity, transferring phosphorus-containing groups",Q9XSC6(Evidence code:IEA/Database source:InterPro:IPR000749|I),CKM,MF,1,1 of 236,0.27,0.42,0.53,0.562
GO:0008092,cytoskeletal protein binding,E1BF59(Evidence code:IEA/Database source:InterPro:IPR030269),PLEC,MF,1,1 of 238,0.27,0.42,0.5308,0.5626
GO:0044877,protein-containing complex binding,Q3ZC66(Evidence code:ISS/Database source:UniProtKB:Q792Q4),CRIPT,MF,1,1 of 243,0.27,0.41,0.5332,0.5648
GO:0006935,chemotaxis,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881),ENPP2,BP,1,1 of 66,0.27,1.52,0.5343,0.5655
GO:0006396,RNA processing,P10881(Evidence code:IEA/Database source:InterPro:IPR002344),SSB,BP,1,1 of 246,0.27,0.41,0.5349,0.5659
GO:0044297,cell body,P68138(Evidence code:ISS/Database source:UniProtKB:P08023),ACTA1,CC,1,1 of 68,0.27,1.47,0.5448,0.5752
GO:0071407,cellular response to organic cyclic compound,Q05717(Evidence code:IEA/Database source:UniProtKB:P24593|ens),IGFBP5,BP,1,1 of 68,0.27,1.47,0.5448,0.5752
GO:0006399,tRNA metabolic process,Q2T9V8(Evidence code:IBA/Database source:PANTHER:PTN000049487),DTD1,BP,1,1 of 68,0.27,1.47,0.5448,0.5752
GO:0048193,Golgi vesicle transport,Q3T086(Evidence code:IEA/Database source:InterPro:IPR037992),TRAPPC6A,BP,1,1 of 69,0.27,1.45,0.5499,0.5803
GO:0070085,glycosylation,Q1ZYR0(Evidence code:ISS/Database source:UniProtKB:O75503),CLN5,BP,1,1 of 70,0.27,1.43,0.555,0.5849
GO:0005667,transcription factor complex,E1BNP7(Evidence code:IEA/Database source:UniProtKB:Q91ZK0|ens),TFAP2D,CC,1,1 of 70,0.27,1.43,0.555,0.5849
GO:0016192,vesicle-mediated transport,Q3T086(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)Q0VC16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)Q2TBU3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)A7MAZ2(Evidence code:IEA/Database source:InterPro:IPR010989), TRAPPC6A MIA3 GOSR1 STX12,BP,4,4 of 277,1.08,1.44,0.5652,0.5952
GO:0005929,cilium,F1MX00(Evidence code:IEA/Database source:InterPro:IPR038844),CFAP157,CC,1,1 of 73,0.27,1.37,0.57,0.5999
GO:0051656,establishment of organelle localization,P40682(Evidence code:IEA/Database source:UniProtKB:Q9R1Q9|ens),ATP6AP1,BP,1,1 of 74,0.27,1.35,0.5748,0.6039
GO:0015711,organic anion transport,F1MIP7(Evidence code:IEA/Database source:GO:0008514),ABCC2,BP,1,1 of 74,0.27,1.35,0.5748,0.6039
GO:0045664,regulation of neuron differentiation,O02675(Evidence code:IEA/Database source:InterPro:IPR030615),DPYSL2,BP,1,1 of 74,0.27,1.35,0.5748,0.6039
GO:0016050,vesicle organization,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens),SORT1,BP,1,1 of 75,0.27,1.33,0.5797,0.6086
GO:0004866,endopeptidase inhibitor activity,E1B805(Evidence code:IEA/Database source:InterPro:IPR001599|I),LOC528040,MF,1,1 of 76,0.27,1.32,0.5844,0.6124
GO:0005681,spliceosomal complex,Q3T0I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747),ALYREF,CC,1,1 of 76,0.27,1.32,0.5844,0.6124
GO:0022407,regulation of cell-cell adhesion,F1N780(Evidence code:IEA/Database source:UniProtKB:Q61772|ens),EPHA7,BP,1,1 of 76,0.27,1.32,0.5844,0.6124
GO:0000977,RNA polymerase II regulatory region sequence-specific DNA binding,E1BNP7(Evidence code:IEA/Database source:UniProtKB:Q91ZK0|ens),TFAP2D,MF,1,1 of 77,0.27,1.3,0.5891,0.6169
GO:0022857,transmembrane transporter activity,F1MIP7(Evidence code:IEA/Database source:InterPro:IPR005292)G5E626(Evidence code:IEA/Database source:InterPro:IPR005292), ABCC2 ABCC6,MF,2,2 of 311,0.54,0.64,0.5917,0.6192
GO:0007276,gamete generation,F1N1D2(Evidence code:IEA/Database source:UniProtKB:Q61880|ens),DMC1,BP,1,1 of 79,0.27,1.27,0.5984,0.6258
GO:0050708,regulation of protein secretion,A6QQQ9(Evidence code:ISS/Database source:UniProtKB:Q9D312),KRT20,BP,1,1 of 80,0.27,1.25,0.6029,0.6294
GO:0009615,response to virus,E1BJZ0(Evidence code:IEA/Database source:UniProtKB:Q8R5F7|ens),IFIH1,BP,1,1 of 80,0.27,1.25,0.6029,0.6294
GO:0019216,regulation of lipid metabolic process,E1BLA8(Evidence code:IEA/Database source:UniProtKB:Q91XA2|ens),GOLM1,BP,1,1 of 80,0.27,1.25,0.6029,0.6294
GO:0004842,ubiquitin-protein transferase activity,A4IFN7(Evidence code:IEA/Database source:InterPro:IPR000569|I),UBE3A,MF,1,1 of 81,0.27,1.23,0.6074,0.6337
GO:0031625,ubiquitin protein ligase binding,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens),PRKAR1A,MF,1,1 of 83,0.27,1.2,0.6163,0.6425
GO:0016746,"transferase activity, transferring acyl groups",Q2KIW4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0012),LCAT,MF,1,1 of 85,0.27,1.18,0.6249,0.6507
GO:0034097,response to cytokine,P16368(Evidence code:IBA/Database source:PANTHER:PTN000931946),TIMP2,BP,1,1 of 85,0.27,1.18,0.6249,0.6507
GO:0051047,positive regulation of secretion,P80109(Evidence code:ISS/Database source:UniProtKB:O70362),GPLD1,BP,1,1 of 86,0.27,1.16,0.6292,0.6543
GO:0006631,fatty acid metabolic process,F1MYJ3(Evidence code:IEA/Database source:UniProtKB:P36269|ens),GGT5,BP,1,1 of 86,0.27,1.16,0.6292,0.6543
GO:0006511,ubiquitin-dependent protein catabolic process,A4IFN7(Evidence code:IEA/Database source:InterPro:IPR017134)A5PJS6(Evidence code:IEA/Database source:InterPro:IPR018200), UBE3A USP10,BP,2,2 of 122,0.54,1.64,0.6538,0.6796
GO:0008283,cell proliferation,E1BPW0(Evidence code:ISS/Database source:UniProtKB:Q9WUZ9)P55906(Evidence code:IEA/Database source:InterPro:IPR032954), ENTPD5 TGFBI,BP,2,2 of 124,0.54,1.61,0.6562,0.6816
GO:0051301,cell division,Q0VC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)A6QNQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132), SEPT5 RBBP8,BP,2,2 of 126,0.54,1.59,0.6586,0.6837
GO:0043086,negative regulation of catalytic activity,P16368(Evidence code:IBA/Database source:PANTHER:PTN000931945)F1MW38(Evidence code:IEA/Database source:GO:0004857), TIMP2 CRIM1,BP,2,2 of 137,0.54,1.46,0.6729,0.6981
GO:0003735,structural constituent of ribosome,Q56JZ1(Evidence code:IEA/Database source:InterPro:IPR001380|I)P63048(Evidence code:IEA/Database source:InterPro:IPR001975), RPL13 UBA52,MF,2,2 of 138,0.54,1.45,0.6743,0.6991
GO:0004175,endopeptidase activity,Q0V8B6(Evidence code:ISS/Database source:UniProtKB:O14773)P00741(Evidence code:ISS/Database source:UniProtKB:P00740), TPP1 F9,MF,2,2 of 139,0.54,1.44,0.6757,0.7001
GO:0019904,protein domain specific binding,P00514(Evidence code:IEA/Database source:UniProtKB:P10644|ens)E1BMK9(Evidence code:IEA/Database source:UniProtKB:Q9NXG0|ens), PRKAR1A CNTLN,MF,2,2 of 145,0.54,1.38,0.6843,0.7085
GO:0006325,chromatin organization,E1BCN3(Evidence code:IEA/Database source:UniProtKB:Q9Z183|ens)Q1RMH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156), PADI4 DNAJC2,BP,2,2 of 148,0.54,1.35,0.6887,0.7126
GO:0005815,microtubule organizing center,Q27965(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4IFD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6K8|ens), HSPA1B Ak5,CC,2,2 of 164,0.54,1.22,0.7129,0.7368
GO:0008284,positive regulation of cell proliferation,A5D7V3(Evidence code:IEA/Database source:UniProtKB:Q9NQ30|ens)A6QL48(Evidence code:IEA/Database source:InterPro:IPR020415), ESM1 IL34,BP,2,2 of 164,0.54,1.22,0.7129,0.7368
GO:0005525,GTP binding,A6QQK5(Evidence code:IEA/Database source:InterPro:IPR005129)Q0VC68(Evidence code:IEA/Database source:InterPro:IPR016491|I), MMAA SEPT5,MF,2,2 of 165,0.54,1.21,0.7144,0.7379
GO:1903507,negative regulation of nucleic acid-templated transcription,A6QNQ6(Evidence code:IEA/Database source:GO:0003714),RBBP8,BP,1,1 of 180,0.27,0.56,0.7272,0.7507
GO:0006886,intracellular protein transport,A7MAZ2(Evidence code:IEA/Database source:InterPro:IPR006012),STX12,BP,1,1 of 196,0.27,0.51,0.7304,0.7535
GO:0060548,negative regulation of cell death,O18739(Evidence code:IBA/Database source:PANTHER:PTN000142748),CTGF,BP,1,1 of 202,0.27,0.5,0.7325,0.7552
GO:0032880,regulation of protein localization,E1BLN1(Evidence code:IEA/Database source:UniProtKB:Q62209|ens),SYCP1,BP,1,1 of 211,0.27,0.47,0.7365,0.7589
GO:0045893,"positive regulation of transcription, DNA-templated",F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens)E1BNP7(Evidence code:IEA/Database source:UniProtKB:Q91ZK0|ens)Q1RMH9(Evidence code:ISS/Database source:UniProtKB:Q99543), RET TFAP2D DNAJC2,BP,3,3 of 255,0.81,1.18,0.7693,0.7922
GO:0010628,positive regulation of gene expression,P68138(Evidence code:ISS/Database source:UniProtKB:P08023)P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)F1MS00(Evidence code:IEA/Database source:UniProtKB:P35546|ens)A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens), ACTA1 LDLR RET EIF2AK3,BP,4,4 of 331,1.08,1.21,0.7938,0.8169
GO:0006357,regulation of transcription by RNA polymerase II,E1BDZ8(Evidence code:IEA/Database source:InterPro:IPR024943)A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q61508|ens)A4Z945(Evidence code:IEA/Database source:GO:0000981)E1BN90(Evidence code:IEA/Database source:GO:0000981), EPC2 ECM1 ZBED8 ZKSCAN2,BP,4,4 of 336,1.08,1.19,0.7964,0.819
GO:0019899,enzyme binding,A4FUZ9(Evidence code:IEA/Database source:UniProtKB:Q6Q788|ens)A5D791(Evidence code:IEA/Database source:UniProtKB:Q9NZJ5|ens)A5PJT7(Evidence code:IEA/Database source:UniProtKB:Q16610|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q99523|ens), APOA5 EIF2AK3 ECM1 CAT SORT1,MF,5,5 of 405,1.35,1.23,0.8119,0.8345
GO:0010629,negative regulation of gene expression,P01131(Evidence code:IEA/Database source:UniProtKB:P35951|ens)O18739(Evidence code:IEA/Database source:UniProtKB:P29268|ens)E1BIR5(Evidence code:IEA/Database source:UniProtKB:O75339|ens), LDLR CTGF CILP,BP,3,3 of 281,0.81,1.07,1,1
GO:0007166,cell surface receptor signaling pathway,E1BEC6(Evidence code:IEA/Database source:InterPro:IPR017981)A2VDS6(Evidence code:IEA/Database source:InterPro:IPR017981)F1MJV6(Evidence code:IEA/Database source:InterPro:IPR017981), ADGRF1 VIPR1 ADGRG6,BP,3,3 of 344,0.81,0.87,1,1
GO:0042995,cell projection,A6QQV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q3ZC66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q8SQ24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966), AFAP1L1 CRIPT MYOZ1,CC,3,3 of 317,0.81,0.95,1,1
GO:0055085,transmembrane transport,G5E626(Evidence code:IEA/Database source:InterPro:IPR005292|I)F1MIP7(Evidence code:IEA/Database source:InterPro:IPR005292|I), ABCC6 ABCC2,BP,2,2 of 183,0.54,1.09,1,1
GO:0031226,intrinsic component of plasma membrane,F1MYJ3(Evidence code:IEA/Database source:UniProtKB:P36269|ens)Q08DN1(Evidence code:IEA/Database source:UniProtKB:Q9EPU5|ens), GGT5 TNFRSF21,CC,2,2 of 226,0.54,0.88,1,1
GO:0016788,"hydrolase activity, acting on ester bonds",P46446(Evidence code:IEA/Database source:InterPro:IPR007036)A6H713(Evidence code:IEA/Database source:InterPro:IPR025483), ASPA LIPA,MF,2,2 of 240,0.54,0.83,1,1
GO:0043085,positive regulation of catalytic activity,E1BI28(Evidence code:IEA/Database source:GO:0008047)F1N7Q0(Evidence code:IEA/Database source:GO:0008047), GM2A SLX4,BP,2,2 of 229,0.54,0.87,1,1
GO:0007346,regulation of mitotic cell cycle,E1B902(Evidence code:IBA/Database source:PANTHER:PTN000684825),MAP4K2,BP,1,1 of 111,0.27,0.9,1,1
GO:0016604,nuclear body,F1MXK2(Evidence code:IEA/Database source:UniProtKB:Q7Z417|ens),NUFIP2,CC,1,1 of 171,0.27,0.58,1,1
GO:0030030,cell projection organization,F1MRZ8(Evidence code:IEA/Database source:UniProtKB:P08567|ens),PLEK,BP,1,1 of 164,0.27,0.61,1,1
GO:0051186,cofactor metabolic process,P45478(Evidence code:ISS/Database source:UniProtKB:P50897),PPT1,BP,1,1 of 123,0.27,0.81,1,1
GO:0008134,transcription factor binding,Q3SZL4(Evidence code:ISS/Database source:UniProtKB:O60934),NBN,MF,1,1 of 98,0.27,1.02,1,1
GO:0009725,response to hormone,P16368(Evidence code:IBA/Database source:PANTHER:PTN000931946),TIMP2,BP,1,1 of 96,0.27,1.04,1,1
GO:0045597,positive regulation of cell differentiation,O18739(Evidence code:IEA/Database source:UniProtKB:P29279|ens),CTGF,BP,1,1 of 167,0.27,0.6,1,1
GO:0030659,cytoplasmic vesicle membrane,E1BKZ9(Evidence code:IEA/Database source:UniProtKB:Q6PHU5|ens),SORT1,CC,1,1 of 126,0.27,0.79,1,1
GO:0003924,GTPase activity,A6QQK5(Evidence code:IEA/Database source:InterPro:IPR005129),MMAA,MF,1,1 of 111,0.27,0.9,1,1
GO:0098655,cation transmembrane transport,Q17QV5(Evidence code:IEA/Database source:GO:0005261),TRPM3,BP,1,1 of 109,0.27,0.92,1,1
GO:0006397,mRNA processing,Q3T0I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507),ALYREF,BP,1,1 of 123,0.27,0.81,1,1
GO:0030334,regulation of cell migration,A1A4K5(Evidence code:IEA/Database source:InterPro:IPR029881),ENPP2,BP,1,1 of 160,0.27,0.62,1,1
GO:0034220,ion transmembrane transport,Q17QV5(Evidence code:IEA/Database source:InterPro:IPR029588),TRPM3,BP,1,1 of 139,0.27,0.72,1,1
GO:0043005,neuron projection,E1BPC9(Evidence code:IEA/Database source:UniProtKB:Q61330|ens),CNTN2,CC,1,1 of 154,0.27,0.65,1,1
GO:0008380,RNA splicing,Q3T0I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508),ALYREF,BP,1,1 of 106,0.27,0.94,1,1
GO:0003690,double-stranded DNA binding,F1N1D2(Evidence code:IBA/Database source:PANTHER:PTN001415033),DMC1,MF,1,1 of 123,0.27,0.81,1,1
GO:0005773,vacuole,A7YWG4(Evidence code:IBA/Database source:PANTHER:PTN000140059),GGH,CC,1,1 of 109,0.27,0.92,1,1
GO:0048468,cell development,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063),BMP3,BP,1,1 of 139,0.27,0.72,1,1
GO:0043408,regulation of MAPK cascade,P22444(Evidence code:IBA/Database source:PANTHER:PTN000218063),BMP3,BP,1,1 of 152,0.27,0.66,1,1
GO:0045786,negative regulation of cell cycle,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,BP,1,1 of 90,0.27,1.11,1,1
GO:0000976,transcription regulatory region sequence-specific DNA binding,F1N685(Evidence code:IBA/Database source:PANTHER:PTN000284569),JMJD1C,MF,1,1 of 93,0.27,1.08,1,1
GO:0030155,regulation of cell adhesion,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 121,0.27,0.83,1,1
GO:0046982,protein heterodimerization activity,Q2M2T1(Evidence code:IEA/Database source:InterPro:IPR009072),HIST1H2BK,MF,1,1 of 103,0.27,0.97,1,1
GO:0006520,cellular amino acid metabolic process,F1MYJ3(Evidence code:IEA/Database source:UniProtKB:P36269|ens),GGT5,BP,1,1 of 118,0.27,0.85,1,1
GO:0016567,protein ubiquitination,A4IFN7(Evidence code:IEA/Database source:UniProtKB:O08759|ens),UBE3A,BP,1,1 of 137,0.27,0.73,1,1
GO:0005759,mitochondrial matrix,Q05JF3(Evidence code:IEA/Database source:UniProtKB:O09165|ens),casq1,CC,1,1 of 111,0.27,0.9,1,1
GO:0006091,generation of precursor metabolites and energy,F1MNS5(Evidence code:IEA/Database source:UniProtKB:P22413|ens),ENPP1,BP,1,1 of 120,0.27,0.83,1,1
GO:0033365,protein localization to organelle,E1BMK9(Evidence code:IEA/Database source:UniProtKB:Q9NXG0|ens),CNTLN,BP,1,1 of 134,0.27,0.75,1,1
GO:0006457,protein folding,A5PJN2(Evidence code:IEA/Database source:UniProtKB:Q8R180|ens),ERO1A ,BP,1,1 of 97,0.27,1.03,1,1
GO:0005911,cell-cell junction,F1MME1(Evidence code:IEA/Database source:UniProtKB:Q15262|ens),PTPRK,CC,1,1 of 88,0.27,1.14,1,1
GO:0050877,nervous system process,E1BI28(Evidence code:IEA/Database source:UniProtKB:Q60648|ens),GM2A,BP,1,1 of 155,0.27,0.65,1,1
GO:0031344,regulation of cell projection organization,A5D7C8(Evidence code:IEA/Database source:UniProtKB:Q92854|ens),SEMA4D,BP,1,1 of 99,0.27,1.01,1,1
GO:0043410,positive regulation of MAPK cascade,F1MS00(Evidence code:IEA/Database source:UniProtKB:P07949|ens),RET,BP,1,1 of 102,0.27,0.98,1,1
GO:0016773,"phosphotransferase activity, alcohol group as acceptor",Q1JPE3(Evidence code:IEA/Database source:InterPro:IPR018484),CARKL,MF,1,1 of 146,0.27,0.68,1,1
GO:0050839,cell adhesion molecule binding,Q2TBL2(Evidence code:IBA/Database source:PANTHER:PTN000589024),CADM1,MF,1,1 of 89,0.27,1.12,1,1
GO:0043565,sequence-specific DNA binding,E1BMT1(Evidence code:IEA/Database source:UniProtKB:Q62233|ens),SIX3,MF,1,1 of 173,0.27,0.58,1,1
GO:0006413,translational initiation,Q2YDE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396),EIF4G3,BP,1,1 of 101,0.27,0.99,1,1
GO:0009888,tissue development,Q9MYM4(Evidence code:IEA/Database source:UniProtKB:P70699|ens),GAA,BP,1,1 of 96,0.27,1.04,1,1
